CYP3A4 Human (+)-artemisinin increases expression EXP 6480464 artemisinin results in increased expression of CYP3A4 mRNA CTD PMID:15761118|PMID:18332078 CYP3A4 Human (+)-artemisinin affects metabolic processing EXP 6480464 CYP3A4 protein affects the metabolism of artemisinin CTD PMID:12920490 CYP3A4 Human (+)-artemisinin multiple interactions EXP 6480464 [artemisinin results in increased activity of NR1I2 protein] which results in increased expression of CYP3A4 more ... CTD PMID:17041008 CYP3A4 Human (+)-schisandrin B increases expression EXP 6480464 schizandrin B results in increased expression of CYP3A4 mRNA CTD PMID:16267138 CYP3A4 Human (+)-Tetrandrine increases glutathionylation EXP 6480464 CYP3A4 protein results in increased glutathionylation of tetrandrine CTD PMID:21992520 CYP3A4 Human (+)-trans-(S)-allethrin increases metabolic processing EXP 6480464 CYP3A4 protein results in increased metabolism of bioallethrin CTD PMID:19249324 CYP3A4 Human (+)-trans-(S)-allethrin increases expression EXP 6480464 bioallethrin results in increased expression of CYP3A4 mRNA CTD PMID:19249324 CYP3A4 Human (-)-epigallocatechin 3-gallate multiple interactions EXP 6480464 [epigallocatechin gallate co-treated with leptomycin B] results in increased expression of CYP3A4 mRNA CTD PMID:25922640 CYP3A4 Human (-)-trans-epsilon-viniferin decreases activity EXP 6480464 epsilon-viniferin results in decreased activity of CYP3A4 protein CTD PMID:12818727 CYP3A4 Human (24S)-24-hydroxycholesterol multiple interactions EXP 6480464 [24-hydroxycholesterol co-treated with NR1H3 protein] results in increased expression of CYP3A4 mRNA CTD PMID:23732298 CYP3A4 Human (3-phenoxyphenyl)methanol increases abundance EXP 6480464 CYP3A4 protein results in increased abundance of 3-phenoxybenzylalcohol CTD PMID:24548679 CYP3A4 Human (E)-roxithromycin multiple interactions EXP 6480464 Roxithromycin inhibits the reaction [CYP3A4 protein results in increased hydroxylation of Testosterone] CTD PMID:16416302 CYP3A4 Human (E)-roxithromycin decreases activity EXP 6480464 Roxithromycin results in decreased activity of CYP3A4 protein CTD PMID:16416302|PMID:17164692 CYP3A4 Human (E)-roxithromycin decreases expression EXP 6480464 Roxithromycin results in decreased expression of CYP3A4 mRNA CTD PMID:16837568 CYP3A4 Human (E)-thiamethoxam multiple interactions EXP 6480464 [NADP co-treated with CYP3A4 protein] results in increased activity of Thiamethoxam CTD PMID:16153789 CYP3A4 Human (E,E)-germacrone decreases activity EXP 6480464 germacrone results in decreased activity of CYP3A4 protein CTD PMID:23850985 CYP3A4 Human (E,E)-germacrone increases expression EXP 6480464 germacrone results in increased expression of CYP3A4 mRNA CTD PMID:23850985 CYP3A4 Human (R)-lipoic acid multiple interactions EXP 6480464 Thioctic Acid inhibits the reaction [[NADP co-treated with CYP1A2 protein co-treated with CYP2C8 protein co-treated more ... CTD PMID:24120545 CYP3A4 Human (R,R,R)-alpha-tocopherol multiple interactions EXP 6480464 alpha-Tocopherol inhibits the reaction [CYP3A4 protein results in increased hydroxylation of Testosterone]; alpha-Tocopherol inhibits the more ... CTD PMID:17936189|PMID:31102695 CYP3A4 Human (R,R,R)-alpha-tocopherol multiple interactions ISO Cyp3a2 (Rattus norvegicus) 6480464 [Methionine co-treated with Thiamine co-treated with Niacinamide co-treated with alpha-Tocopherol co-treated with Zinc] inhibits the more ... CTD PMID:27919644 CYP3A4 Human (R,R,R)-alpha-tocopherol increases expression EXP 6480464 alpha-Tocopherol results in increased expression of CYP3A4 mRNA CTD PMID:17936189 CYP3A4 Human (S)-colchicine affects metabolic processing EXP 6480464 CYP3A4 protein affects the metabolism of Colchicine CTD PMID:15914514|PMID:16007523 CYP3A4 Human (S)-naringenin decreases activity EXP 6480464 naringenin results in decreased activity of CYP3A4 protein CTD PMID:21053930|PMID:29753067 CYP3A4 Human (S)-naringenin increases expression EXP 6480464 naringenin results in increased expression of CYP3A4 mRNA CTD PMID:19148864 CYP3A4 Human (S)-nicotine multiple interactions EXP 6480464 [Nicotine binds to CYP3A4 promoter] which results in increased expression of CYP3A4 mRNA CTD PMID:12851153 CYP3A4 Human (S)-nicotine multiple interactions ISO Cyp3a2 (Rattus norvegicus) 6480464 [Nicotine co-treated with 2,2',3,5',6-pentachlorobiphenyl] results in increased expression of CYP3A2 mRNA CTD PMID:26463278 CYP3A4 Human (Z)-ligustilide multiple interactions EXP 6480464 [ligustilide results in increased activity of NR1I2 protein] which results in increased expression of CYP3A4 more ... CTD PMID:21524698 CYP3A4 Human 1,1,1-Trichloro-2-(4-hydroxyphenyl)-2-(4-methoxyphenyl)ethane increases hydroxylation EXP 6480464 CYP3A4 protein results in increased hydroxylation of 1,1,1-trichloro-2-(4-hydroxyphenyl)-2-(4-methoxyphenyl)ethane CTD PMID:12167570|PMID:9047321|PMID:9714305 CYP3A4 Human 1,1,1-Trichloro-2-(o-chlorophenyl)-2-(p-chlorophenyl)ethane increases expression EXP 6480464 o,p'-DDT results in increased expression of CYP3A4 mRNA; o,p'-DDT results in increased expression of CYP3A4 more ... CTD PMID:15548381|PMID:15795092|PMID:17035600|PMID:21924250 CYP3A4 Human 1,1,1-Trichloro-2-(o-chlorophenyl)-2-(p-chlorophenyl)ethane affects expression ISO Cyp3a2 (Rattus norvegicus) 6480464 o,p'-DDT affects the expression of CYP3A2 mRNA CTD PMID:17984292 CYP3A4 Human 1,1,1-Trichloro-2-(o-chlorophenyl)-2-(p-chlorophenyl)ethane multiple interactions EXP 6480464 Dactinomycin inhibits the reaction [o,p'-DDT results in increased expression of CYP3A4 mRNA] CTD PMID:15795092 CYP3A4 Human 1,1,1-Trichloro-2-(o-chlorophenyl)-2-(p-chlorophenyl)ethane increases activity EXP 6480464 o,p'-DDT results in increased activity of CYP3A4 protein CTD PMID:17035600 CYP3A4 Human 1,2,3,5-tetrachlorobenzene increases oxidation EXP 6480464 CYP3A4 protein results in increased oxidation of 1,2,3,5-tetrachlorobenzene CTD PMID:7747284 CYP3A4 Human 1,2-dichloroethene decreases activity ISO Cyp3a2 (Rattus norvegicus) 6480464 1,2-dichloroethylene results in decreased activity of CYP3A2 protein CTD PMID:9493318 CYP3A4 Human 1,2-dichloroethene decreases expression ISO Cyp3a2 (Rattus norvegicus) 6480464 1,2-dichloroethylene results in decreased expression of CYP3A2 protein CTD PMID:9493318 CYP3A4 Human 1,2-dilauroyl-sn-glycero-3-phosphocholine(1+) multiple interactions EXP 6480464 [1,2-dilauroylphosphatidylcholine co-treated with 1,2-oleoylphosphatidylcholine co-treated with Phosphatidylserines co-treated with Sodium Cholate] results in increased activity more ... CTD PMID:1627548 CYP3A4 Human 1,2-dilauroyl-sn-glycero-3-phosphocholine(1+) multiple interactions ISO Cyp3a2 (Rattus norvegicus) 6480464 [1,2-dilauroylphosphatidylcholine co-treated with 1,2-oleoylphosphatidylcholine co-treated with Phosphatidylserines co-treated with Sodium Cholate] results in increased activity more ... CTD PMID:1627548 CYP3A4 Human 1,4-dichlorobenzene increases oxidation EXP 6480464 CYP3A4 protein results in increased oxidation of 4-dichlorobenzene CTD PMID:9817075 CYP3A4 Human 1,4-naphthoquinone increases expression EXP 6480464 1,4-naphthoquinone results in increased expression of CYP3A4 mRNA CTD PMID:18602459 CYP3A4 Human 1,4-naphthoquinone increases abundance EXP 6480464 CYP3A4 protein results in increased abundance of 1,4-naphthoquinone CTD PMID:16243959 CYP3A4 Human 1,6-Dinitropyrene affects metabolic processing EXP 6480464 CYP3A4 protein affects the metabolism of 1,6-dinitropyrene CTD PMID:2180560 CYP3A4 Human 1,8-cineole multiple interactions EXP 6480464 Eucalyptol inhibits the reaction [CYP3A4 protein results in increased hydroxylation of Midazolam] CTD PMID:18385293 CYP3A4 Human 1,8-cineole increases hydroxylation EXP 6480464 CYP3A4 protein results in increased hydroxylation of Eucalyptol CTD PMID:15715982 CYP3A4 Human 1-(1,3-benzodioxol-5-yl)-4,4-dimethyl-1-penten-3-ol decreases activity EXP 6480464 stiripentol results in decreased activity of CYP3A4 protein CTD PMID:16022579 CYP3A4 Human 1-(3-chlorophenyl)piperazine multiple interactions EXP 6480464 1-(3-chlorophenyl)piperazine promotes the reaction [NR1I2 protein results in increased expression of CYP3A4 mRNA]; N-Methyl-3,4-methylenedioxyamphetamine inhibits more ... CTD PMID:21402137 CYP3A4 Human 1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-1,3-dihydro-2-benzofuran-5-carbonitrile decreases methylation EXP 6480464 CYP3A4 protein results in decreased methylation of Citalopram analog CTD PMID:9110356 CYP3A4 Human 1-\{2-[(4-chlorobenzyl)sulfanyl]-2-(2,4-dichlorophenyl)ethyl\}-1H-imidazole increases expression EXP 6480464 sulconazole results in increased expression of CYP3A4 mRNA CTD PMID:31312845 CYP3A4 Human 1-\{2-[(4-chlorobenzyl)sulfanyl]-2-(2,4-dichlorophenyl)ethyl\}-1H-imidazole multiple interactions EXP 6480464 [sulconazole results in increased activity of NR1I2 protein] which results in increased expression of CYP3A4 more ... CTD PMID:31312845 CYP3A4 Human 1-aminobenzotriazole decreases activity EXP 6480464 1-aminobenzotriazole results in decreased activity of CYP3A4 protein CTD PMID:11375247 CYP3A4 Human 1-hydroxymidazolam increases abundance EXP 6480464 CYP3A4 protein results in increased abundance of 1-hydroxymethylmidazolam CTD PMID:12695342 CYP3A4 Human 1-hydroxymidazolam increases glucuronidation EXP 6480464 CYP3A4 protein results in increased glucuronidation of 1-hydroxymethylmidazolam CTD PMID:27485346 CYP3A4 Human 1-hydroxymidazolam multiple interactions EXP 6480464 [[3-hydroxyflavone results in increased activity of CYP3A4 protein] which results in increased metabolism of Midazolam] more ... CTD PMID:10997946|PMID:12695342|PMID:18191104|PMID:20233841|PMID:21053930|PMID:21915887|PMID:27485346|PMID:30087611|PMID:31756459|PMID:34189909 CYP3A4 Human 1-hydroxymidazolam increases chemical synthesis EXP 6480464 CYP3A4 protein results in increased chemical synthesis of 1-hydroxymethylmidazolam CTD PMID:12401345|PMID:12695342|PMID:18191104|PMID:20233841|PMID:21915887|PMID:23850985|PMID:26958860|PMID:30087611 CYP3A4 Human 1-hydroxymidazolam beta-D-glucuronide multiple interactions EXP 6480464 [CYP3A4 protein results in increased glucuronidation of 1-hydroxymethylmidazolam] which results in increased abundance of 1-hydroxymethylmidazolam more ... CTD PMID:27485346 CYP3A4 Human 1-naphthol increases abundance EXP 6480464 CYP3A4 protein results in increased abundance of 1-naphthol CTD PMID:16243959 CYP3A4 Human 1-naphthyl isothiocyanate multiple interactions ISO Cyp3a2 (Rattus norvegicus) 6480464 ginsenoside Rg1 inhibits the reaction [1-Naphthylisothiocyanate results in increased expression of CYP3A4 mRNA]; ginsenoside Rg1 more ... CTD PMID:32198087 CYP3A4 Human 1-naphthyl isothiocyanate decreases expression ISO Cyp3a2 (Rattus norvegicus) 6480464 1-Naphthylisothiocyanate results in decreased expression of CYP3A2 mRNA CTD PMID:26365562|PMID:30723492 CYP3A4 Human 1-naphthyl isothiocyanate increases expression ISO Cyp3a2 (Rattus norvegicus) 6480464 1-Naphthylisothiocyanate results in increased expression of CYP3A4 mRNA; 1-Naphthylisothiocyanate results in increased expression of CYP3A4 more ... CTD PMID:32198087 CYP3A4 Human 13-cis-retinal increases activity EXP 6480464 13-cis-retinal results in increased activity of CYP3A4 protein CTD PMID:16632523 CYP3A4 Human 13-cis-retinal multiple interactions EXP 6480464 13-cis-retinal promotes the reaction [[RXRA protein binds to NR1I2 protein] which results in increased expression more ... CTD PMID:16632523 CYP3A4 Human 14,15-EET multiple interactions EXP 6480464 Ketoconazole inhibits the reaction [CYP3A4 protein results in increased chemical synthesis of 14,15-epoxy-5,8,11-eicosatrienoic acid] CTD PMID:12675279 CYP3A4 Human 14,15-EET increases chemical synthesis EXP 6480464 CYP3A4 protein results in increased chemical synthesis of 14,15-epoxy-5,8,11-eicosatrienoic acid CTD PMID:12675279 CYP3A4 Human 17alpha-ethynylestradiol affects hydroxylation EXP 6480464 CYP3A4 protein affects the hydroxylation of Ethinyl Estradiol CTD PMID:2271712 CYP3A4 Human 17alpha-ethynylestradiol decreases activity EXP 6480464 Ethinyl Estradiol results in decreased activity of CYP3A4 protein CTD PMID:39023798 CYP3A4 Human 17alpha-ethynylestradiol decreases expression ISO Cyp3a2 (Rattus norvegicus) 6480464 Ethinyl Estradiol results in decreased expression of CYP3A11 mRNA; Ethinyl Estradiol results in decreased expression more ... CTD PMID:15953391|PMID:17108234 CYP3A4 Human 17alpha-ethynylestradiol increases hydroxylation EXP 6480464 CYP3A4 protein results in increased hydroxylation of Ethinyl Estradiol CTD PMID:15304426|PMID:15554232 CYP3A4 Human 17alpha-ethynylestradiol multiple interactions EXP 6480464 [Carbamazepine results in increased expression of CYP3A4 protein] which results in decreased abundance of Ethinyl more ... CTD PMID:11907170|PMID:19299527|PMID:22524704 CYP3A4 Human 17alpha-ethynylestradiol affects metabolic processing EXP 6480464 CYP3A4 protein affects the metabolism of Ethinyl Estradiol CTD PMID:15286053 CYP3A4 Human 17beta-estradiol multiple interactions EXP 6480464 [Estradiol co-treated with [sodium arsenite results in increased abundance of Arsenic]] results in increased expression more ... CTD PMID:12505310|PMID:16790556|PMID:35747940 CYP3A4 Human 17beta-estradiol affects expression ISO Cyp3a2 (Rattus norvegicus) 6480464 Estradiol affects the expression of CYP3A2 mRNA CTD PMID:32145629 CYP3A4 Human 17beta-estradiol increases expression EXP 6480464 Estradiol results in increased expression of CYP3A4 mRNA; Estradiol results in increased expression of CYP3A4 more ... CTD PMID:12505310|PMID:15650019|PMID:22837389|PMID:35747940 CYP3A4 Human 17beta-estradiol increases hydroxylation EXP 6480464 CYP3A4 protein results in increased hydroxylation of Estradiol CTD PMID:9047321|PMID:9714305 CYP3A4 Human 17beta-estradiol affects binding EXP 6480464 Estradiol binds to CYP3A4 protein CTD PMID:9047321 CYP3A4 Human 17beta-estradiol increases metabolic processing EXP 6480464 CYP3A4 protein results in increased metabolism of Estradiol CTD PMID:16790556 CYP3A4 Human 17beta-estradiol affects hydroxylation EXP 6480464 CYP3A4 protein affects the hydroxylation of Estradiol CTD PMID:2271712 CYP3A4 Human 17beta-hydroxy-5alpha-androstan-3-one multiple interactions EXP 6480464 Dihydrotestosterone inhibits the reaction [[Monocrotaline results in increased activity of NR1I2 protein] which results in more ... CTD PMID:32682830 CYP3A4 Human 1H-indole multiple interactions EXP 6480464 NR1I2 protein promotes the reaction [indole results in increased expression of CYP3A4 mRNA] CTD PMID:33002526 CYP3A4 Human 1H-indole increases expression EXP 6480464 indole results in increased expression of CYP3A4 mRNA CTD PMID:33002526 CYP3A4 Human 2'-deoxyguanosine multiple interactions EXP 6480464 CYP3A4 protein promotes the reaction [Aflatoxin B1 binds to Deoxyguanosine]; CYP3A4 protein promotes the reaction more ... CTD PMID:21907773 CYP3A4 Human 2,2',4,4',5,5'-hexachlorobiphenyl increases expression EXP 6480464 2,4,5,2',4',5'-hexachlorobiphenyl results in increased expression of CYP3A4 mRNA CTD PMID:22664347 CYP3A4 Human 2,2',4,4',5,5'-hexachlorobiphenyl multiple interactions EXP 6480464 2,4,5,2',4',5'-hexachlorobiphenyl promotes the reaction [NR1I2 protein results in increased expression of CYP3A4] CTD PMID:36893891 CYP3A4 Human 2,2',4,4'-Tetrabromodiphenyl ether increases expression EXP 6480464 2,2',4,4'-tetrabromodiphenyl ether results in increased expression of CYP3A4 mRNA CTD PMID:24218150 CYP3A4 Human 2,2',4,4'-Tetrabromodiphenyl ether multiple interactions EXP 6480464 [2,2',4,4'-tetrabromodiphenyl ether results in increased activity of CYP3A4 protein] which results in increased expression of more ... CTD PMID:24218150 CYP3A4 Human 2,2',5,5'-tetrachlorobiphenyl multiple interactions EXP 6480464 [POR protein co-treated with CYP3A4 protein] affects the susceptibility to 2,5,2',5'-tetrachlorobiphenyl CTD PMID:27913846 CYP3A4 Human 2,2'-Methylenebis(4-methyl-6-tert-butylphenol) affects response to substance EXP 6480464 CYP3A4 protein affects the susceptibility to 2,2'-methylenebis(4-methyl-6-tert-butylphenol) CTD PMID:38160208 CYP3A4 Human 2,2'-Methylenebis(4-methyl-6-tert-butylphenol) multiple interactions EXP 6480464 [CYP3A4 protein affects the susceptibility to 2,2'-methylenebis(4-methyl-6-tert-butylphenol)] which affects the expression of ABCC1 mRNA; [CYP3A4 more ... CTD PMID:38160208 CYP3A4 Human 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of CYP3A4 mRNA CTD PMID:16985168|PMID:28571685|PMID:31536130 CYP3A4 Human 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO Cyp3a2 (Rattus norvegicus) 6480464 Tetrachlorodibenzodioxin results in decreased expression of CYP3A2 mRNA CTD PMID:18796159|PMID:21215274 CYP3A4 Human 2,3,7,8-tetrachlorodibenzodioxine multiple interactions EXP 6480464 [Tetrachlorodibenzodioxin co-treated with Rifampin] results in increased expression of CYP3A4 mRNA; Tetrachlorodibenzodioxin inhibits the reaction more ... CTD PMID:28571685|PMID:29162470 CYP3A4 Human 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of CYP3A4 mRNA CTD PMID:23669205 CYP3A4 Human 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of CYP3A4 mRNA CTD PMID:22298810 CYP3A4 Human 2,4,6-trinitrobenzenesulfonic acid multiple interactions ISO Cyp3a2 (Rattus norvegicus) 6480464 gadolinium chloride inhibits the reaction [Trinitrobenzenesulfonic Acid results in decreased activity of and results in more ... CTD PMID:18079364 CYP3A4 Human 2,4-dibromophenyl 2,4,5-tribromophenyl ether increases expression EXP 6480464 2,2',4,4',5-brominated diphenyl ether results in increased expression of CYP3A4 mRNA CTD PMID:19270788 CYP3A4 Human 2,4-dibromophenyl 2,4,5-tribromophenyl ether multiple interactions ISO Cyp3a2 (Rattus norvegicus) 6480464 [CYP3A2 protein results in increased oxidation of 2,2',4,4',5-brominated diphenyl ether] which results in increased abundance more ... CTD PMID:21673328 CYP3A4 Human 2,4-dibromophenyl 2,4,5-tribromophenyl ether increases expression ISO Cyp3a2 (Rattus norvegicus) 6480464 2,2',4,4',5-brominated diphenyl ether results in increased expression of CYP3A2 mRNA CTD PMID:22331496 CYP3A4 Human 2,4-dibromophenyl 2,4,5-tribromophenyl ether increases oxidation ISO Cyp3a2 (Rattus norvegicus) 6480464 CYP3A2 protein results in increased oxidation of 2,2',4,4',5-brominated diphenyl ether CTD PMID:21673328 CYP3A4 Human 2,6-di-tert-butyl-4-methylphenol increases expression EXP 6480464 Butylated Hydroxytoluene results in increased expression of CYP3A4 mRNA CTD PMID:18570159 CYP3A4 Human 2,8-bis-Trifluoromethyl-4-quinoline carboxylic acid increases expression EXP 6480464 Ro 21-5104 results in increased expression of CYP3A4 mRNA; Ro 21-5104 results in increased expression more ... CTD PMID:25313206 CYP3A4 Human 2,8-bis-Trifluoromethyl-4-quinoline carboxylic acid multiple interactions EXP 6480464 NR1I2 mRNA promotes the reaction [Ro 21-5104 results in increased expression of CYP3A4 mRNA] CTD PMID:25313206 CYP3A4 Human 2-(3,4-dimethoxyphenyl)-5-\{[2-(3,4-dimethoxyphenyl)ethyl](methyl)amino\}-2-(propan-2-yl)pentanenitrile decreases activity EXP 6480464 Verapamil results in decreased activity of CYP3A4 protein CTD PMID:15689501|PMID:15860655|PMID:21915887|PMID:39023798 CYP3A4 Human 2-(3,4-dimethoxyphenyl)-5-\{[2-(3,4-dimethoxyphenyl)ethyl](methyl)amino\}-2-(propan-2-yl)pentanenitrile affects metabolic processing EXP 6480464 CYP3A4 protein affects the metabolism of Verapamil CTD PMID:15286053|PMID:15692829|PMID:16013069 CYP3A4 Human 2-(3,4-dimethoxyphenyl)-5-\{[2-(3,4-dimethoxyphenyl)ethyl](methyl)amino\}-2-(propan-2-yl)pentanenitrile multiple interactions EXP 6480464 [Verapamil results in increased activity of NR1I2 protein] which results in increased expression of CYP3A4 more ... CTD PMID:16013069|PMID:19299527|PMID:21915887|PMID:25455453 CYP3A4 Human 2-[cyclohexyl(oxo)methyl]-3,6,7,11b-tetrahydro-1H-pyrazino[2,1-a]isoquinolin-4-one affects metabolic processing EXP 6480464 CYP3A4 protein affects the metabolism of Praziquantel CTD PMID:12920490 CYP3A4 Human 2-acetamidofluorene increases expression ISO Cyp3a2 (Rattus norvegicus) 6480464 2-Acetylaminofluorene results in increased expression of CYP3A2 protein CTD PMID:10445401 CYP3A4 Human 2-amino-2-deoxy-D-galactopyranose multiple interactions EXP 6480464 alpha-Tocopherol inhibits the reaction [Galactosamine results in decreased expression of CYP3A4 mRNA]; Galactosamine inhibits the more ... CTD PMID:17936189 CYP3A4 Human 2-amino-2-deoxy-D-galactopyranose decreases expression EXP 6480464 Galactosamine results in decreased expression of CYP3A4 mRNA CTD PMID:17936189 CYP3A4 Human 2-butan-2-yl-4-[4-[4-[4-[[2-(2,4-dichlorophenyl)-2-(1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]-1-piperazinyl]phenyl]-1,2,4-triazol-3-one increases metabolic processing EXP 6480464 CYP3A4 protein results in increased metabolism of Itraconazole CTD PMID:18360572 CYP3A4 Human 2-butan-2-yl-4-[4-[4-[4-[[2-(2,4-dichlorophenyl)-2-(1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]-1-piperazinyl]phenyl]-1,2,4-triazol-3-one decreases expression EXP 6480464 Itraconazole results in decreased expression of CYP3A4 mRNA; Itraconazole results in decreased expression of CYP3A4 more ... CTD PMID:28390928 CYP3A4 Human 2-butan-2-yl-4-[4-[4-[4-[[2-(2,4-dichlorophenyl)-2-(1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]-1-piperazinyl]phenyl]-1,2,4-triazol-3-one affects metabolic processing EXP 6480464 CYP3A4 protein affects the metabolism of Itraconazole CTD PMID:15905803 CYP3A4 Human 2-butan-2-yl-4-[4-[4-[4-[[2-(2,4-dichlorophenyl)-2-(1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]-1-piperazinyl]phenyl]-1,2,4-triazol-3-one increases hydroxylation EXP 6480464 CYP3A4 protein results in increased hydroxylation of Itraconazole CTD PMID:15383492 CYP3A4 Human 2-butan-2-yl-4-[4-[4-[4-[[2-(2,4-dichlorophenyl)-2-(1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]-1-piperazinyl]phenyl]-1,2,4-triazol-3-one decreases activity EXP 6480464 Itraconazole results in decreased activity of CYP3A4 protein CTD PMID:15328084|PMID:15447735|PMID:15684493|PMID:15784650|PMID:15905803|PMID:15963096|PMID:15969931|PMID:16041596 CYP3A4 Human 2-butan-2-yl-4-[4-[4-[4-[[2-(2,4-dichlorophenyl)-2-(1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]-1-piperazinyl]phenyl]-1,2,4-triazol-3-one multiple interactions EXP 6480464 Itraconazole binds to and results in decreased activity of CYP3A4 protein CTD PMID:18218784 CYP3A4 Human 2-butan-2-yl-4-[4-[4-[4-[[2-(2,4-dichlorophenyl)-2-(1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]-1-piperazinyl]phenyl]-1,2,4-triazol-3-one affects activity EXP 6480464 Itraconazole affects the activity of CYP3A4 protein CTD PMID:15964336 CYP3A4 Human 2-hydroxy-17beta-estradiol increases chemical synthesis EXP 6480464 CYP3A4 protein results in increased chemical synthesis of 2-hydroxyestradiol CTD PMID:16790556 CYP3A4 Human 2-hydroxy-17beta-estradiol multiple interactions EXP 6480464 Chlorpyrifos inhibits the reaction [CYP3A4 protein results in increased chemical synthesis of 2-hydroxyestradiol]; decamethrin inhibits more ... CTD PMID:16790556 CYP3A4 Human 2-hydroxychrysophanol multiple interactions EXP 6480464 [CYP3A4 protein results in increased metabolism of chrysophanic acid] which results in increased chemical synthesis more ... CTD PMID:29698620 CYP3A4 Human 2-hydroxychrysophanol increases chemical synthesis EXP 6480464 CYP3A4 protein results in increased chemical synthesis of 2-hydroxychrysophanol CTD PMID:29698620 CYP3A4 Human 2-methyl-1H-indole multiple interactions EXP 6480464 NR1I2 protein affects the reaction [2-methylindole results in increased expression of CYP3A4 mRNA] CTD PMID:32092453 CYP3A4 Human 2-methyl-1H-indole increases expression EXP 6480464 2-methylindole results in increased expression of CYP3A4 mRNA CTD PMID:32092453 CYP3A4 Human 2-Naphthalenethiol increases expression EXP 6480464 2-naphthalenethiol results in increased expression of CYP3A4 mRNA CTD PMID:36356836 CYP3A4 Human 2-naphthol increases abundance EXP 6480464 CYP3A4 protein results in increased abundance of 2-naphthol CTD PMID:16243959 CYP3A4 Human 3',4'-dimethoxyflavone decreases activity EXP 6480464 3',4'-dimethoxyflavone results in decreased activity of CYP3A4 protein CTD PMID:21053930 CYP3A4 Human 3,3',4,4',5-pentachlorobiphenyl decreases expression ISO Cyp3a2 (Rattus norvegicus) 6480464 3,4,5,3',4'-pentachlorobiphenyl results in decreased expression of CYP3A2 mRNA CTD PMID:31820026 CYP3A4 Human 3,3',5-triiodo-L-thyronine increases expression EXP 6480464 Triiodothyronine results in increased expression of CYP3A4 mRNA CTD PMID:21815645 CYP3A4 Human 3,3',5-triiodo-L-thyronine multiple interactions EXP 6480464 SJ 000311413 inhibits the reaction [Triiodothyronine results in increased expression of CYP3A4 mRNA] CTD PMID:21815645 CYP3A4 Human 3,3'-diindolylmethane decreases activity EXP 6480464 3,3'-diindolylmethane results in decreased activity of CYP3A4 protein CTD PMID:19770484 CYP3A4 Human 3,3'-diindolylmethane multiple interactions EXP 6480464 [3,3'-diindolylmethane results in increased activity of NR1I2 protein] which results in increased expression of CYP3A4 more ... CTD PMID:25542144 CYP3A4 Human 3,3'-diindolylmethane increases expression EXP 6480464 3,3'-diindolylmethane results in increased expression of CYP3A4 mRNA CTD PMID:25542144 CYP3A4 Human 3,4-methylenedioxymethamphetamine multiple interactions EXP 6480464 N-Methyl-3,4-methylenedioxyamphetamine inhibits the reaction [1-(3-chlorophenyl)piperazine promotes the reaction [NR1I2 protein results in increased expression of more ... CTD PMID:21402137 CYP3A4 Human 3,4-methylenedioxymethamphetamine decreases activity EXP 6480464 N-Methyl-3,4-methylenedioxyamphetamine results in decreased activity of CYP3A4 protein CTD PMID:24211539 CYP3A4 Human 3,5,6-trichloro-2-pyridinol increases chemical synthesis EXP 6480464 CYP3A4 results in increased chemical synthesis of 3,5,6-trichloro-2-pyridinol CTD PMID:20709133 CYP3A4 Human 3,5,6-trichloropyridine-2-one increases chemical synthesis EXP 6480464 CYP3A4 results in increased chemical synthesis of 3,5,6-trichloro-2-pyridinol CTD PMID:20709133 CYP3A4 Human 3-(Methylthio)-1-propene increases expression ISO Cyp3a2 (Rattus norvegicus) 6480464 allyl methyl sulfide results in increased expression of CYP3A2 protein CTD PMID:16000231 CYP3A4 Human 3-hydroxyquinine affects chemical synthesis EXP 6480464 CYP3A4 protein affects the chemical synthesis of 3-hydroxyquinidine CTD PMID:15896247 CYP3A4 Human 3-methylcholanthrene decreases expression EXP 6480464 Methylcholanthrene results in decreased expression of CYP3A4 protein CTD PMID:10640517 CYP3A4 Human 3-methylcholanthrene multiple interactions ISO Cyp3a2 (Rattus norvegicus) 6480464 Dactinomycin inhibits the reaction [Methylcholanthrene results in increased expression of CYP3A2 mRNA] CTD PMID:11181506 CYP3A4 Human 3-methylcholanthrene increases expression ISO Cyp3a2 (Rattus norvegicus) 6480464 Methylcholanthrene results in increased expression of CYP3A2 mRNA CTD PMID:11181506 CYP3A4 Human 3-methylcholanthrene multiple interactions EXP 6480464 [Methylcholanthrene co-treated with Rifampin co-treated with Phenobarbital] results in increased expression of CYP3A4 mRNA; Methylcholanthrene more ... CTD PMID:23846873|PMID:24999631 CYP3A4 Human 3-oxo-5beta-cholanic acid multiple interactions ISO Cyp3a2 (Rattus norvegicus) 6480464 [CYP3A2 protein results in increased metabolism of Lithocholic Acid] which results in increased chemical synthesis more ... CTD PMID:18039809 CYP3A4 Human 3H-1,2-dithiole-3-thione decreases expression ISO Cyp3a2 (Rattus norvegicus) 6480464 1,2-dithiol-3-thione results in decreased expression of CYP3A2 mRNA CTD PMID:19162173 CYP3A4 Human 3H-1,2-dithiole-3-thione increases expression ISO Cyp3a2 (Rattus norvegicus) 6480464 1,2-dithiol-3-thione results in increased expression of CYP3A11 mRNA CTD PMID:19695238 CYP3A4 Human 4'-tert-Butyl-2',6'-dimethyl-3',5'-dinitroacetophenone decreases activity ISO Cyp3a2 (Rattus norvegicus) 6480464 musk ketone results in decreased activity of CYP3A2 protein CTD PMID:10630706 CYP3A4 Human 4,4'-methanol-bisbenzonitrile increases chemical synthesis EXP 6480464 CYP3A4 protein results in increased chemical synthesis of 4,4'-methanol-bisbenzonitrile CTD PMID:19845430 CYP3A4 Human 4,4'-methylene-bis-(2-chloroaniline) multiple interactions EXP 6480464 alpha-naphthoflavone inhibits the reaction [CYP3A4 protein results in increased oxidation of Methylenebis(chloroaniline)]; Gestodene inhibits the more ... CTD PMID:1740010 CYP3A4 Human 4,4'-methylene-bis-(2-chloroaniline) increases oxidation EXP 6480464 CYP3A4 protein results in increased oxidation of Methylenebis(chloroaniline) CTD PMID:1740010 CYP3A4 Human 4,4'-sulfonyldiphenol increases hydroxylation EXP 6480464 CYP3A4 protein results in increased hydroxylation of bisphenol S CTD PMID:27213244 CYP3A4 Human 4,4'-sulfonyldiphenol multiple interactions EXP 6480464 bisphenol S affects the reaction [SR 12813 results in increased expression of CYP3A4 protein] CTD PMID:28916285 CYP3A4 Human 4-(N-nitrosomethylamino)-1-(3-pyridyl)butan-1-one increases metabolic processing EXP 6480464 CYP3A4 protein results in increased metabolism of 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone CTD PMID:9029045 CYP3A4 Human 4-(N-nitrosomethylamino)-1-(3-pyridyl)butan-1-one multiple interactions EXP 6480464 CYP3A4 protein affects the metabolism of and results in increased activity of 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone CTD PMID:11774366 CYP3A4 Human 4-[(1E)-1,2-diphenylbut-1-en-1-yl]phenol multiple interactions EXP 6480464 [CYP3A4 protein results in increased metabolism of N,N-didesmethyltamoxifen] which results in increased abundance of 1-(4-hydroxyphenyl)-1,2-diphenyl-1-butene; more ... CTD PMID:29285606 CYP3A4 Human 4-[(1E)-1,2-diphenylbut-1-en-1-yl]phenol increases activity EXP 6480464 1-(4-hydroxyphenyl)-1,2-diphenyl-1-butene results in increased activity of CYP3A4 protein CTD PMID:29285606 CYP3A4 Human 4-[(1E)-1,2-diphenylbut-1-en-1-yl]phenol increases abundance EXP 6480464 CYP3A4 protein results in increased abundance of 1-(4-hydroxyphenyl)-1,2-diphenyl-1-butene CTD PMID:29285606 CYP3A4 Human 4-amino-5-chloro-N-[1-[3-(4-fluorophenoxy)propyl]-3-methoxy-4-piperidinyl]-2-methoxybenzamide decreases activity EXP 6480464 Cisapride results in decreased activity of CYP3A4 protein CTD PMID:15306208 CYP3A4 Human 4-amino-5-chloro-N-[1-[3-(4-fluorophenoxy)propyl]-3-methoxy-4-piperidinyl]-2-methoxybenzamide affects metabolic processing EXP 6480464 CYP3A4 protein affects the metabolism of Cisapride CTD PMID:11717173 CYP3A4 Human 4-amino-5-chloro-N-[1-[3-(4-fluorophenoxy)propyl]-3-methoxy-4-piperidinyl]-2-methoxybenzamide affects chemical synthesis EXP 6480464 CYP3A4 protein affects the chemical synthesis of Cisapride metabolite CTD PMID:11717173 CYP3A4 Human 4-amino-5-chloro-N-[1-[3-(4-fluorophenoxy)propyl]-3-methoxy-4-piperidinyl]-2-methoxybenzamide multiple interactions EXP 6480464 Cisapride inhibits the reaction [CYP3A4 protein results in increased oxidation of 7-benzyloxy-4-trifluoromethylcoumarin] CTD PMID:19299527 CYP3A4 Human 4-bromo-2-chlorophenol multiple interactions EXP 6480464 [CYP3A4 protein results in increased metabolism of profenofos] which results in increased abundance of 4-bromo-2-chlorophenol CTD PMID:23415833 CYP3A4 Human 4-hydroxy-3-(2-hydroxy-3-oxo-1-phenylbutyl)-2H-chromen-2-one multiple interactions EXP 6480464 [10-hydroxywarfarin binds to and results in increased activity of NR1I2 protein] which results in increased more ... CTD PMID:20735727 CYP3A4 Human 4-hydroxy-3-(2-hydroxy-3-oxo-1-phenylbutyl)-2H-chromen-2-one affects chemical synthesis EXP 6480464 CYP3A4 protein affects the chemical synthesis of 10-hydroxywarfarin CTD PMID:16035367 CYP3A4 Human 4-hydroxy-3-[1-(4-hydroxyphenyl)-3-oxobutyl]-2H-chromen-2-one multiple interactions EXP 6480464 [4'-hydroxywarfarin binds to and results in increased activity of NR1I2 protein] which results in increased more ... CTD PMID:20735727 CYP3A4 Human 4-Hydroxy-N-desmethyltamoxifen multiple interactions EXP 6480464 [CYP3A4 protein results in increased metabolism of 4-hydroxy-N-desmethyltamoxifen] which results in increased abundance of 4-hydroxy-N-desmethyltamoxifen more ... CTD PMID:29285606 CYP3A4 Human 4-Hydroxy-N-desmethyltamoxifen increases metabolic processing EXP 6480464 CYP3A4 protein results in increased metabolism of 4-hydroxy-N-desmethyltamoxifen CTD PMID:29285606 CYP3A4 Human 4-Hydroxybenzyl isothiocyanate decreases expression ISO Cyp3a2 (Rattus norvegicus) 6480464 4-hydroxybenzyl isothiocyanate results in decreased expression of CYP3A2 mRNA CTD PMID:22664424 CYP3A4 Human 4-Hydroxybenzyl isothiocyanate decreases activity ISO Cyp3a2 (Rattus norvegicus) 6480464 4-hydroxybenzyl isothiocyanate results in decreased activity of CYP3A2 protein CTD PMID:22664424 CYP3A4 Human 4-hydroxycyclophosphamide multiple interactions EXP 6480464 [CYP3A4 protein results in increased hydroxylation of Cyclophosphamide] which results in increased chemical synthesis of more ... CTD PMID:30500380 CYP3A4 Human 4-hydroxymidazolam increases chemical synthesis EXP 6480464 CYP3A4 protein results in increased chemical synthesis of 4-hydroxymidazolam CTD PMID:12695342|PMID:18191104 CYP3A4 Human 4-hydroxymidazolam multiple interactions EXP 6480464 [CYP3A4 protein results in increased hydroxylation of Midazolam] which results in increased abundance of 4-hydroxymidazolam; more ... CTD PMID:12695342|PMID:18191104|PMID:21053930|PMID:27485346 CYP3A4 Human 4-hydroxynon-2-enal multiple interactions EXP 6480464 [[CYP3A4 protein co-treated with Oxygen co-treated with NADP] results in increased reduction of 4-hydroxy-2-nonenal] which more ... CTD PMID:21766881 CYP3A4 Human 4-hydroxyphenyl retinamide multiple interactions EXP 6480464 Fenretinide promotes the reaction [[RXRA protein binds to NR1I2 protein] which results in increased expression more ... CTD PMID:16632523 CYP3A4 Human 4-Ipomeanol increases activity EXP 6480464 CYP3A4 protein results in increased activity of 4-ipomeanol CTD PMID:15892579 CYP3A4 Human 4-isopropylphenol increases glutathionylation EXP 6480464 CYP3A4 protein results in increased glutathionylation of 4-isopropylphenol CTD PMID:23470418 CYP3A4 Human 4beta-hydroxycholesterol multiple interactions EXP 6480464 [CYP3A4 protein results in increased oxidation of Cholesterol] which results in increased chemical synthesis of more ... CTD PMID:11514559 CYP3A4 Human 4beta-hydroxycholesterol increases chemical synthesis EXP 6480464 CYP3A4 protein results in increased chemical synthesis of cholest-5-ene-3,4-diol CTD PMID:19954708 CYP3A4 Human 5,6-dichloro-1-beta-D-ribofuranosyl-1H-benzimidazole multiple interactions EXP 6480464 Dichlororibofuranosylbenzimidazole inhibits the reaction [Methoxsalen results in increased expression of CYP3A4 mRNA]; Dichlororibofuranosylbenzimidazole inhibits the more ... CTD PMID:17003103 CYP3A4 Human 5,6-EET multiple interactions EXP 6480464 Ketoconazole inhibits the reaction [CYP3A4 protein results in increased chemical synthesis of 5,6-epoxy-8,11,14-eicosatrienoic acid] CTD PMID:12675279 CYP3A4 Human 5,6-EET increases chemical synthesis EXP 6480464 CYP3A4 protein results in increased chemical synthesis of 5,6-epoxy-8,11,14-eicosatrienoic acid CTD PMID:12675279 CYP3A4 Human 5,7-dihydroxy-4'-methoxyflavone multiple interactions EXP 6480464 acacetin binds to and results in decreased activity of CYP3A4 protein; acacetin inhibits the reaction more ... CTD PMID:21053930 CYP3A4 Human 5,7-dihydroxy-4'-methoxyflavone decreases activity ISO Cyp3a2 (Rattus norvegicus) 6480464 acacetin results in decreased activity of CYP3A2 protein CTD PMID:32738202 CYP3A4 Human 5,7-dihydroxy-4'-methoxyflavone increases expression EXP 6480464 acacetin results in increased expression of CYP3A4 mRNA CTD PMID:29933105 CYP3A4 Human 5-azacytidine increases expression EXP 6480464 Azacitidine results in increased expression of CYP3A4 mRNA CTD PMID:27590069 CYP3A4 Human 5-fluorouracil affects expression EXP 6480464 Fluorouracil affects the expression of CYP3A4 mRNA CTD PMID:16584549 CYP3A4 Human 5-hydroxydiclofenac multiple interactions EXP 6480464 [[CYP3A4 protein co-treated with GSTP1 protein co-treated with Glutathione] results in increased hydroxylation of Diclofenac] more ... CTD PMID:24246759 CYP3A4 Human 5-Hydroxyflavone decreases activity EXP 6480464 5-hydroxyflavone results in decreased activity of CYP3A4 protein CTD PMID:21053930 CYP3A4 Human 5-Hydroxyflavone multiple interactions EXP 6480464 [5-hydroxyflavone results in increased activity of CYP3A4 protein] which results in increased metabolism of Midazolam; more ... CTD PMID:31756459 CYP3A4 Human 5-Hydroxyflavone increases activity EXP 6480464 5-hydroxyflavone results in increased activity of CYP3A4 protein CTD PMID:31756459 CYP3A4 Human 5-Hydroxythalidomide multiple interactions EXP 6480464 [CYP3A4 protein results in increased hydroxylation of Thalidomide] which results in increased chemical synthesis of more ... CTD PMID:20443640 CYP3A4 Human 5-methoxy-2-\{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl\}-1H-benzimidazole multiple interactions EXP 6480464 [Omeprazole results in increased activity of NR1I2 protein] which results in increased expression of CYP3A4 more ... CTD PMID:12695340|PMID:15802389|PMID:17041008|PMID:19299527 CYP3A4 Human 5-methoxy-2-\{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl\}-1H-benzimidazole affects metabolic processing EXP 6480464 CYP3A4 protein affects the metabolism of Omeprazole CTD PMID:15286053|PMID:15626586 CYP3A4 Human 5-methoxy-2-\{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl\}-1H-benzimidazole increases metabolic processing EXP 6480464 CYP3A4 protein results in increased metabolism of Omeprazole CTD PMID:12485723|PMID:17565714|PMID:22634058|PMID:7870052|PMID:8930576 CYP3A4 Human 5-methoxy-2-\{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl\}-1H-benzimidazole increases expression EXP 6480464 Omeprazole results in increased expression of CYP3A4 mRNA; Omeprazole results in increased expression of CYP3A4 more ... CTD PMID:12235278|PMID:12695340|PMID:15466163|PMID:15802389|PMID:17954527|PMID:19118567|PMID:9744552 CYP3A4 Human 5-methoxyindole decreases activity EXP 6480464 5-methoxyindole results in decreased activity of CYP3A4 protein CTD PMID:18420780 CYP3A4 Human 6',7'-Dihydroxybergamottin decreases activity EXP 6480464 6',7'-dihydroxybergamottin results in decreased activity of CYP3A4 protein CTD PMID:15860655|PMID:23146034 CYP3A4 Human 6',7'-Dihydroxybergamottin multiple interactions EXP 6480464 6',7'-dihydroxybergamottin inhibits the reaction [CYP3A4 protein results in increased oxidation of Nifedipine] CTD PMID:23146034 CYP3A4 Human 6-(4-chlorophenyl)imidazo[2,1-b][1,3]thiazole-5-carbaldehyde O-(3,4-dichlorobenzyl)oxime increases activity EXP 6480464 6-(4-chlorophenyl)imidazo(2,1-b)(1,3)thiazole-5-carbaldehyde O-(3,4-dichlorobenzyl)oxime results in increased activity of CYP3A4 protein CTD PMID:30364229 CYP3A4 Human 6-(4-chlorophenyl)imidazo[2,1-b][1,3]thiazole-5-carbaldehyde O-(3,4-dichlorobenzyl)oxime increases expression EXP 6480464 6-(4-chlorophenyl)imidazo(2,1-b)(1,3)thiazole-5-carbaldehyde O-(3,4-dichlorobenzyl)oxime results in increased expression of CYP3A4 mRNA; 6-(4-chlorophenyl)imidazo(2,1-b)(1,3)thiazole-5-carbaldehyde O-(3,4-dichlorobenzyl)oxime results in increased expression more ... CTD PMID:16608920|PMID:18332078|PMID:21227907|PMID:21315811|PMID:21778469|PMID:24224465|PMID:25069801|PMID:27551952|PMID:28289823|PMID:30364229|PMID:39341470 CYP3A4 Human 6-(4-chlorophenyl)imidazo[2,1-b][1,3]thiazole-5-carbaldehyde O-(3,4-dichlorobenzyl)oxime multiple interactions EXP 6480464 allyl isothiocyanate inhibits the reaction [6-(4-chlorophenyl)imidazo(2,1-b)(1,3)thiazole-5-carbaldehyde O-(3,4-dichlorobenzyl)oxime results in increased expression of CYP3A4 mRNA]; allyl more ... CTD PMID:16608920|PMID:21778469|PMID:24224465|PMID:25069801 CYP3A4 Human 6-chrysenamine affects metabolic processing EXP 6480464 CYP3A4 protein affects the metabolism of 6-chrysenamine CTD PMID:2271712|PMID:2655891 CYP3A4 Human 6-Hydroxyflavone multiple interactions EXP 6480464 [6-hydroxyflavone results in increased activity of CYP3A4 protein] which results in increased metabolism of Midazolam; more ... CTD PMID:31756459 CYP3A4 Human 6-Hydroxyflavone increases activity EXP 6480464 6-hydroxyflavone results in increased activity of CYP3A4 protein CTD PMID:31756459 CYP3A4 Human 6-Methylflavone increases activity EXP 6480464 6-methylflavone results in increased activity of CYP3A4 protein CTD PMID:31756459 CYP3A4 Human 6-Methylflavone multiple interactions EXP 6480464 [6-methylflavone results in increased activity of CYP3A4 protein] which results in increased metabolism of Midazolam; more ... CTD PMID:31756459 CYP3A4 Human 6alpha-methylprednisolone increases activity EXP 6480464 Methylprednisolone results in increased activity of CYP3A4 protein CTD PMID:15964336 CYP3A4 Human 6alpha-methylprednisolone decreases expression EXP 6480464 Methylprednisolone results in decreased expression of CYP3A4 mRNA CTD PMID:16837568 CYP3A4 Human 6beta-hydroxycortisol affects chemical synthesis EXP 6480464 CYP3A4 protein affects the chemical synthesis of 6 beta-hydroxycortisol CTD PMID:15941677 CYP3A4 Human 6beta-hydroxytestosterone multiple interactions EXP 6480464 [[CYP3A4 protein co-treated with NADP] results in increased oxidation of Testosterone] which results in increased more ... CTD PMID:16595712|PMID:17084830|PMID:19135037|PMID:20233841|PMID:20863320|PMID:21915887|PMID:26239802|PMID:27939613|PMID:28238727|PMID:29555536|PMID:30914192|PMID:31102695|PMID:32198085|PMID:34189909|PMID:35366062|PMID:35748891 CYP3A4 Human 6beta-hydroxytestosterone multiple interactions ISO Cyp3a2 (Rattus norvegicus) 6480464 [CYP3A4 protein results in increased metabolism of Testosterone] which results in increased chemical synthesis of more ... CTD PMID:31870919 CYP3A4 Human 6beta-hydroxytestosterone increases chemical synthesis ISO Cyp3a2 (Rattus norvegicus) 6480464 CYP3A4 protein results in increased chemical synthesis of 6 beta-hydroxytestosterone CTD PMID:27836570|PMID:31870919 CYP3A4 Human 6beta-hydroxytestosterone increases chemical synthesis EXP 6480464 CYP3A4 protein results in increased chemical synthesis of 6 beta-hydroxytestosterone CTD PMID:12401345|PMID:20233841|PMID:20863320|PMID:21915887|PMID:23850985|PMID:26239802|PMID:26739624|PMID:27939613 CYP3A4 Human 7,12-dimethyltetraphene increases response to substance EXP 6480464 CYP3A4 protein results in increased susceptibility to 9,10-Dimethyl-1,2-benzanthracene CTD PMID:20507880 CYP3A4 Human 7-hydroxyflavone decreases activity EXP 6480464 7-hydroxyflavone results in decreased activity of CYP3A4 protein CTD PMID:21053930 CYP3A4 Human 7-hydroxyflavone increases activity EXP 6480464 7-hydroxyflavone results in increased activity of CYP3A4 protein CTD PMID:31756459 CYP3A4 Human 7-hydroxyflavone multiple interactions EXP 6480464 [7-hydroxyflavone results in increased activity of CYP3A4 protein] which results in increased metabolism of Midazolam; more ... CTD PMID:31756459 CYP3A4 Human 8,9-EET increases chemical synthesis EXP 6480464 CYP3A4 protein results in increased chemical synthesis of 8,9-epoxyeicosatrienoic acid CTD PMID:12675279 CYP3A4 Human 8,9-EET multiple interactions EXP 6480464 Ketoconazole inhibits the reaction [CYP3A4 protein results in increased chemical synthesis of 8,9-epoxyeicosatrienoic acid] CTD PMID:12675279 CYP3A4 Human 8-Epidiosbulbin E acetate multiple interactions EXP 6480464 Ketoconazole inhibits the reaction [CYP3A4 protein results in increased metabolism of 8-epidiosbulbin E acetate] CTD PMID:26286065 CYP3A4 Human 8-Epidiosbulbin E acetate increases metabolic processing EXP 6480464 CYP3A4 protein results in increased metabolism of 8-epidiosbulbin E acetate CTD PMID:26286065 CYP3A4 Human 9-cis-retinal increases activity EXP 6480464 9-cis-retinal results in increased activity of CYP3A4 protein CTD PMID:16632523 CYP3A4 Human 9-cis-retinal multiple interactions EXP 6480464 1,4-bis(2-(3,5-dichloropyridyloxy))benzene promotes the reaction [9-cis-retinal promotes the reaction [[RXRA protein binds to NR1I3 protein] which more ... CTD PMID:16632523|PMID:19686701 CYP3A4 Human 9-cis-retinoic acid multiple interactions EXP 6480464 1,4-bis(2-(3,5-dichloropyridyloxy))benzene promotes the reaction [Alitretinoin promotes the reaction [[RXRA protein binds to NR1I3 protein] which more ... CTD PMID:16632523|PMID:19686701 CYP3A4 Human 9-cis-retinoic acid increases activity EXP 6480464 Alitretinoin results in increased activity of CYP3A4 protein CTD PMID:16632523 CYP3A4 Human 9-hydroxyellipticine multiple interactions EXP 6480464 [[CYP3A4 protein co-treated with NADP] results in increased oxidation of ellipticine] which results in increased more ... CTD PMID:22390216|PMID:30914192 CYP3A4 Human [2,8-bis(trifluoromethyl)quinolin-4-yl]-(2-piperidyl)methanol multiple interactions EXP 6480464 Ketoconazole inhibits the reaction [CYP3A4 protein affects the metabolism of Mefloquine] CTD PMID:15896247 CYP3A4 Human acalabrutinib increases metabolic processing EXP 6480464 CYP3A4 protein results in increased metabolism of acalabrutinib CTD PMID:34153224 CYP3A4 Human acalabrutinib multiple interactions EXP 6480464 Ketoconazole affects the reaction [CYP3A4 protein alternative form affects the metabolism of acalabrutinib] CTD PMID:34153224 CYP3A4 Human acalabrutinib affects metabolic processing EXP 6480464 CYP3A4 protein alternative form affects the metabolism of acalabrutinib CTD PMID:34153224 CYP3A4 Human acenaphthylene increases oxidation EXP 6480464 CYP3A4 protein results in increased oxidation of acenaphthylene CTD PMID:25642975 CYP3A4 Human acetamide decreases expression ISO Cyp3a2 (Rattus norvegicus) 6480464 acetamide results in decreased expression of CYP3A2 mRNA CTD PMID:31881176 CYP3A4 Human acetochlor increases metabolic processing EXP 6480464 CYP3A4 protein results in increased metabolism of acetochlor CTD PMID:11133395 CYP3A4 Human Acetyl tributyl citrate multiple interactions EXP 6480464 2-acetyltributylcitrate promotes the reaction [Calcitriol results in increased expression of CYP3A4 mRNA]; 2-acetyltributylcitrate promotes the more ... CTD PMID:21742782 CYP3A4 Human Acetyl tributyl citrate increases expression EXP 6480464 2-acetyltributylcitrate results in increased expression of CYP3A4 mRNA CTD PMID:21742782 CYP3A4 Human Acetyl tributyl citrate increases activity EXP 6480464 2-acetyltributylcitrate results in increased activity of CYP3A4 protein CTD PMID:21742782 CYP3A4 Human aconitine increases metabolic processing EXP 6480464 CYP3A4 protein results in increased metabolism of Aconitine CTD PMID:21277363 CYP3A4 Human aconitine increases expression EXP 6480464 Aconitine results in increased expression of CYP3A4 mRNA CTD PMID:30303438 CYP3A4 Human aconitine multiple interactions EXP 6480464 [Aconitine co-treated with mesaconitine co-treated with hypaconitine] results in increased expression of CYP3A4 mRNA; [CYP3A4 more ... CTD PMID:21277363|PMID:30303438 CYP3A4 Human acrolein multiple interactions EXP 6480464 [CYP3A4 protein results in increased hydroxylation of Cyclophosphamide] which results in increased chemical synthesis of more ... CTD PMID:30500380 CYP3A4 Human actinomycin D multiple interactions EXP 6480464 Dactinomycin inhibits the reaction [o,p'-DDT results in increased expression of CYP3A4 mRNA]; Dactinomycin inhibits the more ... CTD PMID:15795092|PMID:24819614 CYP3A4 Human actinomycin D multiple interactions ISO Cyp3a2 (Rattus norvegicus) 6480464 Dactinomycin inhibits the reaction [Methylcholanthrene results in increased expression of CYP3A2 mRNA]; Dactinomycin inhibits the more ... CTD PMID:11181506 CYP3A4 Human adefovir pivoxil decreases activity EXP 6480464 adefovir dipivoxil results in decreased activity of CYP3A4 protein CTD PMID:17162464 CYP3A4 Human adinazolam multiple interactions EXP 6480464 Ketoconazole inhibits the reaction [CYP3A4 protein results in decreased methylation of adinazolam]; Troleandomycin inhibits the more ... CTD PMID:9600717 CYP3A4 Human adinazolam decreases methylation EXP 6480464 CYP3A4 protein results in decreased methylation of adinazolam CTD PMID:9600717 CYP3A4 Human afimoxifene decreases activity EXP 6480464 afimoxifene results in decreased activity of CYP3A4 protein CTD PMID:12419016 CYP3A4 Human afimoxifene increases expression EXP 6480464 afimoxifene results in increased expression of CYP3A4 mRNA CTD PMID:29285606 CYP3A4 Human afimoxifene increases activity EXP 6480464 afimoxifene results in increased activity of CYP3A4 protein CTD PMID:29285606 CYP3A4 Human afimoxifene increases metabolic processing EXP 6480464 CYP3A4 protein results in increased metabolism of afimoxifene CTD PMID:29285606 CYP3A4 Human afimoxifene multiple interactions EXP 6480464 [CYP3A4 protein results in increased metabolism of afimoxifene] which results in increased abundance of afimoxifene more ... CTD PMID:20507880|PMID:29285606 CYP3A4 Human aflatoxin B1 affects expression EXP 6480464 Aflatoxin B1 affects the expression of CYP3A4 protein CTD PMID:20106945 CYP3A4 Human aflatoxin B1 increases activity ISO Cyp3a2 (Rattus norvegicus) 6480464 CYP3A2 protein results in increased activity of Aflatoxin B1 CTD PMID:11346484 CYP3A4 Human aflatoxin B1 decreases expression EXP 6480464 Aflatoxin B1 results in decreased expression of CYP3A4 mRNA; Aflatoxin B1 results in decreased expression more ... CTD PMID:18347083|PMID:22100608|PMID:27153756 CYP3A4 Human aflatoxin B1 increases expression EXP 6480464 Aflatoxin B1 results in increased expression of CYP3A4 mRNA CTD PMID:21641981|PMID:21994236|PMID:29549414|PMID:33984424 CYP3A4 Human aflatoxin B1 multiple interactions EXP 6480464 [CYP1A2 protein co-treated with CYP2C9 protein co-treated with CYP3A4 protein co-treated with CYP2D6 protein co-treated more ... CTD PMID:20655369|PMID:20707407|PMID:21641981|PMID:21907773|PMID:23397584|PMID:27913846|PMID:31103741|PMID:33164849 CYP3A4 Human aflatoxin B1 increases metabolic processing EXP 6480464 CYP3A4 protein results in increased metabolism of Aflatoxin B1 CTD PMID:20707407 CYP3A4 Human aflatoxin B1 increases response to substance EXP 6480464 CYP3A4 mRNA results in increased susceptibility to Aflatoxin B1; CYP3A4 protein results in increased susceptibility more ... CTD PMID:11189750|PMID:29555536 CYP3A4 Human aflatoxin B1 increases activity EXP 6480464 Aflatoxin B1 results in increased activity of CYP3A4 protein; CYP3A4 protein results in increased activity more ... CTD PMID:15988000|PMID:33164849 CYP3A4 Human aflatoxin B1 affects metabolic processing EXP 6480464 CYP3A4 protein affects the metabolism of Aflatoxin B1 CTD PMID:2271712|PMID:2655891 CYP3A4 Human aflatoxin B1 exo-8,9-epoxide multiple interactions EXP 6480464 [CYP3A4 protein results in increased metabolism of Aflatoxin B1] which results in increased chemical synthesis more ... CTD PMID:20707407 CYP3A4 Human Aflatoxin G1 multiple interactions EXP 6480464 aflatoxin G1 promotes the reaction [NR1I2 protein binds to CYP3A4 promoter] CTD PMID:21641981 CYP3A4 Human Aflatoxin G1 increases expression EXP 6480464 aflatoxin G1 results in increased expression of CYP3A4 mRNA CTD PMID:21641981 CYP3A4 Human Aflatoxin G1 increases response to substance EXP 6480464 CYP3A4 protein results in increased susceptibility to aflatoxin G1 CTD PMID:11189750 CYP3A4 Human Aflatoxin G1 affects metabolic processing EXP 6480464 CYP3A4 protein affects the metabolism of aflatoxin G1 CTD PMID:2271712|PMID:2655891 CYP3A4 Human aflatoxin M1 increases expression EXP 6480464 Aflatoxin M1 results in increased expression of CYP3A4 mRNA CTD PMID:21641981 CYP3A4 Human aflatoxin M1 multiple interactions EXP 6480464 Aflatoxin M1 promotes the reaction [NR1I2 protein binds to CYP3A4 promoter] CTD PMID:21641981 CYP3A4 Human aflatoxin Q1 multiple interactions EXP 6480464 [CYP3A4 protein results in increased metabolism of Aflatoxin B1] which results in increased chemical synthesis more ... CTD PMID:20707407 CYP3A4 Human ajmalicine multiple interactions EXP 6480464 raubasine inhibits the reaction [Calcitriol results in increased expression of CYP3A4 protein] CTD PMID:29782822 CYP3A4 Human ajmaline multiple interactions EXP 6480464 Ajmaline inhibits the reaction [Calcitriol results in increased expression of CYP3A4 protein] CTD PMID:29782822 CYP3A4 Human alachlor increases expression EXP 6480464 alachlor results in increased expression of CYP3A4 mRNA CTD PMID:16565514 CYP3A4 Human alachlor multiple interactions EXP 6480464 [CYP3A4 protein results in increased metabolism of alachlor] which results in increased abundance of 2-chloro-N-(2,6-diethylphenyl)acetamide CTD PMID:18273908 CYP3A4 Human alachlor increases metabolic processing EXP 6480464 CYP3A4 protein results in increased metabolism of alachlor CTD PMID:10475613|PMID:18273908 CYP3A4 Human albendazole multiple interactions EXP 6480464 [Albendazole co-treated with CYP3A4 protein] results in increased expression of CD86 protein; [Albendazole co-treated with more ... CTD PMID:22785256 CYP3A4 Human albendazole multiple interactions ISO Cyp3a2 (Rattus norvegicus) 6480464 [SOD2 co-treated with CYP3A4] affects the susceptibility to Albendazole CTD PMID:19501153 CYP3A4 Human alcohol multiple interactions EXP 6480464 Alcohols inhibits the reaction [ferric citrate results in increased expression of CYP3A4 mRNA]; Alcohols promotes more ... CTD PMID:24025710 CYP3A4 Human alcohol increases expression EXP 6480464 Alcohols results in increased expression of CYP3A4 mRNA; Alcohols results in increased expression of CYP3A4 more ... CTD PMID:24025710 CYP3A4 Human aldrin increases expression EXP 6480464 Aldrin results in increased expression of CYP3A4 protein CTD PMID:15548381 CYP3A4 Human alectinib affects metabolic processing EXP 6480464 CYP3A4 polymorphism affects the metabolism of alectinib CTD PMID:37209178 CYP3A4 Human alfacalcidol increases hydroxylation EXP 6480464 CYP3A4 protein results in increased hydroxylation of alfacalcidol CTD PMID:15005856 CYP3A4 Human alfentanil multiple interactions EXP 6480464 CYB5A protein promotes the reaction [CYP3A4 protein affects the metabolism of Alfentanil] CTD PMID:15557344 CYP3A4 Human alfentanil affects metabolic processing EXP 6480464 CYP3A4 protein affects the metabolism of Alfentanil CTD PMID:15557344|PMID:15731592 CYP3A4 Human all-trans-4-hydroxyretinoic acid increases chemical synthesis EXP 6480464 CYP3A4 protein results in increased chemical synthesis of 4-hydroxyretinoic acid CTD PMID:10874126 CYP3A4 Human all-trans-4-oxoretinoic acid increases chemical synthesis EXP 6480464 CYP3A4 protein results in increased chemical synthesis of 4-oxoretinoic acid CTD PMID:10874126 CYP3A4 Human all-trans-retinoic acid multiple interactions EXP 6480464 [Tretinoin results in increased activity of NR1I2 protein] which results in increased expression of CYP3A4 more ... CTD PMID:16632523|PMID:25455453 CYP3A4 Human all-trans-retinoic acid increases hydroxylation EXP 6480464 CYP3A4 protein results in increased hydroxylation of Tretinoin CTD PMID:10874126 CYP3A4 Human all-trans-retinoic acid decreases activity EXP 6480464 Tretinoin results in decreased activity of CYP3A4 protein CTD PMID:18420780 CYP3A4 Human all-trans-retinoic acid decreases expression EXP 6480464 Tretinoin results in decreased expression of CYP3A4 mRNA CTD PMID:16985168 CYP3A4 Human all-trans-retinoic acid increases activity EXP 6480464 Tretinoin results in increased activity of CYP3A4 protein CTD PMID:16632523 CYP3A4 Human allethrin multiple interactions ISO Cyp3a2 (Rattus norvegicus) 6480464 Allethrins results in increased expression of and results in increased activity of CYP3A2 protein CTD PMID:22080754 CYP3A4 Human allyl alcohol decreases expression ISO Cyp3a2 (Rattus norvegicus) 6480464 allyl alcohol results in decreased expression of CYP3A2 protein CTD PMID:10445401 CYP3A4 Human allyl isothiocyanate multiple interactions EXP 6480464 allyl isothiocyanate inhibits the reaction [6-(4-chlorophenyl)imidazo(2,1-b)(1,3)thiazole-5-carbaldehyde O-(3,4-dichlorobenzyl)oxime results in increased expression of CYP3A4 mRNA]; allyl more ... CTD PMID:25069801 CYP3A4 Human allyl isothiocyanate decreases activity ISO Cyp3a2 (Rattus norvegicus) 6480464 allyl isothiocyanate results in decreased activity of CYP3A2 protein CTD PMID:22664424 CYP3A4 Human allyl isothiocyanate decreases expression ISO Cyp3a2 (Rattus norvegicus) 6480464 allyl isothiocyanate results in decreased expression of CYP3A2 mRNA CTD PMID:22664424 CYP3A4 Human allyl isothiocyanate multiple interactions ISO Cyp3a2 (Rattus norvegicus) 6480464 allyl isothiocyanate inhibits the reaction [[NR1I2 protein co-treated with Pregnenolone Carbonitrile] results in increased expression more ... CTD PMID:25069801 CYP3A4 Human allyl isothiocyanate decreases activity EXP 6480464 allyl isothiocyanate results in decreased activity of CYP3A4 protein CTD PMID:25069801 CYP3A4 Human allyl methyl disulfide decreases activity EXP 6480464 allyl methyl disulfide results in decreased activity of CYP3A4 protein CTD PMID:18385293 CYP3A4 Human allyl methyl disulfide multiple interactions EXP 6480464 allyl methyl disulfide inhibits the reaction [CYP3A4 protein results in increased hydroxylation of Midazolam] CTD PMID:18385293 CYP3A4 Human almotriptan increases hydroxylation EXP 6480464 CYP3A4 protein results in increased hydroxylation of almotriptan CTD PMID:12642466 CYP3A4 Human almotriptan decreases methylation EXP 6480464 CYP3A4 protein results in decreased methylation of almotriptan CTD PMID:12642466 CYP3A4 Human Aloe emodin multiple interactions EXP 6480464 [CYP3A4 protein results in increased metabolism of chrysophanic acid] which results in increased chemical synthesis more ... CTD PMID:29698620 CYP3A4 Human Aloe emodin increases chemical synthesis EXP 6480464 CYP3A4 protein results in increased chemical synthesis of aloe emodin CTD PMID:29698620 CYP3A4 Human alpha-hexachlorocyclohexane increases expression ISO Cyp3a2 (Rattus norvegicus) 6480464 alpha-hexachlorocyclohexane results in increased expression of CYP3A2 mRNA CTD PMID:16940010 CYP3A4 Human alpha-hexachlorocyclohexane multiple interactions ISO Cyp3a2 (Rattus norvegicus) 6480464 [Diethylnitrosamine co-treated with alpha-hexachlorocyclohexane] results in decreased expression of CYP3A2 mRNA; [Diethylnitrosamine co-treated with alpha-hexachlorocyclohexane] more ... CTD PMID:11165752|PMID:16246485 CYP3A4 Human alpha-Hydroxyalprazolam affects chemical synthesis EXP 6480464 CYP3A4 protein affects the chemical synthesis of alpha-hydroxyalprazolam CTD PMID:12196913 CYP3A4 Human alpha-linolenic acid decreases activity EXP 6480464 alpha-Linolenic Acid results in decreased activity of CYP3A4 protein CTD PMID:16978661 CYP3A4 Human alpha-naphthoflavone multiple interactions EXP 6480464 [[alpha-naphthoflavone results in increased activity of CYP3A4 protein] which results in increased metabolism of Midazolam] more ... CTD PMID:1740010|PMID:19299527|PMID:21053930|PMID:31756459 CYP3A4 Human alpha-naphthoflavone increases activity EXP 6480464 alpha-naphthoflavone results in increased activity of CYP3A4 protein CTD PMID:2271712|PMID:31756459 CYP3A4 Human alpha-naphthoflavone decreases activity EXP 6480464 alpha-naphthoflavone results in decreased activity of CYP3A4 protein CTD PMID:15005856 CYP3A4 Human alpha-naphthoflavone affects binding EXP 6480464 alpha-naphthoflavone binds to CYP3A4 protein CTD PMID:17198380 CYP3A4 Human alpha-santonin multiple interactions EXP 6480464 [Santonin results in increased activity of NR1I2 protein] which results in increased expression of CYP3A4 more ... CTD PMID:25455453 CYP3A4 Human alpha-tocotrienol increases expression EXP 6480464 tocotrienol, alpha results in increased expression of CYP3A4 CTD PMID:15269186 CYP3A4 Human alpha-tocotrienol multiple interactions EXP 6480464 tocotrienol, alpha inhibits the reaction [CYP3A4 protein results in increased hydroxylation of Testosterone]; tocotrienol, alpha more ... CTD PMID:31102695 CYP3A4 Human alprazolam multiple interactions EXP 6480464 CYP3A4 protein binds to and affects the metabolism of Alprazolam CTD PMID:15856409 CYP3A4 Human alprazolam affects metabolic processing EXP 6480464 CYP3A4 protein affects the metabolism of Alprazolam CTD PMID:12196913|PMID:16042670 CYP3A4 Human Amaranth decreases activity EXP 6480464 Amaranth Dye results in decreased activity of CYP3A4 protein CTD PMID:20041016 CYP3A4 Human amiodarone multiple interactions EXP 6480464 [Amiodarone co-treated with Benzoic Acid co-treated with cyproconazole co-treated with flusilazole co-treated with enilconazole co-treated more ... CTD PMID:15869686|PMID:19299527|PMID:22652334|PMID:22785256|PMID:27485346|PMID:34273450 CYP3A4 Human amiodarone increases degradation EXP 6480464 CYP3A4 protein results in increased degradation of Amiodarone CTD PMID:32305697 CYP3A4 Human amiodarone increases expression ISO Cyp3a2 (Rattus norvegicus) 6480464 Amiodarone results in increased expression of CYP3A4 mRNA CTD PMID:19224547 CYP3A4 Human amiodarone increases response to substance EXP 6480464 CYP3A4 protein results in increased susceptibility to Amiodarone CTD PMID:21540358|PMID:26477383 CYP3A4 Human amiodarone decreases activity EXP 6480464 Amiodarone results in decreased activity of CYP3A4 protein CTD PMID:15304522|PMID:16449812|PMID:22652334 CYP3A4 Human amiodarone decreases ethylation EXP 6480464 CYP3A4 protein results in decreased ethylation of Amiodarone CTD PMID:7905403 CYP3A4 Human amiodarone increases metabolic processing EXP 6480464 CYP3A4 protein results in increased metabolism of Amiodarone CTD PMID:15869686|PMID:16449812|PMID:22785256|PMID:27485346|PMID:8445979 CYP3A4 Human amitriptyline increases metabolic processing EXP 6480464 Amitriptyline results in increased metabolism of CYP3A4 protein CTD PMID:18359012 CYP3A4 Human amitriptyline multiple interactions EXP 6480464 [CYP1A2 protein co-treated with CYP2C9 protein co-treated with CYP3A4 protein co-treated with CYP2D6 protein co-treated more ... CTD PMID:23397584 CYP3A4 Human amlodipine decreases activity EXP 6480464 Amlodipine results in decreased activity of CYP3A4 protein CTD PMID:39023798 CYP3A4 Human ammonium chloride affects expression ISO Cyp3a2 (Rattus norvegicus) 6480464 Ammonium Chloride affects the expression of CYP3A2 mRNA CTD PMID:16483693 CYP3A4 Human amodiaquine increases metabolic processing EXP 6480464 CYP3A4 protein results in increased metabolism of Amodiaquine CTD PMID:28478157|PMID:31629065 CYP3A4 Human amodiaquine decreases activity EXP 6480464 Amodiaquine results in decreased activity of CYP3A4 protein CTD PMID:39023798 CYP3A4 Human amodiaquine multiple interactions EXP 6480464 [CYP3A4 protein results in increased metabolism of Amodiaquine] which results in increased abundance of and more ... CTD PMID:28478157|PMID:31629065 CYP3A4 Human amodiaquine increases response to substance EXP 6480464 CYP3A4 protein results in increased susceptibility to Amodiaquine CTD PMID:31629065 CYP3A4 Human amoxapine increases chemical synthesis EXP 6480464 CYP3A4 results in increased chemical synthesis of Amoxapine CTD PMID:21826677 CYP3A4 Human amphetamine decreases alkylation EXP 6480464 CYP3A4 protein results in decreased alkylation of Amphetamine analog CTD PMID:29277574 CYP3A4 Human amphetamine affects chemical synthesis EXP 6480464 CYP3A4 protein affects the chemical synthesis of Amphetamine CTD PMID:15294457 CYP3A4 Human amphetamine multiple interactions EXP 6480464 Amphetamine promotes the reaction [NR1I2 protein results in increased expression of CYP3A4 mRNA]; N-Methyl-3,4-methylenedioxyamphetamine inhibits more ... CTD PMID:21402137 CYP3A4 Human amphetamine decreases methylation EXP 6480464 CYP3A4 protein results in decreased methylation of Amphetamine analog CTD PMID:29277574 CYP3A4 Human ampicillin multiple interactions ISO Cyp3a2 (Rattus norvegicus) 6480464 [Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in more ... CTD PMID:30545405 CYP3A4 Human amprenavir decreases activity EXP 6480464 amprenavir results in decreased activity of CYP3A4 protein CTD PMID:15523003 CYP3A4 Human Ancriviroc affects metabolic processing EXP 6480464 CYP3A4 protein affects the metabolism of Ancriviroc CTD PMID:16012074 CYP3A4 Human Ancriviroc decreases ethylation EXP 6480464 CYP3A4 protein results in decreased ethylation of Ancriviroc CTD PMID:16012074 CYP3A4 Human andrographolide decreases expression EXP 6480464 andrographolide results in decreased expression of CYP3A4 mRNA CTD PMID:19041297 CYP3A4 Human androst-4-ene-3,17-dione multiple interactions EXP 6480464 Androstenedione promotes the reaction [CYP3A4 protein results in increased oxidation of 7-benzyloxy-4-trifluoromethylcoumarin] CTD PMID:19299527 CYP3A4 Human aniline multiple interactions EXP 6480464 CYP3A4 protein affects the metabolism of [norharman co-treated with aniline] CTD PMID:15279827 CYP3A4 Human anthocyanin increases expression ISO Cyp3a2 (Rattus norvegicus) 6480464 Anthocyanins results in increased expression of CYP3A2 mRNA CTD PMID:18803703 CYP3A4 Human anthra[1,9-cd]pyrazol-6(2H)-one multiple interactions EXP 6480464 pyrazolanthrone inhibits the reaction [Calcitriol results in increased expression of CYP3A4 mRNA] CTD PMID:17965521 CYP3A4 Human antirheumatic drug decreases expression EXP 6480464 Antirheumatic Agents results in decreased expression of CYP3A4 mRNA CTD PMID:24449571 CYP3A4 Human apigenin multiple interactions EXP 6480464 Apigenin inhibits the reaction [[CYP3A4 protein results in increased oxidation of Midazolam] which results in more ... CTD PMID:21053930 CYP3A4 Human apigenin decreases activity EXP 6480464 Apigenin results in decreased activity of CYP3A4 protein CTD PMID:21053930|PMID:29753067 CYP3A4 Human arachidonic acid decreases activity EXP 6480464 Arachidonic Acid results in decreased activity of CYP3A4 protein CTD PMID:16978661 CYP3A4 Human arachidonic acid multiple interactions EXP 6480464 Ketoconazole inhibits the reaction [CYP3A4 protein results in increased metabolism of Arachidonic Acid] CTD PMID:12675279 CYP3A4 Human arachidonic acid increases metabolic processing EXP 6480464 CYP3A4 protein results in increased metabolism of Arachidonic Acid CTD PMID:12675279 CYP3A4 Human Aroclor 1254 increases expression EXP 6480464 Chlorodiphenyl (54% Chlorine) results in increased expression of CYP3A4 mRNA CTD PMID:17851650 CYP3A4 Human Aroclor 1254 increases expression ISO Cyp3a2 (Rattus norvegicus) 6480464 Chlorodiphenyl (54% Chlorine) results in increased expression of CYP3A2 mRNA CTD PMID:22659317 CYP3A4 Human arsane decreases activity ISO Cyp3a2 (Rattus norvegicus) 6480464 Arsenic results in decreased activity of CYP3A4 protein CTD PMID:19932728 CYP3A4 Human arsane multiple interactions EXP 6480464 [Estradiol co-treated with [sodium arsenite results in increased abundance of Arsenic]] results in increased expression more ... CTD PMID:35747940 CYP3A4 Human arsane multiple interactions ISO Cyp3a2 (Rattus norvegicus) 6480464 Arsenic inhibits the reaction [Acetaminophen results in increased activity of CYP3A4 protein] CTD PMID:19932728 CYP3A4 Human arsenic atom multiple interactions ISO Cyp3a2 (Rattus norvegicus) 6480464 Arsenic inhibits the reaction [Acetaminophen results in increased activity of CYP3A4 protein] CTD PMID:19932728 CYP3A4 Human arsenic atom multiple interactions EXP 6480464 [Estradiol co-treated with [sodium arsenite results in increased abundance of Arsenic]] results in increased expression more ... CTD PMID:35747940 CYP3A4 Human arsenic atom decreases activity ISO Cyp3a2 (Rattus norvegicus) 6480464 Arsenic results in decreased activity of CYP3A4 protein CTD PMID:19932728 CYP3A4 Human arsenite(3-) multiple interactions ISO Cyp3a2 (Rattus norvegicus) 6480464 arsenite inhibits the reaction [Rifampin results in increased expression of and results in increased activity more ... CTD PMID:22159698 CYP3A4 Human arsenous acid increases expression EXP 6480464 Arsenic Trioxide results in increased expression of CYP3A4 mRNA CTD PMID:20458559 CYP3A4 Human arsenous acid multiple interactions EXP 6480464 Arsenic Trioxide inhibits the reaction [Rifampin results in increased expression of CYP3A4 protein] CTD PMID:16184197 CYP3A4 Human Artemetin increases activity EXP 6480464 artemetin results in increased activity of CYP3A4 protein CTD PMID:31756459 CYP3A4 Human Artemetin multiple interactions EXP 6480464 [[artemetin results in increased activity of CYP3A4 protein] which results in increased metabolism of Midazolam] more ... CTD PMID:31756459 CYP3A4 Human asiaticoside decreases activity EXP 6480464 asiaticoside results in decreased activity of CYP3A4 protein CTD PMID:21349323 CYP3A4 Human astemizole increases degradation EXP 6480464 CYP3A4 protein results in increased degradation of Astemizole CTD PMID:15684493 CYP3A4 Human atazanavir sulfate multiple interactions EXP 6480464 [Atazanavir Sulfate co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated more ... CTD PMID:32152650 CYP3A4 Human atazanavir sulfate decreases expression EXP 6480464 Atazanavir Sulfate results in decreased expression of CYP3A4 mRNA CTD PMID:32152650 CYP3A4 Human atorvastatin calcium increases expression EXP 6480464 Atorvastatin results in increased expression of CYP3A4 protein CTD PMID:26616219 CYP3A4 Human atorvastatin calcium decreases expression ISO Cyp3a2 (Rattus norvegicus) 6480464 Atorvastatin results in decreased expression of CYP3A4 mRNA; Atorvastatin results in decreased expression of CYP3A4 more ... CTD PMID:30086269 CYP3A4 Human atorvastatin calcium decreases activity ISO Cyp3a2 (Rattus norvegicus) 6480464 Atorvastatin results in decreased activity of CYP3A4 protein CTD PMID:30086269 CYP3A4 Human atorvastatin calcium multiple interactions ISO Cyp3a2 (Rattus norvegicus) 6480464 Atorvastatin promotes the reaction [Berberine results in decreased activity of CYP3A4 protein]; Berberine promotes the more ... CTD PMID:30086269 CYP3A4 Human atorvastatin calcium affects metabolic processing EXP 6480464 CYP3A4 protein affects the metabolism of Atorvastatin CTD PMID:15963098|PMID:16011971 CYP3A4 Human atorvastatin calcium affects response to substance EXP 6480464 CYP3A4 polymorphism affects the susceptibility to Atorvastatin CTD PMID:18528690|PMID:19802823 CYP3A4 Human atorvastatin calcium increases metabolic processing EXP 6480464 CYP3A4 protein results in increased metabolism of Atorvastatin CTD PMID:18846481 CYP3A4 Human atorvastatin calcium decreases activity EXP 6480464 Atorvastatin results in decreased activity of CYP3A4 protein CTD PMID:16029222|PMID:39023798 CYP3A4 Human atorvastatin calcium multiple interactions EXP 6480464 ABCB1 alternative form affects the reaction [CYP3A4 polymorphism affects the susceptibility to Atorvastatin]; Atorvastatin inhibits more ... CTD PMID:16029222|PMID:19802823 CYP3A4 Human atrazine increases activity EXP 6480464 Atrazine results in increased activity of CYP3A4 protein CTD PMID:22310298 CYP3A4 Human atrazine decreases activity EXP 6480464 Atrazine results in decreased activity of CYP3A4 protein CTD PMID:20183062 CYP3A4 Human atrazine increases expression EXP 6480464 Atrazine results in increased expression of CYP3A4 mRNA CTD PMID:22310298|PMID:24343343 CYP3A4 Human atrazine multiple interactions EXP 6480464 [Atrazine co-treated with Chlorpyrifos co-treated with Endosulfan] results in increased expression of CYP3A4 protein; [Endosulfan more ... CTD PMID:22515965|PMID:24343343 CYP3A4 Human Auriculasin decreases activity EXP 6480464 auriculasin results in decreased activity of CYP3A4 protein CTD PMID:31515991 CYP3A4 Human Avasimibe multiple interactions EXP 6480464 avasimibe results in increased activity of and results in increased expression of CYP3A4 protein CTD PMID:19202563 CYP3A4 Human Avasimibe increases expression EXP 6480464 avasimibe results in increased expression of CYP3A4 mRNA CTD PMID:16837568 CYP3A4 Human axitinib multiple interactions EXP 6480464 [Axitinib results in decreased activity of CYP3A4 protein] which results in decreased metabolism of Loperamide CTD PMID:31299239 CYP3A4 Human axitinib decreases activity EXP 6480464 Axitinib results in decreased activity of CYP3A4 protein CTD PMID:31299239 CYP3A4 Human Azamulin decreases activity EXP 6480464 azamulin results in decreased activity of CYP3A4 protein CTD PMID:15860655 CYP3A4 Human azithromycin multiple interactions EXP 6480464 Azithromycin inhibits the reaction [CYP3A4 protein results in increased hydroxylation of Testosterone] CTD PMID:16416302 CYP3A4 Human azithromycin decreases activity EXP 6480464 Azithromycin results in decreased activity of CYP3A4 protein CTD PMID:16416302 CYP3A4 Human azoxystrobin multiple interactions EXP 6480464 [azoxystrobin co-treated with cyproconazole] results in increased expression of CYP3A4 protein; [cyproconazole co-treated with azoxystrobin] more ... CTD PMID:29294346 CYP3A4 Human azoxystrobin increases expression EXP 6480464 azoxystrobin results in increased expression of CYP3A4 mRNA CTD PMID:29294346 CYP3A4 Human baicalein decreases activity EXP 6480464 baicalein results in decreased activity of CYP3A4 protein CTD PMID:21053930|PMID:29753067 CYP3A4 Human barbiturates increases expression EXP 6480464 Barbiturates results in increased expression of CYP3A4 CTD PMID:15554232|PMID:15955870 CYP3A4 Human barnidipine decreases activity EXP 6480464 mepirodipine results in decreased activity of CYP3A4 protein CTD PMID:10805063 CYP3A4 Human benfuracarb increases activity EXP 6480464 benfuracarb results in increased activity of CYP3A4 protein CTD PMID:22310298 CYP3A4 Human benfuracarb multiple interactions EXP 6480464 [CYP3A4 protein results in increased metabolism of benfuracarb] which results in increased chemical synthesis of more ... CTD PMID:24016712 CYP3A4 Human benfuracarb increases metabolic processing EXP 6480464 CYP3A4 protein results in increased metabolism of benfuracarb CTD PMID:24016712 CYP3A4 Human benfuracarb increases expression EXP 6480464 benfuracarb results in increased expression of CYP3A4 mRNA CTD PMID:22310298 CYP3A4 Human benidipine decreases activity EXP 6480464 benidipine results in decreased activity of CYP3A4 protein CTD PMID:10805063 CYP3A4 Human benidipine increases expression EXP 6480464 benidipine results in increased expression of CYP3A4 mRNA CTD PMID:27732883 CYP3A4 Human benidipine multiple interactions EXP 6480464 benidipine results in increased expression of and results in decreased activity of CYP3A4 protein CTD PMID:27732883 CYP3A4 Human benzbromarone decreases activity EXP 6480464 Benzbromarone results in decreased activity of CYP3A4 protein CTD PMID:39023798 CYP3A4 Human benzo[a]pyrene increases expression EXP 6480464 Benzo(a)pyrene results in increased expression of CYP3A4 mRNA CTD PMID:16545412|PMID:31096615 CYP3A4 Human benzo[a]pyrene decreases expression EXP 6480464 Benzo(a)pyrene results in decreased expression of CYP3A4 mRNA CTD PMID:32234424 CYP3A4 Human benzo[a]pyrene increases methylation EXP 6480464 Benzo(a)pyrene results in increased methylation of CYP3A4 promoter CTD PMID:27901495 CYP3A4 Human benzo[a]pyrene multiple interactions EXP 6480464 [[POR protein co-treated with CYP3A4 protein] results in increased susceptibility to Benzo(a)pyrene] which results in more ... CTD PMID:23845848|PMID:2509067|PMID:27913846 CYP3A4 Human benzo[a]pyrene increases metabolic processing EXP 6480464 CYP3A4 protein results in increased metabolism of Benzo(a)pyrene CTD PMID:2509067 CYP3A4 Human benzo[a]pyrene diol epoxide I multiple interactions EXP 6480464 [7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide binds to and results in increased activity of NR1I2 protein] which results in more ... CTD PMID:23845848 CYP3A4 Human Benzo[a]pyrene-7,8-diol affects metabolic processing EXP 6480464 CYP3A4 protein affects the metabolism of benzo(a)pyrene 7,8-dihydrodiol CTD PMID:2271712|PMID:2655891 CYP3A4 Human Benzo[a]pyrene-7,8-diol multiple interactions EXP 6480464 [benzo(a)pyrene 7,8-dihydrodiol binds to and results in increased activity of NR1I2 protein] which results in more ... CTD PMID:23845848|PMID:2509067 CYP3A4 Human benzo[c]phenanthrene multiple interactions EXP 6480464 [benzo(c)phenanthrene binds to and results in increased activity of NR1I2 protein] which results in increased more ... CTD PMID:23845848 CYP3A4 Human benzoic acid multiple interactions EXP 6480464 [Amiodarone co-treated with Benzoic Acid co-treated with cyproconazole co-treated with flusilazole co-treated with enilconazole co-treated more ... CTD PMID:34273450 CYP3A4 Human benzphetamine multiple interactions EXP 6480464 Benzphetamine inhibits the reaction [CYP3A4 protein results in increased oxidation of 7-benzyloxy-4-trifluoromethylcoumarin] CTD PMID:19299527 CYP3A4 Human benzyl isothiocyanate decreases expression ISO Cyp3a2 (Rattus norvegicus) 6480464 benzyl isothiocyanate results in decreased expression of CYP3A2 mRNA CTD PMID:22664424 CYP3A4 Human benzyl isothiocyanate decreases activity ISO Cyp3a2 (Rattus norvegicus) 6480464 benzyl isothiocyanate results in decreased activity of CYP3A2 protein CTD PMID:22664424 CYP3A4 Human bepridil affects metabolic processing EXP 6480464 CYP3A4 protein affects the metabolism of Bepridil CTD PMID:15286053 CYP3A4 Human berberine multiple interactions EXP 6480464 [Berberine results in increased activity of NR1I2 protein] which results in increased expression of CYP3A4 more ... CTD PMID:21524698 CYP3A4 Human berberine multiple interactions ISO Cyp3a2 (Rattus norvegicus) 6480464 Atorvastatin promotes the reaction [Berberine results in decreased activity of CYP3A4 protein]; Berberine promotes the more ... CTD PMID:30086269 CYP3A4 Human berberine decreases activity ISO Cyp3a2 (Rattus norvegicus) 6480464 Berberine results in decreased activity of CYP3A4 protein CTD PMID:30086269 CYP3A4 Human berberine decreases expression ISO Cyp3a2 (Rattus norvegicus) 6480464 Berberine results in decreased expression of CYP3A4 mRNA; Berberine results in decreased expression of CYP3A4 more ... CTD PMID:30086269 CYP3A4 Human bergomottin decreases activity EXP 6480464 bergamottin results in decreased activity of CYP3A4 protein CTD PMID:11451028|PMID:15860655 CYP3A4 Human bergomottin increases expression EXP 6480464 bergamottin results in increased expression of CYP3A4 mRNA CTD PMID:19148864 CYP3A4 Human Besigomsin increases expression EXP 6480464 schizandrol B results in increased expression of CYP3A4 mRNA CTD PMID:16267138 CYP3A4 Human beta-carboline multiple interactions EXP 6480464 CYP3A4 protein affects the metabolism of [norharman co-treated with aniline] CTD PMID:15279827 CYP3A4 Human beta-carotene multiple interactions EXP 6480464 beta Carotene promotes the reaction [[RXRA protein binds to NR1I2 protein] which results in increased more ... CTD PMID:16632523 CYP3A4 Human beta-naphthoflavone decreases expression EXP 6480464 beta-Naphthoflavone results in decreased expression of CYP3A4 mRNA CTD PMID:16837568|PMID:16985168|PMID:22258563 CYP3A4 Human beta-naphthoflavone multiple interactions ISO Cyp3a2 (Rattus norvegicus) 6480464 [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in decreased expression of CYP3A2 mRNA; [Phenobarbital co-treated with beta-Naphthoflavone] more ... CTD PMID:18164116|PMID:26880746|PMID:30842367 CYP3A4 Human beta-naphthoflavone increases activity ISO Cyp3a2 (Rattus norvegicus) 6480464 beta-Naphthoflavone results in increased activity of CYP3A2 protein CTD PMID:26880746 CYP3A4 Human beta-naphthoflavone multiple interactions EXP 6480464 [[beta-Naphthoflavone results in increased activity of CYP3A4 protein] which results in increased metabolism of Midazolam] more ... CTD PMID:31756459 CYP3A4 Human beta-naphthoflavone increases activity EXP 6480464 beta-Naphthoflavone results in increased activity of CYP3A4 protein CTD PMID:31756459 CYP3A4 Human beta-naphthoflavone affects binding EXP 6480464 beta-Naphthoflavone binds to CYP3A4 protein CTD PMID:21053930 CYP3A4 Human beta-naphthoflavone increases expression EXP 6480464 beta-Naphthoflavone results in increased expression of CYP3A4 mRNA CTD PMID:22258563 CYP3A4 Human beta-tocotrienol increases expression EXP 6480464 tocotrienol, beta results in increased expression of CYP3A4 CTD PMID:15269186 CYP3A4 Human Betanin multiple interactions ISO Cyp3a2 (Rattus norvegicus) 6480464 betanin inhibits the reaction [Paraquat results in increased expression of CYP3A2 mRNA] CTD PMID:24799198 CYP3A4 Human bexarotene multiple interactions ISO Cyp3a2 (Rattus norvegicus) 6480464 [Bexarotene co-treated with Tamoxifen] results in increased expression of CYP3A11 mRNA CTD PMID:17630414 CYP3A4 Human bifenthrin increases expression EXP 6480464 bifenthrin results in increased expression of CYP3A4 mRNA CTD PMID:19249324 CYP3A4 Human bifonazole decreases activity EXP 6480464 bifonazole results in decreased activity of CYP3A4 protein CTD PMID:15135088 CYP3A4 Human bilirubin IXalpha increases expression EXP 6480464 Bilirubin results in increased expression of CYP3A4 mRNA CTD PMID:15382119 CYP3A4 Human bilirubin IXalpha multiple interactions ISO Cyp3a2 (Rattus norvegicus) 6480464 [CYP3A23-3A1 gene mutant form co-treated with CYP3A2 gene mutant form] results in increased abundance of more ... CTD PMID:34461081 CYP3A4 Human bilirubin IXalpha multiple interactions EXP 6480464 IL1B protein inhibits the reaction [Bilirubin results in increased expression of CYP3A4 mRNA] CTD PMID:15382119 CYP3A4 Human bioresmethrin increases expression EXP 6480464 bioresmethrin results in increased expression of CYP3A4 mRNA CTD PMID:19249324 CYP3A4 Human bis(2-ethylhexyl) phthalate multiple interactions EXP 6480464 [Dexamethasone co-treated with Diethylhexyl Phthalate] results in increased activity of CYP3A4 protein; [Dexamethasone co-treated with more ... CTD PMID:11581012|PMID:18332045|PMID:34801851|PMID:36893891 CYP3A4 Human bis(2-ethylhexyl) phthalate increases expression EXP 6480464 Diethylhexyl Phthalate results in increased expression of CYP3A4 mRNA CTD PMID:34801851|PMID:39341470 CYP3A4 Human bis(2-ethylhexyl) phthalate increases expression ISO Cyp3a2 (Rattus norvegicus) 6480464 Diethylhexyl Phthalate results in increased expression of CYP3A2 mRNA CTD PMID:19850644 CYP3A4 Human bis(2-ethylhexyl) phthalate increases activity EXP 6480464 Diethylhexyl Phthalate results in increased activity of CYP3A4 protein CTD PMID:21742782 CYP3A4 Human bisphenol A multiple interactions EXP 6480464 [bisphenol A binds to CYP3A4 promoter] which results in decreased expression of CYP3A4 mRNA; [CYP3A4 more ... CTD PMID:11581012|PMID:12851153|PMID:21402134|PMID:36893891 CYP3A4 Human bisphenol A increases expression ISO Cyp3a2 (Rattus norvegicus) 6480464 bisphenol A results in increased expression of CYP3A2 protein CTD PMID:32145629 CYP3A4 Human bisphenol A decreases expression ISO Cyp3a2 (Rattus norvegicus) 6480464 bisphenol A results in decreased expression of CYP3A4 mRNA; bisphenol A results in decreased expression more ... CTD PMID:25181051 CYP3A4 Human bisphenol A multiple interactions ISO Cyp3a2 (Rattus norvegicus) 6480464 [bisphenol A co-treated with Genistein] results in decreased methylation of CYP3A2 gene CTD PMID:28505145 CYP3A4 Human bisphenol A increases methylation ISO Cyp3a2 (Rattus norvegicus) 6480464 bisphenol A results in increased methylation of CYP3A2 gene CTD PMID:28505145 CYP3A4 Human bisphenol A affects expression ISO Cyp3a2 (Rattus norvegicus) 6480464 bisphenol A affects the expression of CYP3A2 mRNA CTD PMID:30903817|PMID:32145629 CYP3A4 Human bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of CYP3A4 mRNA; bisphenol A results in increased expression more ... CTD PMID:15650019|PMID:22214767|PMID:23384967|PMID:26196221|PMID:27177772|PMID:36893891 CYP3A4 Human bisphenol A increases glutathionylation EXP 6480464 CYP3A4 protein results in increased glutathionylation of bisphenol A; CYP3A4 protein results in increased glutathionylation more ... CTD PMID:23470418 CYP3A4 Human bisphenol A increases hydroxylation EXP 6480464 CYP3A4 protein results in increased hydroxylation of bisphenol A; CYP3A4 protein results in increased hydroxylation more ... CTD PMID:23470418 CYP3A4 Human bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of CYP3A4 mRNA CTD PMID:24793377 CYP3A4 Human bisphenol A increases activity EXP 6480464 bisphenol A results in increased activity of CYP3A4 protein CTD PMID:23384967 CYP3A4 Human bisphenol A increases metabolic processing EXP 6480464 CYP3A4 protein results in increased metabolism of bisphenol A CTD PMID:21402134 CYP3A4 Human bisphenol AF increases hydroxylation EXP 6480464 CYP3A4 protein results in increased hydroxylation of bisphenol AF CTD PMID:23470418 CYP3A4 Human Bisphenol B increases expression EXP 6480464 bisphenol B results in increased expression of CYP3A4 mRNA CTD PMID:22214767 CYP3A4 Human bisphenol F increases hydroxylation EXP 6480464 CYP3A4 protein results in increased hydroxylation of 4,4'-bisphenol F CTD PMID:23470418 CYP3A4 Human bisphenol F increases glutathionylation EXP 6480464 CYP3A4 protein results in increased glutathionylation of 4,4'-bisphenol F CTD PMID:23470418 CYP3A4 Human bortezomib affects metabolic processing EXP 6480464 CYP3A4 protein affects the metabolism of Bortezomib CTD PMID:15764713 CYP3A4 Human bosentan increases expression EXP 6480464 Bosentan results in increased expression of CYP3A4 mRNA CTD PMID:18332078|PMID:29761207 CYP3A4 Human brequinar increases expression EXP 6480464 brequinar results in increased expression of CYP3A4 mRNA CTD PMID:39900124 CYP3A4 Human Bromadiolone decreases response to substance ISO Cyp3a2 (Rattus norvegicus) 6480464 CYP3A2 protein results in decreased susceptibility to bromadiolone CTD PMID:18080289 CYP3A4 Human Bromadiolone increases expression ISO Cyp3a2 (Rattus norvegicus) 6480464 bromadiolone results in increased expression of CYP3A2 mRNA CTD PMID:18080289 CYP3A4 Human bromfenac increases metabolic processing EXP 6480464 CYP3A4 protein results in increased metabolism of bromfenac metabolite CTD PMID:31815452 CYP3A4 Human bromocriptine affects binding EXP 6480464 Bromocriptine binds to CYP3A4 protein CTD PMID:17198380 CYP3A4 Human bromocriptine multiple interactions EXP 6480464 Bromocriptine inhibits the reaction [CYP3A4 protein results in increased oxidation of 7-benzyloxy-4-trifluoromethylcoumarin] CTD PMID:19299527 CYP3A4 Human bromocriptine affects metabolic processing EXP 6480464 CYP3A4 protein affects the metabolism of Bromocriptine CTD PMID:15286053 CYP3A4 Human bromodichloromethane increases metabolic processing EXP 6480464 CYP3A4 protein results in increased metabolism of bromodichloromethane CTD PMID:12076521 CYP3A4 Human brotizolam affects metabolic processing EXP 6480464 CYP3A4 protein affects the metabolism of brotizolam CTD PMID:16042670 CYP3A4 Human brotizolam multiple interactions EXP 6480464 Erythromycin inhibits the reaction [CYP3A4 protein affects the metabolism of brotizolam] CTD PMID:16042670 CYP3A4 Human budesonide increases expression EXP 6480464 Budesonide results in increased expression of CYP3A4 mRNA CTD PMID:19562681 CYP3A4 Human budesonide decreases expression ISO Cyp3a2 (Rattus norvegicus) 6480464 Budesonide results in decreased expression of CYP3A2 mRNA CTD PMID:20888898 CYP3A4 Human budesonide multiple interactions EXP 6480464 [Budesonide results in increased activity of NR1I2 protein] which results in increased expression of CYP3A4 more ... CTD PMID:25455453 CYP3A4 Human bufalin multiple interactions EXP 6480464 bufalin promotes the reaction [CYP3A4 protein results in increased metabolism of Midazolam]; bufalin results in more ... CTD PMID:22178124 CYP3A4 Human bufalin increases metabolic processing EXP 6480464 CYP3A4 protein results in increased metabolism of bufalin CTD PMID:22178124 CYP3A4 Human bufalin increases expression EXP 6480464 bufalin results in increased expression of CYP3A4 mRNA CTD PMID:22178124 CYP3A4 Human bufogenin increases metabolic processing EXP 6480464 CYP3A4 protein results in increased metabolism of bufogenin CTD PMID:22178124 CYP3A4 Human bufogenin increases expression EXP 6480464 bufogenin results in increased expression of CYP3A4 mRNA CTD PMID:22178124 CYP3A4 Human bufogenin increases activity EXP 6480464 bufogenin results in increased activity of CYP3A4 protein CTD PMID:22178124 CYP3A4 Human bufogenin multiple interactions EXP 6480464 bufogenin promotes the reaction [CYP3A4 protein results in increased metabolism of Midazolam]; Ketoconazole inhibits the more ... CTD PMID:22178124 CYP3A4 Human Bufotalin increases hydroxylation EXP 6480464 CYP3A4 protein results in increased hydroxylation of bufotalin CTD PMID:30778299 CYP3A4 Human buprenorphine affects metabolic processing EXP 6480464 CYP3A4 protein affects the metabolism of Buprenorphine CTD PMID:16010532 CYP3A4 Human buprenorphine increases metabolic processing EXP 6480464 CYP3A4 protein results in increased metabolism of Buprenorphine CTD PMID:12756210 CYP3A4 Human buprenorphine decreases alkylation EXP 6480464 CYP3A4 protein results in decreased alkylation of Buprenorphine CTD PMID:15966752 CYP3A4 Human buprenorphine decreases activity EXP 6480464 Buprenorphine results in decreased activity of CYP3A4 protein CTD PMID:12756210 CYP3A4 Human buspirone increases oxidation EXP 6480464 CYP3A4 protein results in increased oxidation of Buspirone CTD PMID:15640381 CYP3A4 Human buspirone increases metabolic processing EXP 6480464 CYP3A4 protein results in increased metabolism of Buspirone CTD PMID:20716633 CYP3A4 Human buspirone multiple interactions EXP 6480464 resveratrol inhibits the reaction [CYP3A4 protein results in increased metabolism of Buspirone] CTD PMID:20716633 CYP3A4 Human butachlor increases metabolic processing EXP 6480464 CYP3A4 protein results in increased metabolism of butachlor CTD PMID:11133395 CYP3A4 Human butan-1-ol multiple interactions ISO Cyp3a2 (Rattus norvegicus) 6480464 1-Butanol promotes the reaction [Toluene results in increased expression of CYP3A2 mRNA] CTD PMID:17209515 CYP3A4 Human Butylbenzyl phthalate increases expression EXP 6480464 butylbenzyl phthalate results in increased expression of CYP3A4 protein CTD PMID:33965509 CYP3A4 Human C.I. Natural Red 20 decreases activity EXP 6480464 shikonin results in decreased activity of CYP3A4 protein CTD PMID:28941798 CYP3A4 Human C.I. Natural Red 20 multiple interactions ISO Cyp3a2 (Rattus norvegicus) 6480464 shikonin inhibits the reaction [CYP3A2 protein results in increased hydroxylation of Midazolam] CTD PMID:28941798 CYP3A4 Human C.I. Natural Red 20 decreases activity ISO Cyp3a2 (Rattus norvegicus) 6480464 shikonin results in decreased activity of CYP3A2 protein CTD PMID:28941798 CYP3A4 Human cabozantinib multiple interactions EXP 6480464 Ketoconazole affects the reaction [CYP3A4 polymorphism affects the metabolism of cabozantinib]; Ketoconazole inhibits the reaction more ... CTD PMID:31293154 CYP3A4 Human cabozantinib increases metabolic processing EXP 6480464 CYP3A4 protein results in increased metabolism of cabozantinib CTD PMID:31293154 CYP3A4 Human cabozantinib affects metabolic processing EXP 6480464 CYP3A4 polymorphism affects the metabolism of cabozantinib; CYP3A4 protein alternative form affects the metabolism of more ... CTD PMID:31293154|PMID:34648813 CYP3A4 Human cafestol multiple interactions ISO Cyp3a2 (Rattus norvegicus) 6480464 [cafestol co-treated with kahweol] results in decreased expression of CYP3A2; [cafestol co-treated with kahweol] results more ... CTD PMID:11346484|PMID:9744531 CYP3A4 Human caffeine decreases activity EXP 6480464 Caffeine results in decreased activity of CYP3A4 protein CTD PMID:24211539|PMID:39023798 CYP3A4 Human calciol increases expression EXP 6480464 Cholecalciferol metabolite results in increased expression of CYP3A4; Cholecalciferol results in increased expression of CYP3A4 more ... CTD PMID:11991950|PMID:16207822 CYP3A4 Human calciol decreases activity EXP 6480464 Cholecalciferol results in decreased activity of CYP3A4 protein CTD PMID:18420780 CYP3A4 Human calciol increases hydroxylation EXP 6480464 CYP3A4 protein results in increased hydroxylation of Cholecalciferol CTD PMID:16207822 CYP3A4 Human calciol multiple interactions EXP 6480464 Ketoconazole inhibits the reaction [CYP3A4 protein results in increased hydroxylation of Cholecalciferol]; Phenytoin promotes the more ... CTD PMID:16207822 CYP3A4 Human calcitriol multiple interactions EXP 6480464 2-acetyltributylcitrate promotes the reaction [Calcitriol results in increased expression of CYP3A4 mRNA]; [Calcitriol binds to more ... CTD PMID:15489543|PMID:15578590|PMID:17270371|PMID:17965521|PMID:19766177|PMID:21742782|PMID:29782822 CYP3A4 Human calcitriol multiple interactions ISO Cyp3a2 (Rattus norvegicus) 6480464 Chenodeoxycholic Acid inhibits the reaction [Calcitriol results in increased expression of CYP3A2 mRNA] CTD PMID:20006981 CYP3A4 Human calcitriol increases expression EXP 6480464 [Calcitriol results in increased expression of NR1I2 protein] which results in increased expression of CYP3A4 more ... CTD PMID:11723248|PMID:15992766|PMID:17270371|PMID:17965521|PMID:19562681|PMID:21742782|PMID:22687401|PMID:26366751|PMID:27107558|PMID:29782822 CYP3A4 Human calcitriol increases expression ISO Cyp3a2 (Rattus norvegicus) 6480464 Calcitriol results in increased expression of CYP3A2 mRNA CTD PMID:20006981 CYP3A4 Human calcitriol increases activity EXP 6480464 Calcitriol results in increased activity of CYP3A4 protein CTD PMID:19766177 CYP3A4 Human camptothecin multiple interactions EXP 6480464 Camptothecin inhibits the reaction [Rifampin results in increased expression of CYP3A4 mRNA] CTD PMID:29356861 CYP3A4 Human cannabidiol decreases activity EXP 6480464 Cannabidiol results in decreased activity of CYP3A4 protein CTD PMID:24667653 CYP3A4 Human capsaicin decreases activity EXP 6480464 Capsaicin results in decreased activity of CYP3A4 protein CTD PMID:20388821 CYP3A4 Human capsaicin decreases expression ISO Cyp3a2 (Rattus norvegicus) 6480464 Capsaicin results in decreased expression of CYP3A2 mRNA; Capsaicin results in decreased expression of CYP3A2 more ... CTD PMID:24013073 CYP3A4 Human captan multiple interactions EXP 6480464 [Omite co-treated with Diphenylamine co-treated with phosalone co-treated with Captan co-treated with N-dichlorofluoromethylthio-N',N'-dimethyl-N-p-tolylsulfamide] results in more ... CTD PMID:25028461 CYP3A4 Human carbamazepine multiple interactions EXP 6480464 [Carbamazepine results in increased expression of CYP3A4 protein] which results in decreased abundance of Ethinyl more ... CTD PMID:10219967|PMID:12606595|PMID:15915352|PMID:16390352|PMID:22524704|PMID:23397584 CYP3A4 Human carbamazepine decreases activity EXP 6480464 Carbamazepine results in decreased activity of CYP3A4 protein CTD PMID:39023798 CYP3A4 Human carbamazepine multiple interactions ISO Cyp3a2 (Rattus norvegicus) 6480464 [SOD2 co-treated with CYP3A4] affects the susceptibility to Carbamazepine CTD PMID:19501153 CYP3A4 Human carbamazepine increases expression EXP 6480464 Carbamazepine results in increased expression of CYP3A4 mRNA; Carbamazepine results in increased expression of CYP3A4 more ... CTD PMID:10219967|PMID:12505310|PMID:12673034|PMID:16837568|PMID:17112801|PMID:17954527|PMID:22524704 CYP3A4 Human carbamazepine increases metabolic processing EXP 6480464 CYP3A4 protein results in increased metabolism of Carbamazepine CTD PMID:12606595|PMID:19255940 CYP3A4 Human carbamazepine increases activity EXP 6480464 Carbamazepine results in increased activity of CYP3A4 protein CTD PMID:12065438|PMID:9512926 CYP3A4 Human carbamazepine affects metabolic processing EXP 6480464 CYP3A4 protein affects the metabolism of Carbamazepine CTD PMID:15286053|PMID:15915352 CYP3A4 Human carbamazepine-10,11-epoxide affects chemical synthesis EXP 6480464 CYP3A4 protein affects the chemical synthesis of carbamazepine epoxide CTD PMID:15915352 CYP3A4 Human carbamazepine-10,11-epoxide multiple interactions EXP 6480464 [CYP3A4 protein results in increased metabolism of Carbamazepine] which results in increased chemical synthesis of more ... CTD PMID:12606595|PMID:15915352 CYP3A4 Human carbaryl increases expression EXP 6480464 Carbaryl results in increased expression of CYP3A4 mRNA CTD PMID:22310298 CYP3A4 Human carbendazim increases expression EXP 6480464 carbendazim results in increased expression of CYP3A4 mRNA CTD PMID:22310298 CYP3A4 Human carbofuran multiple interactions EXP 6480464 [CYP3A4 protein results in increased metabolism of benfuracarb] which results in increased chemical synthesis of more ... CTD PMID:15560889|PMID:24016712 CYP3A4 Human carbofuran increases chemical synthesis EXP 6480464 CYP3A4 protein results in increased chemical synthesis of Carbofuran CTD PMID:24016712 CYP3A4 Human carbofuran increases expression EXP 6480464 Carbofuran results in increased expression of CYP3A4 mRNA CTD PMID:22310298 CYP3A4 Human carbofuran increases activity EXP 6480464 Carbofuran results in increased activity of CYP3A4 protein CTD PMID:22310298 CYP3A4 Human carbofuran increases hydroxylation EXP 6480464 CYP3A4 protein results in increased hydroxylation of Carbofuran CTD PMID:15560889 CYP3A4 Human carbosulfan decreases activity EXP 6480464 carbosulfan results in decreased activity of CYP3A4 protein CTD PMID:20307514 CYP3A4 Human carbosulfan multiple interactions EXP 6480464 CYP3A4 protein results in increased metabolism of and results in increased activity of carbosulfan; Ketoconazole more ... CTD PMID:20307514 CYP3A4 Human carbosulfan increases expression EXP 6480464 carbosulfan results in increased expression of CYP3A4 mRNA CTD PMID:22310298 CYP3A4 Human carbosulfan increases activity EXP 6480464 carbosulfan results in increased activity of CYP3A4 protein CTD PMID:22310298 CYP3A4 Human carfentanil increases metabolic processing EXP 6480464 CYP3A4 protein results in increased metabolism of carfentanil CTD PMID:33652071 CYP3A4 Human carmustine multiple interactions EXP 6480464 CYP3A4 gene affects the susceptibility to [Carmustine co-treated with Cyclophosphamide co-treated with Cisplatin] CTD PMID:16087946 CYP3A4 Human Carnosol decreases activity EXP 6480464 carnosol results in decreased activity of CYP3A4 protein CTD PMID:34592323 CYP3A4 Human carvedilol increases metabolic processing ISO Cyp3a2 (Rattus norvegicus) 6480464 CYP3A2 protein results in increased metabolism of Carvedilol CTD PMID:29415952 CYP3A4 Human cefaclor increases expression EXP 6480464 Cefaclor results in increased expression of CYP3A4 mRNA; Cefaclor results in increased expression of CYP3A4 more ... CTD PMID:18505790 CYP3A4 Human cefadroxil increases expression EXP 6480464 Cefadroxil results in increased expression of CYP3A4 mRNA; Cefadroxil results in increased expression of CYP3A4 more ... CTD PMID:18505790 CYP3A4 Human celecoxib decreases activity EXP 6480464 Celecoxib results in decreased activity of CYP3A4 protein CTD PMID:39023798 CYP3A4 Human cerivastatin increases metabolic processing EXP 6480464 CYP3A4 protein results in increased metabolism of cerivastatin CTD PMID:15365880 CYP3A4 Human cetirizine decreases activity EXP 6480464 Cetirizine analog results in decreased activity of CYP3A4 protein; Cetirizine results in decreased activity of more ... CTD PMID:15482930 CYP3A4 Human CGP 52608 multiple interactions EXP 6480464 CGP 52608 promotes the reaction [RORA protein binds to CYP3A4 gene] CTD PMID:28238834 CYP3A4 Human chelidonine increases metabolic processing EXP 6480464 CYP3A4 protein results in increased metabolism of chelidonine CTD PMID:31102647 CYP3A4 Human chelidonine multiple interactions EXP 6480464 [CYP3A4 protein results in increased metabolism of chelidonine] which results in increased abundance of Glutathione more ... CTD PMID:31102647 CYP3A4 Human chenodeoxycholic acid multiple interactions EXP 6480464 [Atazanavir Sulfate co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated more ... CTD PMID:19299527|PMID:32152650|PMID:33819548|PMID:36473578 CYP3A4 Human chenodeoxycholic acid increases hydroxylation EXP 6480464 CYP3A4 protein results in increased hydroxylation of Chenodeoxycholic Acid CTD PMID:36473578 CYP3A4 Human chenodeoxycholic acid decreases activity ISO Cyp3a2 (Rattus norvegicus) 6480464 Chenodeoxycholic Acid results in decreased activity of CYP3A2 protein CTD PMID:8889968 CYP3A4 Human chenodeoxycholic acid multiple interactions ISO Cyp3a2 (Rattus norvegicus) 6480464 [CYP3A23-3A1 gene mutant form co-treated with CYP3A2 gene mutant form] results in increased abundance of more ... CTD PMID:20006981|PMID:34461081 CYP3A4 Human chenodeoxycholic acid decreases expression EXP 6480464 Chenodeoxycholic Acid results in decreased expression of CYP3A4 mRNA CTD PMID:27174168 CYP3A4 Human CHIR 99021 increases expression EXP 6480464 Chir 99021 results in increased expression of CYP3A4 mRNA CTD PMID:26259606 CYP3A4 Human chitosan increases activity EXP 6480464 Chitosan analog results in increased activity of CYP3A4 protein CTD PMID:20831879 CYP3A4 Human chloramphenicol multiple interactions EXP 6480464 Chloramphenicol inhibits the reaction [CYP3A4 protein results in increased oxidation of 7-benzyloxy-4-trifluoromethylcoumarin] CTD PMID:19299527 CYP3A4 Human chlordecone increases expression EXP 6480464 Chlordecone results in increased expression of CYP3A4 protein CTD PMID:15548381 CYP3A4 Human chlorfenvinfos multiple interactions EXP 6480464 [Chlorfenvinphos co-treated with ethion co-treated with Linuron] results in increased expression of CYP3A4 mRNA CTD PMID:25028461 CYP3A4 Human chlorfluazuron increases expression EXP 6480464 chlorfluazuron results in increased expression of CYP3A4 mRNA CTD PMID:22310298 CYP3A4 Human chloroquine decreases activity EXP 6480464 Chloroquine results in decreased activity of CYP3A4 protein CTD PMID:11124226 CYP3A4 Human chloroquine multiple interactions EXP 6480464 [CYP3A4 protein results in increased metabolism of Chloroquine] which results in increased abundance of desethylchloroquine CTD PMID:12756207 CYP3A4 Human chloroquine affects metabolic processing EXP 6480464 CYP3A4 protein affects the metabolism of Chloroquine CTD PMID:12920490 CYP3A4 Human chlorpromazine decreases activity EXP 6480464 Chlorpromazine results in decreased activity of CYP3A4 protein CTD PMID:15135088 CYP3A4 Human chlorpromazine decreases response to substance EXP 6480464 CYP3A4 protein results in decreased susceptibility to Chlorpromazine CTD PMID:26477383 CYP3A4 Human chlorpromazine affects oxidation EXP 6480464 CYP3A4 protein affects the oxidation of Chlorpromazine CTD PMID:20615392 CYP3A4 Human chlorpromazine affects methylation EXP 6480464 CYP3A4 protein affects the methylation of Chlorpromazine CTD PMID:20615392 CYP3A4 Human chlorpromazine multiple interactions EXP 6480464 [Chlorpromazine results in increased activity of NR1I2 protein] which results in increased expression of CYP3A4 more ... CTD PMID:17041008|PMID:23397584 CYP3A4 Human chlorpropham multiple interactions EXP 6480464 [Maleic Hydrazide co-treated with Chlorpropham] results in increased expression of CYP3A4 mRNA CTD PMID:25028461 CYP3A4 Human chlorpyrifos multiple interactions EXP 6480464 [Atrazine co-treated with Chlorpyrifos co-treated with Endosulfan] results in increased expression of CYP3A4 protein; [Endosulfan more ... CTD PMID:15560889|PMID:16790556|PMID:22515965|PMID:24343343|PMID:36893891 CYP3A4 Human chlorpyrifos affects metabolic processing ISO Cyp3a2 (Rattus norvegicus) 6480464 CYP3A2 protein affects the metabolism of Chlorpyrifos CTD PMID:15587241 CYP3A4 Human chlorpyrifos decreases activity ISO Cyp3a2 (Rattus norvegicus) 6480464 Chlorpyrifos results in decreased activity of CYP3A2 protein CTD PMID:15587241 CYP3A4 Human chlorpyrifos decreases activity EXP 6480464 Chlorpyrifos results in decreased activity of CYP3A4 protein CTD PMID:15560889|PMID:16790556|PMID:20183062 CYP3A4 Human chlorpyrifos affects metabolic processing EXP 6480464 CYP3A4 protein affects the metabolism of Chlorpyrifos CTD PMID:16190164|PMID:17079358|PMID:17110060 CYP3A4 Human chlorpyrifos increases activity EXP 6480464 Chlorpyrifos results in increased activity of CYP3A4 protein CTD PMID:22310298 CYP3A4 Human chlorpyrifos increases expression EXP 6480464 Chlorpyrifos results in increased expression of CYP3A4 mRNA; Chlorpyrifos results in increased expression of CYP3A4 more ... CTD PMID:15548381|PMID:16190164|PMID:16757081|PMID:17293382|PMID:19326769|PMID:22310298|PMID:22515965|PMID:24343343|PMID:36893891 CYP3A4 Human chlorpyrifos increases metabolic processing EXP 6480464 CYP3A4 results in increased metabolism of Chlorpyrifos CTD PMID:20709133 CYP3A4 Human chlorzoxazone affects metabolic processing ISO Cyp3a2 (Rattus norvegicus) 6480464 CYP3A2 protein affects the metabolism of Chlorzoxazone CTD PMID:15879494 CYP3A4 Human cholesterol multiple interactions EXP 6480464 [CYP3A4 protein results in increased oxidation of Cholesterol] which results in increased chemical synthesis of more ... CTD PMID:11514559|PMID:19299527 CYP3A4 Human cholesterol multiple interactions ISO Cyp3a2 (Rattus norvegicus) 6480464 [CYP3A23-3A1 gene mutant form co-treated with CYP3A2 gene mutant form] results in decreased abundance of more ... CTD PMID:34461081 CYP3A4 Human cholic acid decreases activity EXP 6480464 Cholic Acid metabolite results in decreased activity of CYP3A4 protein CTD PMID:27871908 CYP3A4 Human cholic acid multiple interactions ISO Cyp3a2 (Rattus norvegicus) 6480464 [CYP3A23-3A1 gene mutant form co-treated with CYP3A2 gene mutant form] results in increased abundance of more ... CTD PMID:34461081 CYP3A4 Human cholic acid decreases activity ISO Cyp3a2 (Rattus norvegicus) 6480464 Cholic Acid results in decreased activity of CYP3A2 protein CTD PMID:8889968 CYP3A4 Human cholic acid multiple interactions EXP 6480464 Cholic Acid promotes the reaction [CYP3A4 protein results in increased oxidation of 7-benzyloxy-4-trifluoromethylcoumarin] CTD PMID:19299527 CYP3A4 Human choline multiple interactions ISO Cyp3a2 (Rattus norvegicus) 6480464 [Choline deficiency co-treated with Methionine deficiency] results in decreased activity of CYP3A2 protein; [Choline deficiency more ... CTD PMID:38663832 CYP3A4 Human chrysin multiple interactions EXP 6480464 [[chrysin results in increased activity of CYP3A4 protein] which results in increased metabolism of Midazolam] more ... CTD PMID:19766177|PMID:21053930|PMID:31756459 CYP3A4 Human chrysin increases activity EXP 6480464 chrysin results in increased activity of CYP3A4 protein CTD PMID:31756459 CYP3A4 Human chrysophanol increases metabolic processing EXP 6480464 CYP3A4 protein results in increased metabolism of chrysophanic acid CTD PMID:29698620 CYP3A4 Human chrysophanol multiple interactions EXP 6480464 [CYP3A4 protein results in increased metabolism of chrysophanic acid] which results in increased chemical synthesis more ... CTD PMID:29698620 CYP3A4 Human chrysophanol increases chemical synthesis EXP 6480464 CYP3A4 protein results in increased chemical synthesis of chrysophanic acid metabolite CTD PMID:29698620 CYP3A4 Human chrysosplenetin affects activity EXP 6480464 chrysosplenetin affects the activity of CYP3A4 protein CTD PMID:29753067 CYP3A4 Human cimetidine decreases activity EXP 6480464 Cimetidine results in decreased activity of CYP3A4 protein CTD PMID:16041596|PMID:19909766|PMID:2271712 CYP3A4 Human cimetidine decreases expression EXP 6480464 Cimetidine results in decreased expression of CYP3A4 protein CTD PMID:22733800 CYP3A4 Human cimetidine multiple interactions EXP 6480464 [Monocrotophos co-treated with Cimetidine] results in increased expression of CYP3A4 protein; Cimetidine inhibits the reaction more ... CTD PMID:18846481|PMID:19909766|PMID:22733800 CYP3A4 Human cinitapride increases metabolic processing EXP 6480464 CYP3A4 protein results in increased metabolism of cinitapride CTD PMID:17437965 CYP3A4 Human Cinobufagin increases metabolic processing EXP 6480464 CYP3A4 protein results in increased metabolism of cinobufagin CTD PMID:22178124 CYP3A4 Human Cinobufagin multiple interactions EXP 6480464 cinobufagin promotes the reaction [CYP3A4 protein results in increased metabolism of Midazolam]; cinobufagin results in more ... CTD PMID:22178124 CYP3A4 Human Cinobufagin increases expression EXP 6480464 cinobufagin results in increased expression of CYP3A4 mRNA CTD PMID:22178124 CYP3A4 Human ciprofibrate decreases expression ISO Cyp3a2 (Rattus norvegicus) 6480464 ciprofibrate results in decreased expression of CYP3A2 mRNA CTD PMID:7676460 CYP3A4 Human ciprofloxacin decreases activity EXP 6480464 Ciprofloxacin results in decreased activity of CYP3A4 protein CTD PMID:11145498 CYP3A4 Human cisapride decreases activity EXP 6480464 Cisapride results in decreased activity of CYP3A4 protein CTD PMID:15306208 CYP3A4 Human cisapride multiple interactions EXP 6480464 Cisapride inhibits the reaction [CYP3A4 protein results in increased oxidation of 7-benzyloxy-4-trifluoromethylcoumarin] CTD PMID:19299527 CYP3A4 Human cisapride affects metabolic processing EXP 6480464 CYP3A4 protein affects the metabolism of Cisapride CTD PMID:11717173 CYP3A4 Human cisapride affects chemical synthesis EXP 6480464 CYP3A4 protein affects the chemical synthesis of Cisapride metabolite CTD PMID:11717173 CYP3A4 Human cisplatin increases expression EXP 6480464 Cisplatin results in increased expression of CYP3A4 mRNA; Cisplatin results in increased expression of CYP3A4 more ... CTD PMID:15650019 CYP3A4 Human cisplatin decreases expression EXP 6480464 Cisplatin results in decreased expression of CYP3A4 protein CTD PMID:26721606 CYP3A4 Human cisplatin multiple interactions EXP 6480464 [ACE2 protein promotes the reaction [CAV1 protein results in increased expression of CYP3A4 protein]] which more ... CTD PMID:16087946|PMID:26721606|PMID:35622184 CYP3A4 Human citalopram decreases methylation EXP 6480464 CYP3A4 protein results in decreased methylation of Citalopram analog CTD PMID:9110356 CYP3A4 Human citral multiple interactions EXP 6480464 citral inhibits the reaction [CYP3A4 protein results in increased hydroxylation of Midazolam] CTD PMID:18385293 CYP3A4 Human Citreorosein increases chemical synthesis EXP 6480464 CYP3A4 protein results in increased chemical synthesis of 1,3,8-trihydroxy-6-hydroxymethylanthraquinone CTD PMID:27989148 CYP3A4 Human clarithromycin multiple interactions EXP 6480464 [Ofloxacin co-treated with Clarithromycin] inhibits the reaction [CYP3A4 protein results in increased metabolism of Theophylline]; more ... CTD PMID:10234723|PMID:11408986|PMID:16416302 CYP3A4 Human clarithromycin decreases activity EXP 6480464 Clarithromycin results in decreased activity of CYP3A4 protein CTD PMID:16416302|PMID:23748747 CYP3A4 Human clarithromycin decreases expression EXP 6480464 Clarithromycin results in decreased expression of CYP3A4 mRNA CTD PMID:16837568 CYP3A4 Human clemizole multiple interactions EXP 6480464 [clemizole results in increased activity of NR1I2 protein] which results in increased expression of CYP3A4 more ... CTD PMID:31312845 CYP3A4 Human clemizole increases expression EXP 6480464 clemizole results in increased expression of CYP3A4 mRNA CTD PMID:31312845 CYP3A4 Human climbazole increases expression ISO Cyp3a2 (Rattus norvegicus) 6480464 climbazole results in increased expression of CYP3A2 protein CTD PMID:11552297|PMID:11824557 CYP3A4 Human clindamycin multiple interactions EXP 6480464 Clindamycin results in increased expression of and results in increased activity of CYP3A4 protein CTD PMID:18505790 CYP3A4 Human clindamycin increases expression EXP 6480464 Clindamycin results in increased expression of CYP3A4 mRNA CTD PMID:18505790 CYP3A4 Human clobetasol multiple interactions EXP 6480464 [Clobetasol results in increased activity of NR1I2 protein] which results in increased expression of CYP3A4 more ... CTD PMID:25455453 CYP3A4 Human clofibrate increases expression ISO Cyp3a2 (Rattus norvegicus) 6480464 Clofibrate results in increased expression of CYP3A11 mRNA CTD PMID:18670166 CYP3A4 Human clofibric acid increases activity EXP 6480464 Clofibric Acid results in increased activity of CYP3A4 protein CTD PMID:15771232 CYP3A4 Human clofibric acid increases expression ISO Cyp3a2 (Rattus norvegicus) 6480464 Clofibric Acid results in increased expression of CYP3A2 mRNA CTD PMID:15788368 CYP3A4 Human clofibric acid multiple interactions ISO Cyp3a2 (Rattus norvegicus) 6480464 [sudan III binds to AHR protein] inhibits the reaction [[Clofibric Acid binds to PPARA protein] more ... CTD PMID:15788368 CYP3A4 Human clofibric acid increases expression EXP 6480464 Clofibric Acid results in increased expression of CYP3A4 mRNA CTD PMID:15771232 CYP3A4 Human Clofop increases expression EXP 6480464 fenofibric acid results in increased expression of CYP3A4 mRNA CTD PMID:15771232 CYP3A4 Human Clofop increases activity EXP 6480464 fenofibric acid results in increased activity of CYP3A4 protein CTD PMID:15771232 CYP3A4 Human clomiphene multiple interactions EXP 6480464 [Clomiphene results in increased activity of NR1I2 protein] which results in increased expression of CYP3A4 more ... CTD PMID:25455453 CYP3A4 Human clopidogrel affects response to substance EXP 6480464 CYP3A4 gene polymorphism affects the susceptibility to clopidogrel CTD PMID:16645157 CYP3A4 Human clopidogrel increases expression EXP 6480464 Clopidogrel results in increased expression of CYP3A4 mRNA CTD PMID:31312845 CYP3A4 Human clopidogrel increases response to substance EXP 6480464 CYP3A4 protein results in increased susceptibility to clopidogrel CTD PMID:22651985 CYP3A4 Human clopidogrel multiple interactions EXP 6480464 CYP3A4 protein results in increased oxidation of and results in increased cleavage of clopidogrel metabolite; more ... CTD PMID:19170597|PMID:22651985 CYP3A4 Human clopidogrel increases degradation EXP 6480464 CYP3A4 protein results in increased degradation of clopidogrel CTD PMID:22651985 CYP3A4 Human clothianidin increases expression EXP 6480464 clothianidin results in increased expression of CYP3A4 mRNA CTD PMID:32201337 CYP3A4 Human clothianidin multiple interactions EXP 6480464 [clothianidin co-treated with enilconazole] results in increased expression of CYP3A4 mRNA; [clothianidin co-treated with enilconazole] more ... CTD PMID:32201337 CYP3A4 Human clotrimazole decreases activity EXP 6480464 Clotrimazole results in decreased activity of CYP3A4 protein CTD PMID:15135088 CYP3A4 Human clotrimazole multiple interactions ISO Cyp3a2 (Rattus norvegicus) 6480464 Clotrimazole inhibits the reaction [CYP3A2 protein results in increased metabolism of 7-benzyloxyquinoline] CTD PMID:19858067 CYP3A4 Human clotrimazole multiple interactions EXP 6480464 Clotrimazole inhibits the reaction [CYP3A4 protein results in increased oxidation of 7-benzyloxy-4-trifluoromethylcoumarin]; Clotrimazole promotes the more ... CTD PMID:17998298|PMID:19299527|PMID:27507784 CYP3A4 Human clotrimazole increases expression EXP 6480464 Clotrimazole results in increased expression of CYP3A4 mRNA; Clotrimazole results in increased expression of CYP3A4 more ... CTD PMID:12505310|PMID:12673034|PMID:15466163|PMID:16837568|PMID:17998298|PMID:27507784|PMID:8632764 CYP3A4 Human clotrimazole increases activity EXP 6480464 Clotrimazole results in increased activity of CYP3A4 protein CTD PMID:12065438|PMID:14977870 CYP3A4 Human clozapine affects metabolic processing EXP 6480464 CYP3A4 protein affects the metabolism of Clozapine CTD PMID:15286053 CYP3A4 Human clozapine decreases activity EXP 6480464 Clozapine results in decreased activity of CYP3A4 protein CTD PMID:39023798 CYP3A4 Human clozapine increases metabolic processing EXP 6480464 CYP3A4 protein results in increased metabolism of Clozapine CTD PMID:18809730|PMID:27320963 CYP3A4 Human clozapine multiple interactions EXP 6480464 [CYP1A2 protein co-treated with CYP2C9 protein co-treated with CYP3A4 protein co-treated with CYP2D6 protein co-treated more ... CTD PMID:21402137|PMID:23397584 CYP3A4 Human Clozapine N-oxide increases abundance EXP 6480464 CYP3A4 protein results in increased abundance of clozapine N-oxide CTD PMID:27320963 CYP3A4 Human Clozapine N-oxide increases chemical synthesis EXP 6480464 CYP3A4 protein results in increased chemical synthesis of clozapine N-oxide CTD PMID:18809730 CYP3A4 Human Clozapine N-oxide multiple interactions EXP 6480464 Ketoconazole inhibits the reaction [CYP3A4 protein results in increased chemical synthesis of clozapine N-oxide] CTD PMID:18809730 CYP3A4 Human cobalt dichloride decreases expression EXP 6480464 cobaltous chloride results in decreased expression of CYP3A4 mRNA; cobaltous chloride results in decreased expression more ... CTD PMID:19695866 CYP3A4 Human cobicistat multiple interactions EXP 6480464 [[Rifampin results in increased activity of NR1I2 protein] which results in increased activity of CYP3A4 more ... CTD PMID:33629115 CYP3A4 Human codeine increases metabolic processing EXP 6480464 CYP3A4 protein results in increased metabolism of Codeine CTD PMID:16595712 CYP3A4 Human codeine multiple interactions EXP 6480464 [CYP3A4 protein results in increased metabolism of Codeine] which results in increased chemical synthesis of more ... CTD PMID:16595712 CYP3A4 Human codeine affects metabolic processing EXP 6480464 CYP3A4 protein affects the metabolism of Codeine CTD PMID:15286053 CYP3A4 Human colforsin daropate hydrochloride multiple interactions EXP 6480464 [S-(1,2-dichlorovinyl)cysteine co-treated with Colforsin] results in increased expression of CYP3A4 mRNA CTD PMID:37544576 CYP3A4 Human colforsin daropate hydrochloride increases expression EXP 6480464 Colforsin results in increased expression of CYP3A4 mRNA CTD PMID:37544576 CYP3A4 Human Columbin increases metabolic processing EXP 6480464 CYP3A4 protein results in increased metabolism of columbin CTD PMID:32162908 CYP3A4 Human cordycepin multiple interactions ISO Cyp3a2 (Rattus norvegicus) 6480464 cordycepin inhibits the reaction [pyridine results in increased expression of CYP3A2 mRNA] CTD PMID:11181506 CYP3A4 Human corticosterone multiple interactions EXP 6480464 [Corticosterone binds to CYP3A4 promoter] which results in increased expression of CYP3A4 mRNA; Corticosterone promotes more ... CTD PMID:11581012|PMID:12072427|PMID:12851153 CYP3A4 Human corticosterone increases expression EXP 6480464 Corticosterone results in increased expression of CYP3A4 mRNA; Corticosterone results in increased expression of CYP3A4 more ... CTD PMID:12072427|PMID:35301062 CYP3A4 Human cortisol increases metabolic processing EXP 6480464 CYP3A4 protein results in increased metabolism of Hydrocortisone CTD PMID:11907490 CYP3A4 Human cortisol increases expression ISO Cyp3a2 (Rattus norvegicus) 6480464 Hydrocortisone results in increased expression of CYP3A2 mRNA CTD PMID:10476907 CYP3A4 Human cortisol increases expression EXP 6480464 Hydrocortisone results in increased expression of CYP3A4 mRNA CTD PMID:12505310|PMID:23223499 CYP3A4 Human cortisol affects metabolic processing EXP 6480464 CYP3A4 protein affects the metabolism of Hydrocortisone CTD PMID:15025748|PMID:15941677|PMID:16024008 CYP3A4 Human cortisol multiple interactions EXP 6480464 CYP3A4 promoter mutant form inhibits the reaction [Hydrocortisone results in increased expression of CYP3A4 mRNA]; more ... CTD PMID:12505310|PMID:15266218 CYP3A4 Human cortisol affects hydroxylation EXP 6480464 CYP3A4 protein affects the hydroxylation of Hydrocortisone CTD PMID:2271712 CYP3A4 Human coumarin affects expression ISO Cyp3a2 (Rattus norvegicus) 6480464 coumarin affects the expression of CYP3A2 mRNA CTD PMID:16963487 CYP3A4 Human crizotinib increases expression EXP 6480464 crizotinib results in increased expression of CYP3A4 mRNA CTD PMID:23129213 CYP3A4 Human Cryptotanshinone increases expression EXP 6480464 cryptotanshinone results in increased expression of CYP3A4 protein CTD PMID:18805405 CYP3A4 Human curcumin multiple interactions EXP 6480464 [Curcumin binds to and results in increased activity of VDR protein] which results in increased more ... CTD PMID:17270371|PMID:17965521|PMID:18385293|PMID:20153625 CYP3A4 Human curcumin decreases expression EXP 6480464 Curcumin results in decreased expression of CYP3A4 mRNA CTD PMID:20816778 CYP3A4 Human curcumin increases expression EXP 6480464 Curcumin results in increased expression of CYP3A4 mRNA CTD PMID:17210444 CYP3A4 Human cycloheximide decreases expression EXP 6480464 Cycloheximide results in decreased expression of CYP3A4 mRNA CTD PMID:21466820 CYP3A4 Human cycloheximide multiple interactions ISO Cyp3a2 (Rattus norvegicus) 6480464 Cycloheximide inhibits the reaction [pyridine results in increased expression of CYP3A2 mRNA] CTD PMID:11181506 CYP3A4 Human cyclophosphamide increases expression EXP 6480464 Cyclophosphamide results in increased expression of CYP3A4 mRNA CTD PMID:18839173 CYP3A4 Human cyclophosphamide increases expression ISO Cyp3a2 (Rattus norvegicus) 6480464 Cyclophosphamide results in increased expression of CYP3A2 mRNA; Cyclophosphamide results in increased expression of CYP3A2 more ... CTD PMID:16019949 CYP3A4 Human cyclophosphamide increases hydroxylation EXP 6480464 CYP3A4 protein results in increased hydroxylation of Cyclophosphamide CTD PMID:30500380 CYP3A4 Human cyclophosphamide increases response to substance EXP 6480464 CYP3A4 protein results in increased susceptibility to Cyclophosphamide CTD PMID:26718876|PMID:30500380 CYP3A4 Human cyclophosphamide increases metabolic processing EXP 6480464 CYP3A4 protein results in increased metabolism of Cyclophosphamide CTD PMID:11377097 CYP3A4 Human cyclophosphamide affects metabolic processing EXP 6480464 CYP3A4 protein affects the metabolism of Cyclophosphamide CTD PMID:16087946 CYP3A4 Human cyclophosphamide affects response to substance EXP 6480464 CYP3A4 gene polymorphism affects the susceptibility to Cyclophosphamide CTD PMID:16087946 CYP3A4 Human cyclophosphamide multiple interactions EXP 6480464 [Cyclophosphamide results in increased activity of NR1I2 protein] which results in increased expression of CYP3A4 more ... CTD PMID:16087946|PMID:17041008|PMID:25860621|PMID:30500380 CYP3A4 Human cyclosporin A affects expression EXP 6480464 Cyclosporine affects the expression of CYP3A4 mRNA CTD PMID:24973091 CYP3A4 Human cyclosporin A decreases expression ISO Cyp3a2 (Rattus norvegicus) 6480464 Cyclosporine results in decreased expression of CYP3A4 mRNA CTD PMID:19224547 CYP3A4 Human cyclosporin A affects metabolic processing EXP 6480464 CYP3A4 protein affects the metabolism of Cyclosporine CTD PMID:15286053|PMID:15450954|PMID:15964336|PMID:15964407|PMID:8114683 CYP3A4 Human cyclosporin A increases metabolic processing EXP 6480464 CYP3A4 protein results in increased metabolism of Cyclosporine CTD PMID:20599501 CYP3A4 Human cyclosporin A increases expression EXP 6480464 Cyclosporine results in increased expression of CYP3A4 mRNA CTD PMID:12673034 CYP3A4 Human cyclosporin A multiple interactions EXP 6480464 [Cyclosporine co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with more ... CTD PMID:19299527|PMID:32152650|PMID:8114683 CYP3A4 Human cyclosporin A decreases expression EXP 6480464 Cyclosporine results in decreased expression of CYP3A4 mRNA CTD PMID:20106945|PMID:27989131|PMID:30008028|PMID:32152650|PMID:32253466 CYP3A4 Human cyfluthrin increases expression EXP 6480464 cyfluthrin results in increased expression of CYP3A4 mRNA CTD PMID:19249324 CYP3A4 Human cyhalothrin multiple interactions EXP 6480464 [procymidone co-treated with iprodione co-treated with cyprodinil co-treated with fludioxonil co-treated with cyhalothrin] results in more ... CTD PMID:25028461 CYP3A4 Human cyhalothrin increases expression ISO Cyp3a2 (Rattus norvegicus) 6480464 cyhalothrin results in increased expression of CYP3A2 mRNA CTD PMID:29727961 CYP3A4 Human cyhalothrin decreases activity EXP 6480464 cyhalothrin results in decreased activity of CYP3A4 protein CTD PMID:20183062 CYP3A4 Human cyhalothrin increases expression EXP 6480464 cyhalothrin results in increased expression of CYP3A4 mRNA; cyhalothrin results in increased expression of CYP3A4 more ... CTD PMID:19249324|PMID:22310298 CYP3A4 Human cyhalothrin increases activity EXP 6480464 cyhalothrin results in increased activity of CYP3A4 protein CTD PMID:22310298 CYP3A4 Human cylindrospermopsin decreases activity EXP 6480464 cylindrospermopsin results in decreased activity of CYP3A4 protein CTD PMID:30905859 CYP3A4 Human cypermethrin increases expression EXP 6480464 cypermethrin results in increased expression of CYP3A4 mRNA; cypermethrin results in increased expression of CYP3A4 more ... CTD PMID:15548381|PMID:22310298 CYP3A4 Human cypermethrin decreases activity EXP 6480464 cypermethrin results in decreased activity of CYP3A4 protein CTD PMID:18420780|PMID:22634058 CYP3A4 Human cypermethrin increases activity EXP 6480464 cypermethrin results in increased activity of CYP3A4 protein CTD PMID:22310298 CYP3A4 Human cyproconazole increases expression EXP 6480464 cyproconazole results in increased expression of CYP3A4 mRNA; cyproconazole results in increased expression of CYP3A4 more ... CTD PMID:29294346|PMID:29995386|PMID:33150952 CYP3A4 Human cyproconazole decreases expression EXP 6480464 cyproconazole results in decreased expression of CYP3A4 mRNA CTD PMID:38953992 CYP3A4 Human cyproconazole multiple interactions ISO Cyp3a2 (Rattus norvegicus) 6480464 [cyproconazole co-treated with epoxiconazole co-treated with prochloraz] results in increased expression of CYP3A2 mRNA; [cyproconazole more ... CTD PMID:29038839 CYP3A4 Human cyproconazole multiple interactions EXP 6480464 [Amiodarone co-treated with Benzoic Acid co-treated with cyproconazole co-treated with flusilazole co-treated with enilconazole co-treated more ... CTD PMID:29294346|PMID:34273450 CYP3A4 Human cyprodinil multiple interactions EXP 6480464 [procymidone co-treated with iprodione co-treated with cyprodinil co-treated with fludioxonil co-treated with cyhalothrin] results in more ... CTD PMID:25028461 CYP3A4 Human cyproterone acetate increases expression EXP 6480464 Cyproterone Acetate results in increased expression of CYP3A4 mRNA CTD PMID:12505310 CYP3A4 Human dabrafenib increases expression EXP 6480464 dabrafenib results in increased expression of CYP3A4 mRNA CTD PMID:34780725 CYP3A4 Human dabrafenib decreases activity EXP 6480464 dabrafenib results in decreased activity of CYP3A4 protein CTD PMID:34780725 CYP3A4 Human dabrafenib multiple interactions EXP 6480464 dabrafenib inhibits the reaction [CYP3A4 protein results in decreased susceptibility to Docetaxel] CTD PMID:34780725 CYP3A4 Human daidzein decreases activity EXP 6480464 daidzein results in decreased activity of CYP3A4 protein CTD PMID:18420780 CYP3A4 Human daidzein increases expression ISO Cyp3a2 (Rattus norvegicus) 6480464 daidzein results in increased expression of CYP3A4 mRNA CTD PMID:31870919 CYP3A4 Human dapsone affects metabolic processing EXP 6480464 CYP3A4 protein affects the metabolism of Dapsone CTD PMID:12920490|PMID:15327588 CYP3A4 Human dapsone multiple interactions ISO Cyp3a2 (Rattus norvegicus) 6480464 [SOD2 co-treated with CYP3A4] affects the susceptibility to Dapsone CTD PMID:19501153 CYP3A4 Human dapsone multiple interactions EXP 6480464 CYP3A4 protein results in increased metabolism of and results in increased susceptibility to Dapsone CTD PMID:19998329 CYP3A4 Human dauricine multiple interactions EXP 6480464 [CYP3A4 protein results in increased glutathionylation of dauricine] which results in increased chemical synthesis of more ... CTD PMID:19358519 CYP3A4 Human dauricine increases glutathionylation EXP 6480464 CYP3A4 protein results in increased glutathionylation of dauricine CTD PMID:19358519 CYP3A4 Human DDD increases expression EXP 6480464 Dichlorodiphenyldichloroethane results in increased expression of CYP3A4 mRNA CTD PMID:20686338 CYP3A4 Human DDE increases expression EXP 6480464 Dichlorodiphenyl Dichloroethylene results in increased expression of CYP3A4 mRNA CTD PMID:20686338 CYP3A4 Human DDT multiple interactions EXP 6480464 [DDT co-treated with Dieldrin] results in increased expression of CYP3A4 mRNA CTD PMID:25028461 CYP3A4 Human DDT decreases expression ISO Cyp3a2 (Rattus norvegicus) 6480464 DDT results in decreased expression of CYP3A11 protein CTD PMID:11948501 CYP3A4 Human DDT increases expression ISO Cyp3a2 (Rattus norvegicus) 6480464 DDT results in increased expression of CYP3A11 protein CTD PMID:11948501|PMID:12597452 CYP3A4 Human DDT multiple interactions ISO Cyp3a2 (Rattus norvegicus) 6480464 [DDT co-treated with Diethylnitrosamine] results in decreased expression of CYP3A2 mRNA; [DDT co-treated with Diethylnitrosamine] more ... CTD PMID:15885732 CYP3A4 Human DDT increases expression EXP 6480464 DDT results in increased expression of CYP3A4 mRNA; DDT results in increased expression of CYP3A4 more ... CTD PMID:15548381|PMID:17035600|PMID:20686338 CYP3A4 Human decabromodiphenyl ether increases expression EXP 6480464 decabromobiphenyl ether results in increased expression of CYP3A4 mRNA CTD PMID:19270788 CYP3A4 Human Dechloroethylcyclophosphamide affects chemical synthesis EXP 6480464 CYP3A4 protein affects the chemical synthesis of dechloroethylcyclophosphamide CTD PMID:15875221 CYP3A4 Human dehydroepiandrosterone increases hydroxylation EXP 6480464 CYP3A4 protein results in increased hydroxylation of Dehydroepiandrosterone CTD PMID:15845858 CYP3A4 Human dehydroepiandrosterone multiple interactions EXP 6480464 Dehydroepiandrosterone promotes the reaction [CYP3A4 protein results in increased oxidation of 7-benzyloxy-4-trifluoromethylcoumarin] CTD PMID:19299527 CYP3A4 Human dehydroepiandrosterone sulfate affects metabolic processing EXP 6480464 CYP3A4 protein affects the metabolism of Dehydroepiandrosterone Sulfate CTD PMID:2271712 CYP3A4 Human dehydroepiandrosterone sulfate multiple interactions ISO Cyp3a2 (Rattus norvegicus) 6480464 [Dehydroepiandrosterone Sulfate co-treated with Phenobarbital] results in increased expression of CYP3A2 protein CTD PMID:25786523 CYP3A4 Human delta-tocotrienol increases expression EXP 6480464 tocotrienol, delta results in increased expression of CYP3A4 CTD PMID:15269186 CYP3A4 Human delta-tocotrienol multiple interactions EXP 6480464 tocotrienol, delta inhibits the reaction [CYP3A4 protein results in increased hydroxylation of Testosterone]; tocotrienol, delta more ... CTD PMID:31102695 CYP3A4 Human deoxycholic acid affects metabolic processing EXP 6480464 CYP3A4 protein affects the metabolism of Deoxycholic Acid CTD PMID:15708356 CYP3A4 Human deoxycholic acid increases hydroxylation EXP 6480464 CYP3A4 protein results in increased hydroxylation of Deoxycholic Acid CTD PMID:36473578 CYP3A4 Human deoxycholic acid multiple interactions EXP 6480464 [Atazanavir Sulfate co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated more ... CTD PMID:32152650|PMID:33819548 CYP3A4 Human deoxycholic acid decreases expression ISO Cyp3a2 (Rattus norvegicus) 6480464 Deoxycholic Acid results in decreased expression of CYP3A2 mRNA CTD PMID:10453939 CYP3A4 Human deoxycholic acid multiple interactions ISO Cyp3a2 (Rattus norvegicus) 6480464 [CYP3A23-3A1 gene mutant form co-treated with CYP3A2 gene mutant form] results in increased abundance of more ... CTD PMID:10453939|PMID:34461081 CYP3A4 Human deoxycholic acid decreases activity ISO Cyp3a2 (Rattus norvegicus) 6480464 Deoxycholic Acid results in decreased activity of CYP3A2 protein CTD PMID:8889968 CYP3A4 Human deoxycholic acid increases expression EXP 6480464 Deoxycholic Acid metabolite results in increased expression of CYP3A4 mRNA CTD PMID:27871908 CYP3A4 Human deoxycholic acid decreases activity EXP 6480464 Deoxycholic Acid metabolite results in decreased activity of CYP3A4 protein CTD PMID:27871908 CYP3A4 Human Deoxyelephantopin multiple interactions EXP 6480464 deoxyelephantopin inhibits the reaction [CYP3A4 protein results in increased hydroxylation of Midazolam]; deoxyelephantopin inhibits the more ... CTD PMID:23876819 CYP3A4 Human Deoxyelephantopin increases expression EXP 6480464 deoxyelephantopin results in increased expression of CYP3A4 mRNA CTD PMID:23876819 CYP3A4 Human Deoxyelephantopin decreases activity EXP 6480464 deoxyelephantopin results in decreased activity of CYP3A4 protein CTD PMID:23876819 CYP3A4 Human deoxynivalenol affects expression EXP 6480464 deoxynivalenol affects the expression of CYP3A4 mRNA CTD PMID:28865950 CYP3A4 Human deoxynivalenol multiple interactions EXP 6480464 [deoxynivalenol co-treated with Zearalenone] affects the expression of CYP3A4 mRNA; [deoxynivalenol co-treated with Zearalenone] results more ... CTD PMID:28865950|PMID:28935499 CYP3A4 Human Deoxyschizandrin increases expression EXP 6480464 schizandrin A results in increased expression of CYP3A4 mRNA CTD PMID:16267138 CYP3A4 Human Desethylchloroquine decreases activity EXP 6480464 desethylchloroquine results in decreased activity of CYP3A4 protein CTD PMID:11124226 CYP3A4 Human Desethylchloroquine multiple interactions EXP 6480464 [CYP3A4 protein results in increased metabolism of Chloroquine] which results in increased abundance of desethylchloroquine CTD PMID:12756207 CYP3A4 Human desferrioxamine B decreases expression EXP 6480464 Deferoxamine results in decreased expression of CYP3A4 mRNA; Deferoxamine results in decreased expression of CYP3A4 more ... CTD PMID:19695866 CYP3A4 Human desipramine increases response to substance EXP 6480464 CYP3A4 protein results in increased susceptibility to Desipramine CTD PMID:21540358 CYP3A4 Human desipramine decreases activity EXP 6480464 Desipramine results in decreased activity of CYP3A4 protein CTD PMID:15135088 CYP3A4 Human dexamethasone affects metabolic processing EXP 6480464 CYP3A4 protein affects the metabolism of Dexamethasone CTD PMID:8114683 CYP3A4 Human dexamethasone increases expression ISO Cyp3a2 (Rattus norvegicus) 6480464 Dexamethasone results in increased expression of CYP3A11 mRNA; Dexamethasone results in increased expression of CYP3A2 more ... CTD PMID:15258109|PMID:15588932|PMID:19118567|PMID:20035846|PMID:20607812|PMID:21084653|PMID:25612170 CYP3A4 Human dexamethasone multiple interactions ISO Cyp3a2 (Rattus norvegicus) 6480464 Plant Preparations promotes the reaction [Dexamethasone results in increased expression of CYP3A2 mRNA] CTD PMID:21084653 CYP3A4 Human dexamethasone affects expression ISO Cyp3a2 (Rattus norvegicus) 6480464 Dexamethasone affects the expression of CYP3A2 mRNA CTD PMID:15102944 CYP3A4 Human dexamethasone increases activity EXP 6480464 Dexamethasone results in increased activity of CYP3A4 protein CTD PMID:10923861|PMID:11409940|PMID:12065438|PMID:18094037|PMID:19118567|PMID:22310298|PMID:23274770|PMID:23876819|PMID:23899473|PMID:9512926 CYP3A4 Human dexamethasone increases expression EXP 6480464 Dexamethasone results in increased expression of CYP3A4 mRNA; Dexamethasone results in increased expression of CYP3A4 more ... CTD PMID:10219967|PMID:10640517|PMID:12505310|PMID:12695351|PMID:15466163|PMID:15548381|PMID:16837568|PMID:17954527|PMID:18094037|PMID:19041297|PMID:19118567|PMID:19562681|PMID:20599767|PMID:20888898|PMID:22310298|PMID:22524704|PMID:23274770|PMID:24146111|PMID:39909212 CYP3A4 Human dexamethasone multiple interactions EXP 6480464 [Dexamethasone binds to CYP3A4 promoter] which results in increased expression of CYP3A4 mRNA; [Dexamethasone co-treated more ... CTD PMID:10219967|PMID:12505310|PMID:12851153|PMID:18332045|PMID:20599767|PMID:22524704|PMID:8114683 CYP3A4 Human dextromethorphan decreases methylation EXP 6480464 CYP3A4 protein results in decreased methylation of Dextromethorphan CTD PMID:15383492 CYP3A4 Human dextromethorphan increases metabolic processing EXP 6480464 CYP3A4 protein results in increased metabolism of Dextromethorphan CTD PMID:16595712|PMID:17267297 CYP3A4 Human dextromethorphan multiple interactions EXP 6480464 Dextromethorphan inhibits the reaction [[retrorsine co-treated with NADP] results in decreased activity of CYP3A4 protein] CTD PMID:19818743 CYP3A4 Human dextromethorphan increases oxidation EXP 6480464 CYP3A4 protein results in increased oxidation of Dextromethorphan CTD PMID:15383492 CYP3A4 Human dextromethorphan affects metabolic processing EXP 6480464 CYP3A4 protein affects the metabolism of Dextromethorphan CTD PMID:15988119 CYP3A4 Human dextrorphan affects metabolic processing EXP 6480464 CYP3A4 protein affects the metabolism of Dextrorphan CTD PMID:15988119 CYP3A4 Human diallyl disulfide increases expression ISO Cyp3a2 (Rattus norvegicus) 6480464 diallyl disulfide results in increased expression of CYP3A2 protein CTD PMID:16000231 CYP3A4 Human Diallyl sulfide increases expression ISO Cyp3a2 (Rattus norvegicus) 6480464 allyl sulfide results in increased expression of CYP3A11 mRNA; allyl sulfide results in increased expression more ... CTD PMID:16000231|PMID:19695238 CYP3A4 Human diarsenic trioxide increases expression EXP 6480464 Arsenic Trioxide results in increased expression of CYP3A4 mRNA CTD PMID:20458559 CYP3A4 Human diarsenic trioxide multiple interactions EXP 6480464 Arsenic Trioxide inhibits the reaction [Rifampin results in increased expression of CYP3A4 protein] CTD PMID:16184197 CYP3A4 Human diarylheptanoid decreases activity EXP 6480464 Diarylheptanoids results in decreased activity of CYP3A4 protein CTD PMID:23850985 CYP3A4 Human diarylheptanoid increases expression EXP 6480464 Diarylheptanoids results in increased expression of CYP3A4 mRNA CTD PMID:23850985 CYP3A4 Human diazepam affects metabolic processing EXP 6480464 CYP3A4 protein affects the metabolism of Diazepam CTD PMID:16048486 CYP3A4 Human diazepam increases metabolic processing EXP 6480464 CYP3A4 protein results in increased metabolism of Diazepam CTD PMID:18846481 CYP3A4 Human diazepam multiple interactions EXP 6480464 Diazepam inhibits the reaction [CYP3A4 protein results in increased oxidation of 7-benzyloxy-4-trifluoromethylcoumarin]; Diazepam promotes the more ... CTD PMID:19299527|PMID:21402137 CYP3A4 Human diazinon affects metabolic processing EXP 6480464 CYP3A4 protein affects the metabolism of Diazinon CTD PMID:15764407 CYP3A4 Human diazinon increases methylation EXP 6480464 Diazinon results in increased methylation of CYP3A4 promoter CTD PMID:35331105 CYP3A4 Human diazinon increases expression EXP 6480464 Diazinon results in increased expression of CYP3A4 mRNA CTD PMID:16757081|PMID:35331105 CYP3A4 Human diazinon multiple interactions EXP 6480464 CYP3A4 protein results in decreased sulfation of and results in increased activity of Diazinon; CYP3A4 more ... CTD PMID:11708902|PMID:15764407 CYP3A4 Human dibenziodolium multiple interactions ISO Cyp3a2 (Rattus norvegicus) 6480464 diphenyleneiodonium inhibits the reaction [beta-Naphthoflavone results in increased activity of CYP3A2 protein] CTD PMID:26880746 CYP3A4 Human dibenziodolium decreases activity ISO Cyp3a2 (Rattus norvegicus) 6480464 diphenyleneiodonium results in decreased activity of CYP3A4 protein CTD PMID:26880746 CYP3A4 Human dibutyl phthalate multiple interactions EXP 6480464 Dibutyl Phthalate promotes the reaction [NR1I2 protein results in increased expression of CYP3A4 mRNA]; Dibutyl more ... CTD PMID:21742782|PMID:36893891 CYP3A4 Human diclofenac increases expression EXP 6480464 Diclofenac results in increased expression of CYP3A4 mRNA CTD PMID:19022234|PMID:29027214 CYP3A4 Human diclofenac increases response to substance EXP 6480464 CYP3A4 protein results in increased susceptibility to Diclofenac CTD PMID:28762043 CYP3A4 Human diclofenac multiple interactions EXP 6480464 [[CYP3A4 protein co-treated with GSTP1 protein co-treated with Glutathione] results in increased hydroxylation of Diclofenac] more ... CTD PMID:23397584|PMID:24246759|PMID:28762043 CYP3A4 Human diclofenac increases metabolic processing EXP 6480464 CYP3A4 protein results in increased metabolism of Diclofenac CTD PMID:24104198|PMID:33259822 CYP3A4 Human diclofenac decreases activity EXP 6480464 Diclofenac metabolite results in decreased activity of CYP3A4 protein; Diclofenac results in decreased activity of more ... CTD PMID:15135088|PMID:28960974|PMID:39023798 CYP3A4 Human dicloxacillin multiple interactions EXP 6480464 Dicloxacillin results in increased expression of and results in increased activity of CYP3A4 protein CTD PMID:18505790 CYP3A4 Human dicloxacillin increases expression EXP 6480464 Dicloxacillin results in increased expression of CYP3A4 mRNA CTD PMID:18505790 CYP3A4 Human dieldrin multiple interactions EXP 6480464 [DDT co-treated with Dieldrin] results in increased expression of CYP3A4 mRNA; Dieldrin promotes the reaction more ... CTD PMID:12417264|PMID:25028461 CYP3A4 Human dieldrin increases expression EXP 6480464 Dieldrin results in increased expression of CYP3A4 protein CTD PMID:15548381 CYP3A4 Human diethyl phthalate increases expression ISO Cyp3a2 (Rattus norvegicus) 6480464 diethyl phthalate results in increased expression of CYP3A2 protein CTD PMID:16641546 CYP3A4 Human diethylstilbestrol increases activity EXP 6480464 Diethylstilbestrol results in increased activity of CYP3A4 protein CTD PMID:23384967 CYP3A4 Human diethylstilbestrol increases expression EXP 6480464 Diethylstilbestrol results in increased expression of CYP3A4 mRNA CTD PMID:21924250|PMID:23384967 CYP3A4 Human difenoconazole increases expression EXP 6480464 difenoconazole results in increased expression of CYP3A4 mRNA CTD PMID:33575850 CYP3A4 Human diflubenzuron affects binding EXP 6480464 Diflubenzuron binds to CYP3A4 protein CTD PMID:32278787 CYP3A4 Human dihydroartemisinin decreases activity EXP 6480464 artenimol results in decreased activity of CYP3A4 protein CTD PMID:11124226 CYP3A4 Human dihydroergotamine decreases activity EXP 6480464 Dihydroergotamine results in decreased activity of CYP3A4 protein CTD PMID:18420780 CYP3A4 Human diltiazem affects metabolic processing EXP 6480464 CYP3A4 protein affects the metabolism of Diltiazem CTD PMID:15286053 CYP3A4 Human diltiazem multiple interactions EXP 6480464 Diltiazem inhibits the reaction [CYP3A4 protein results in increased hydroxylation of Midazolam]; Diltiazem inhibits the more ... CTD PMID:19299527|PMID:22652334 CYP3A4 Human diltiazem decreases activity EXP 6480464 Diltiazem results in decreased activity of CYP3A4 protein CTD PMID:22652334 CYP3A4 Human diltiazem decreases methylation EXP 6480464 CYP3A4 protein results in decreased methylation of Diltiazem CTD PMID:15499178 CYP3A4 Human dimemorfan increases oxidation EXP 6480464 CYP3A4 protein results in increased oxidation of dimemorfan CTD PMID:19593786 CYP3A4 Human dimemorfan multiple interactions EXP 6480464 Ketoconazole inhibits the reaction [CYP3A4 protein results in increased oxidation of dimemorfan] CTD PMID:19593786 CYP3A4 Human dimethocaine decreases ethylation EXP 6480464 CYP3A4 protein results in decreased ethylation of dimethocaine CTD PMID:24309420 CYP3A4 Human dimethocaine increases hydroxylation EXP 6480464 CYP3A4 protein results in increased hydroxylation of dimethocaine CTD PMID:24309420 CYP3A4 Human dimethyl sulfoxide affects expression EXP 6480464 Dimethyl Sulfoxide affects the expression of CYP3A4 mRNA CTD PMID:12843640 CYP3A4 Human dimethyl sulfoxide multiple interactions ISO Cyp3a2 (Rattus norvegicus) 6480464 Dimethyl Sulfoxide inhibits the reaction [CYP3A2 protein results in increased metabolism of 7-benzyloxyquinoline] CTD PMID:19858067 CYP3A4 Human dimethyl sulfoxide increases expression EXP 6480464 Dimethyl Sulfoxide results in increased expression of CYP3A4 mRNA; Dimethyl Sulfoxide results in increased expression more ... CTD PMID:30262279|PMID:31096615 CYP3A4 Human dimethyl sulfoxide multiple interactions EXP 6480464 [Dimethyl Sulfoxide co-treated with TGFB1 protein] results in decreased expression of CYP3A4 mRNA; [Dimethyl Sulfoxide more ... CTD PMID:18347083|PMID:31877331|PMID:35366062 CYP3A4 Human dimethylarsinous acid increases activity EXP 6480464 dimethylarsinous acid results in increased activity of CYP3A4 protein CTD PMID:19084030 CYP3A4 Human dimethylarsinous acid increases expression EXP 6480464 dimethylarsinous acid results in increased expression of CYP3A4 mRNA; dimethylarsinous acid results in increased expression more ... CTD PMID:19084030 CYP3A4 Human dioleoyl phosphatidylcholine multiple interactions EXP 6480464 [1,2-dilauroylphosphatidylcholine co-treated with 1,2-oleoylphosphatidylcholine co-treated with Phosphatidylserines co-treated with Sodium Cholate] results in increased activity more ... CTD PMID:1627548 CYP3A4 Human dioleoyl phosphatidylcholine multiple interactions ISO Cyp3a2 (Rattus norvegicus) 6480464 [1,2-dilauroylphosphatidylcholine co-treated with 1,2-oleoylphosphatidylcholine co-treated with Phosphatidylserines co-treated with Sodium Cholate] results in increased activity more ... CTD PMID:1627548 CYP3A4 Human diosmetin multiple interactions EXP 6480464 diosmetin inhibits the reaction [CYP3A4 protein results in increased chemical synthesis of 1-hydroxymethylmidazolam]; diosmetin inhibits more ... CTD PMID:18191104 CYP3A4 Human dioxygen multiple interactions EXP 6480464 [[CYP3A4 protein co-treated with Oxygen co-treated with NADP] results in increased reduction of 4-hydroxy-2-nonenal] which more ... CTD PMID:19695866|PMID:21566342|PMID:21766881 CYP3A4 Human dioxygen decreases expression EXP 6480464 Oxygen deficiency results in decreased expression of CYP3A4 mRNA CTD PMID:19695866 CYP3A4 Human diphenylamine multiple interactions EXP 6480464 [Omite co-treated with Diphenylamine co-treated with phosalone co-treated with Captan co-treated with N-dichlorofluoromethylthio-N',N'-dimethyl-N-p-tolylsulfamide] results in more ... CTD PMID:25028461 CYP3A4 Human dipropyl disulfide increases expression ISO Cyp3a2 (Rattus norvegicus) 6480464 n-propyl disulfide results in increased expression of CYP3A2 protein CTD PMID:16000231 CYP3A4 Human Dipropyl sulfide increases expression ISO Cyp3a2 (Rattus norvegicus) 6480464 dipropyl sulfide results in increased expression of CYP3A2 protein CTD PMID:16000231 CYP3A4 Human diquat decreases expression ISO Cyp3a2 (Rattus norvegicus) 6480464 Diquat results in decreased expression of CYP3A2 mRNA CTD PMID:7676460 CYP3A4 Human disopyramide multiple interactions EXP 6480464 Clarithromycin inhibits the reaction [CYP3A4 protein results in increased metabolism of Disopyramide] CTD PMID:10234723 CYP3A4 Human disopyramide increases metabolic processing EXP 6480464 CYP3A4 protein results in increased metabolism of Disopyramide CTD PMID:10901704 CYP3A4 Human disulfiram increases response to substance EXP 6480464 CYP3A4 protein results in increased susceptibility to Disulfiram CTD PMID:21540358 CYP3A4 Human disulfiram decreases activity ISO Cyp3a2 (Rattus norvegicus) 6480464 Disulfiram results in decreased activity of CYP3A2 protein CTD PMID:9393675 CYP3A4 Human disulfiram decreases expression ISO Cyp3a2 (Rattus norvegicus) 6480464 Disulfiram results in decreased expression of CYP3A2 mRNA CTD PMID:9393675 CYP3A4 Human Dithiopyr increases expression EXP 6480464 dithiopyr results in increased expression of CYP3A4 mRNA CTD PMID:17293382 CYP3A4 Human diuron increases expression EXP 6480464 Diuron results in increased expression of CYP3A4 mRNA CTD PMID:22310298 CYP3A4 Human domperidone multiple interactions EXP 6480464 CYP3A4 protein results in increased hydroxylation of and results in decreased alkylation of Domperidone CTD PMID:15327587 CYP3A4 Human dopamine decreases activity EXP 6480464 Dopamine results in decreased activity of CYP3A4 protein CTD PMID:18420780 CYP3A4 Human doxorubicin multiple interactions EXP 6480464 [Diethylhexyl Phthalate results in increased expression of CYP3A4] which results in increased metabolism of and more ... CTD PMID:34801851 CYP3A4 Human Droloxifene decreases activity EXP 6480464 droloxifene results in decreased activity of CYP3A4 protein CTD PMID:12419016 CYP3A4 Human drometrizole increases metabolic processing EXP 6480464 CYP3A4 protein results in increased metabolism of benazol P CTD PMID:27743791 CYP3A4 Human dronedarone decreases response to substance EXP 6480464 CYP3A4 protein results in decreased susceptibility to dronedarone CTD PMID:29616291 CYP3A4 Human dronedarone multiple interactions EXP 6480464 [CYP3A4 protein results in increased metabolism of Dronedarone] which results in increased abundance of N-desbutyldronedarone; more ... CTD PMID:29616291|PMID:31756459 CYP3A4 Human dronedarone increases metabolic processing EXP 6480464 CYP3A4 protein results in increased metabolism of Dronedarone CTD PMID:29616291|PMID:31756459 CYP3A4 Human Echimidine multiple interactions EXP 6480464 [CYP3A4 protein results in increased metabolism of echimidine] which affects the expression of CDC20 mRNA; more ... CTD PMID:33884520 CYP3A4 Human Echimidine increases response to substance EXP 6480464 CYP3A4 protein results in increased susceptibility to echimidine CTD PMID:32910235 CYP3A4 Human Echimidine increases metabolic processing EXP 6480464 CYP3A4 protein results in increased metabolism of echimidine CTD PMID:33884520 CYP3A4 Human econazole decreases activity EXP 6480464 Econazole results in decreased activity of CYP3A4 protein CTD PMID:15135088 CYP3A4 Human econazole increases expression EXP 6480464 Econazole results in increased expression of CYP3A4 mRNA CTD PMID:17998298 CYP3A4 Human econazole multiple interactions EXP 6480464 Econazole promotes the reaction [NR1I2 results in increased expression of CYP3A4 mRNA]; Econazole promotes the more ... CTD PMID:17998298 CYP3A4 Human efavirenz increases activity EXP 6480464 efavirenz results in increased activity of CYP3A4 protein CTD PMID:15980690 CYP3A4 Human efavirenz increases expression EXP 6480464 efavirenz results in increased expression of CYP3A4 mRNA CTD PMID:16837568 CYP3A4 Human efavirenz decreases activity EXP 6480464 efavirenz results in decreased activity of CYP3A4 protein CTD PMID:15980690 CYP3A4 Human elemental selenium decreases expression EXP 6480464 Selenium results in decreased expression of CYP3A4 mRNA CTD PMID:19244175 CYP3A4 Human ellipticine increases metabolic processing EXP 6480464 CYP3A4 protein results in increased metabolism of ellipticine CTD PMID:22917556 CYP3A4 Human ellipticine multiple interactions EXP 6480464 [[CYP3A4 protein co-treated with NADP] results in increased oxidation of ellipticine] which results in increased more ... CTD PMID:22390216|PMID:30914192 CYP3A4 Human emodin increases oxidation EXP 6480464 CYP3A4 protein results in increased oxidation of Emodin CTD PMID:27989148 CYP3A4 Human emodin decreases activity EXP 6480464 Emodin results in decreased activity of CYP3A4 protein CTD PMID:33438235 CYP3A4 Human emodin affects response to substance EXP 6480464 CYP3A4 protein affects the susceptibility to Emodin CTD PMID:34875353 CYP3A4 Human emodin increases hydroxylation EXP 6480464 CYP3A4 protein results in increased hydroxylation of Emodin CTD PMID:30672276 CYP3A4 Human emodin multiple interactions EXP 6480464 [CYP3A4 protein co-treated with Acetylcysteine] results in increased metabolism of Emodin metabolite CTD PMID:27989148 CYP3A4 Human enalapril multiple interactions EXP 6480464 Enalapril inhibits the reaction [CYP3A4 protein results in increased oxidation of 7-benzyloxy-4-trifluoromethylcoumarin] CTD PMID:19299527 CYP3A4 Human endosulfan affects metabolic processing EXP 6480464 CYP3A4 protein affects the metabolism of Endosulfan CTD PMID:16581944|PMID:16855053 CYP3A4 Human endosulfan decreases activity EXP 6480464 Endosulfan results in decreased activity of CYP3A4 protein CTD PMID:24832206 CYP3A4 Human endosulfan increases expression EXP 6480464 Endosulfan results in increased expression of CYP3A4 mRNA; Endosulfan results in increased expression of CYP3A4 more ... CTD PMID:12417264|PMID:15548381|PMID:20361990|PMID:22515965|PMID:24343343|PMID:24832206|PMID:28673560 CYP3A4 Human endosulfan multiple interactions EXP 6480464 [Atrazine co-treated with Chlorpyrifos co-treated with Endosulfan] results in increased expression of CYP3A4 protein; [Endosulfan more ... CTD PMID:12417264|PMID:16855053|PMID:20361990|PMID:20507880|PMID:22515965|PMID:24343343|PMID:24832206|PMID:28673560 CYP3A4 Human endosulfan increases response to substance EXP 6480464 CYP3A4 protein results in increased susceptibility to Endosulfan CTD PMID:20507880 CYP3A4 Human endrin increases expression EXP 6480464 Endrin results in increased expression of CYP3A4 protein CTD PMID:15548381 CYP3A4 Human enilconazole multiple interactions EXP 6480464 [Amiodarone co-treated with Benzoic Acid co-treated with cyproconazole co-treated with flusilazole co-treated with enilconazole co-treated more ... CTD PMID:25028461|PMID:32201337|PMID:34273450 CYP3A4 Human enilconazole increases expression EXP 6480464 enilconazole results in increased expression of CYP3A4 protein CTD PMID:32201337|PMID:34273450 CYP3A4 Human enilconazole affects expression EXP 6480464 enilconazole affects the expression of CYP3A4 mRNA CTD PMID:32201337 CYP3A4 Human enilconazole decreases activity EXP 6480464 enilconazole results in decreased activity of CYP3A4 protein CTD PMID:21762035 CYP3A4 Human eplerenone increases abundance EXP 6480464 CYP3A4 protein results in increased abundance of Eplerenone metabolite CTD PMID:31408697 CYP3A4 Human eplerenone increases metabolic processing EXP 6480464 CYP3A4 protein results in increased metabolism of Eplerenone CTD PMID:31408697 CYP3A4 Human epoxiconazole increases expression EXP 6480464 epoxiconazole results in increased expression of CYP3A4 mRNA; epoxiconazole results in increased expression of CYP3A4 more ... CTD PMID:29294346 CYP3A4 Human epoxiconazole multiple interactions ISO Cyp3a2 (Rattus norvegicus) 6480464 [cyproconazole co-treated with epoxiconazole co-treated with prochloraz] results in increased expression of CYP3A2 mRNA; [cyproconazole more ... CTD PMID:29038839 CYP3A4 Human epoxiconazole increases expression ISO Cyp3a2 (Rattus norvegicus) 6480464 epoxiconazole results in increased expression of CYP3A2 mRNA CTD PMID:29038839 CYP3A4 Human epoxiconazole multiple interactions EXP 6480464 [fluxapyroxad co-treated with epoxiconazole] results in increased expression of CYP3A4 mRNA; [fluxapyroxad co-treated with epoxiconazole] more ... CTD PMID:29294346 CYP3A4 Human Erdafitinib decreases activity EXP 6480464 erdafitinib results in decreased activity of CYP3A4 protein CTD PMID:34189909 CYP3A4 Human Erdafitinib increases metabolic processing EXP 6480464 CYP3A4 protein results in increased metabolism of erdafitinib CTD PMID:34189909 CYP3A4 Human Erdafitinib multiple interactions EXP 6480464 erdafitinib inhibits the reaction [[CYP3A4 protein results in increased hydroxylation of Midazolam] which results in more ... CTD PMID:34189909 CYP3A4 Human erlotinib hydrochloride decreases activity EXP 6480464 Erlotinib Hydrochloride results in decreased activity of CYP3A4 protein CTD PMID:18839173 CYP3A4 Human erlotinib hydrochloride increases expression EXP 6480464 Erlotinib Hydrochloride results in increased expression of CYP3A4 mRNA CTD PMID:18839173 CYP3A4 Human erythromycin A increases expression EXP 6480464 Erythromycin results in increased expression of CYP3A4 mRNA; Erythromycin results in increased expression of CYP3A4 more ... CTD PMID:18505790 CYP3A4 Human erythromycin A decreases activity EXP 6480464 Erythromycin results in decreased activity of CYP3A4 protein CTD PMID:15466163|PMID:15845683|PMID:16041596|PMID:16042670|PMID:16416302|PMID:39023798 CYP3A4 Human erythromycin A increases metabolic processing EXP 6480464 CYP3A4 protein results in increased metabolism of Erythromycin CTD PMID:21466820 CYP3A4 Human erythromycin A multiple interactions EXP 6480464 Erythromycin inhibits the reaction [CYP3A4 protein affects the metabolism of brotizolam]; Erythromycin inhibits the reaction more ... CTD PMID:16042670|PMID:16416302|PMID:19299527|PMID:21466820|PMID:8114683 CYP3A4 Human erythromycin A decreases methylation EXP 6480464 CYP3A4 protein results in decreased methylation of Erythromycin CTD PMID:15383492|PMID:2271712 CYP3A4 Human erythromycin A affects metabolic processing EXP 6480464 CYP3A4 protein affects the metabolism of Erythromycin CTD PMID:8114683 CYP3A4 Human erythrosin B decreases activity EXP 6480464 Erythrosine results in decreased activity of CYP3A4 protein CTD PMID:20041016 CYP3A4 Human estazolam increases hydroxylation EXP 6480464 CYP3A4 protein results in increased hydroxylation of Estazolam CTD PMID:16012077 CYP3A4 Human estrone multiple interactions EXP 6480464 CYP3A4 protein promotes the reaction [Estrone binds to Deoxyguanosine]; Estrone inhibits the reaction [CYP3A4 protein more ... CTD PMID:19299527|PMID:21907773 CYP3A4 Human estrone affects binding EXP 6480464 CYP3A4 protein binds to Estrone CTD PMID:27966929 CYP3A4 Human ethambutol multiple interactions ISO Cyp3a2 (Rattus norvegicus) 6480464 [Isoniazid co-treated with Rifampin co-treated with Ethambutol co-treated with Pyrazinamide] results in increased expression of more ... CTD PMID:27919644 CYP3A4 Human ethanol increases expression EXP 6480464 Ethanol results in increased expression of CYP3A4 mRNA; Ethanol results in increased expression of CYP3A4 more ... CTD PMID:28062356|PMID:35301062 CYP3A4 Human ethanol decreases expression ISO Cyp3a2 (Rattus norvegicus) 6480464 Ethanol results in decreased expression of CYP3A2 mRNA CTD PMID:26109895 CYP3A4 Human ethion multiple interactions EXP 6480464 [Chlorfenvinphos co-treated with ethion co-treated with Linuron] results in increased expression of CYP3A4 mRNA CTD PMID:25028461 CYP3A4 Human ethoxyquin increases expression ISO Cyp3a2 (Rattus norvegicus) 6480464 Ethoxyquin results in increased expression of CYP3A11 mRNA CTD PMID:19695238 CYP3A4 Human eticlopride(1+) multiple interactions EXP 6480464 [eticlopride results in increased activity of NR1I2 protein] which results in increased expression of CYP3A4 more ... CTD PMID:25455453 CYP3A4 Human etonogestrel affects metabolic processing EXP 6480464 CYP3A4 protein affects the metabolism of etonogestrel CTD PMID:15963096 CYP3A4 Human etoposide multiple interactions EXP 6480464 [Etoposide results in increased activity of NR1I2 protein] which results in increased expression of CYP3A4 more ... CTD PMID:25455453|PMID:8114683 CYP3A4 Human etoposide increases expression EXP 6480464 Etoposide results in increased expression of CYP3A4 mRNA CTD PMID:31542801 CYP3A4 Human etoposide decreases methylation EXP 6480464 CYP3A4 protein results in decreased methylation of Etoposide CTD PMID:8114683 CYP3A4 Human etoposide affects response to substance EXP 6480464 CYP3A4 gene polymorphism affects the susceptibility to Etoposide; CYP3A4 protein affects the susceptibility to Etoposide CTD PMID:12969965|PMID:17279585 CYP3A4 Human etoricoxib increases metabolic processing EXP 6480464 CYP3A4 protein results in increased metabolism of etoricoxib CTD PMID:18084859 CYP3A4 Human etoxazole increases expression EXP 6480464 etoxazole results in increased expression of CYP3A4 mRNA CTD PMID:17293382 CYP3A4 Human eupatilin increases activity EXP 6480464 eupatilin results in increased activity of CYP3A4 protein CTD PMID:31756459 CYP3A4 Human eupatilin multiple interactions EXP 6480464 [[eupatilin results in increased activity of CYP3A4 protein] which results in increased metabolism of Midazolam] more ... CTD PMID:31756459 CYP3A4 Human eupatorin decreases activity EXP 6480464 eupatorin results in decreased activity of CYP3A4 protein CTD PMID:21276781 CYP3A4 Human farnesol multiple interactions EXP 6480464 Farnesol analog inhibits the reaction [Oleic Acid results in decreased expression of CYP3A4 mRNA] CTD PMID:30611723 CYP3A4 Human farnesol increases activity ISO Cyp3a2 (Rattus norvegicus) 6480464 Farnesol results in increased activity of CYP3A2 protein CTD PMID:15840382 CYP3A4 Human farnesol increases expression EXP 6480464 Farnesol results in increased expression of CYP3A4 mRNA CTD PMID:30611723 CYP3A4 Human farrerol decreases activity EXP 6480464 farrerol results in decreased activity of CYP3A4 protein CTD PMID:29753067 CYP3A4 Human felbamate multiple interactions EXP 6480464 felbamate affects the reaction [[CYP3A4 protein results in increased metabolism of Carbamazepine] which results in more ... CTD PMID:12606595 CYP3A4 Human felodipine increases metabolic processing EXP 6480464 CYP3A4 protein results in increased metabolism of Felodipine CTD PMID:23876819 CYP3A4 Human felodipine increases expression EXP 6480464 Felodipine results in increased expression of CYP3A4 mRNA CTD PMID:27732883 CYP3A4 Human felodipine multiple interactions EXP 6480464 deoxyelephantopin inhibits the reaction [CYP3A4 protein results in increased metabolism of Felodipine]; Felodipine results in more ... CTD PMID:23876819|PMID:27732883 CYP3A4 Human fenhexamid multiple interactions EXP 6480464 [N-(2,3-dichloro-4-hydroxyphenyl)-1-methylcyclohexanecarboxamide co-treated with pyrimethanil co-treated with Fenitrothion co-treated with triadimefon co-treated with quinoxyfen co-treated with more ... CTD PMID:25028461 CYP3A4 Human fenitrothion multiple interactions EXP 6480464 [N-(2,3-dichloro-4-hydroxyphenyl)-1-methylcyclohexanecarboxamide co-treated with pyrimethanil co-treated with Fenitrothion co-treated with triadimefon co-treated with quinoxyfen co-treated with more ... CTD PMID:25028461 CYP3A4 Human fenitrothion decreases activity EXP 6480464 Fenitrothion results in decreased activity of CYP3A4 protein CTD PMID:20183062 CYP3A4 Human fenitrothion increases expression EXP 6480464 Fenitrothion results in increased expression of CYP3A4 mRNA CTD PMID:17293382|PMID:22310298 CYP3A4 Human fenitrothion increases activity EXP 6480464 Fenitrothion results in increased activity of CYP3A4 protein CTD PMID:22310298 CYP3A4 Human fenproporex decreases alkylation EXP 6480464 CYP3A4 protein results in decreased alkylation of fenproporex CTD PMID:15294457 CYP3A4 Human fentanyl increases metabolic processing EXP 6480464 CYP3A4 protein results in increased metabolism of Fentanyl CTD PMID:11811955 CYP3A4 Human fenthion affects metabolic processing EXP 6480464 CYP3A4 protein affects the metabolism of Fenthion CTD PMID:17110060 CYP3A4 Human fenvalerate increases expression EXP 6480464 fenvalerate results in increased expression of CYP3A4 mRNA; fenvalerate results in increased expression of CYP3A4 more ... CTD PMID:15548381|PMID:19249324|PMID:20599767|PMID:22310298 CYP3A4 Human fenvalerate decreases activity EXP 6480464 fenvalerate results in decreased activity of CYP3A4 protein CTD PMID:22634058 CYP3A4 Human fenvalerate multiple interactions EXP 6480464 Dexamethasone promotes the reaction [fenvalerate results in increased expression of CYP3A4 mRNA]; fenvalerate promotes the more ... CTD PMID:20599767 CYP3A4 Human fenvalerate increases activity EXP 6480464 fenvalerate results in increased activity of CYP3A4 protein CTD PMID:22310298 CYP3A4 Human ferroheme b multiple interactions EXP 6480464 [CYB5A protein co-treated with Heme] promotes the reaction [[CYP3A4 protein co-treated with POR protein co-treated more ... CTD PMID:22390216 CYP3A4 Human fimasartan increases metabolic processing EXP 6480464 CYP3A4 protein results in increased metabolism of fimasartan CTD PMID:29596975 CYP3A4 Human fimasartan increases oxidation EXP 6480464 CYP3A4 protein results in increased oxidation of fimasartan CTD PMID:29596975 CYP3A4 Human fipronil multiple interactions EXP 6480464 [fipronil co-treated with DEET] results in increased expression of CYP3A4 mRNA; fipronil promotes the reaction more ... CTD PMID:17084830|PMID:27091632 CYP3A4 Human fipronil increases expression ISO Cyp3a2 (Rattus norvegicus) 6480464 fipronil results in increased expression of CYP3A2 mRNA CTD PMID:23962444 CYP3A4 Human fipronil increases expression EXP 6480464 fipronil results in increased expression of CYP3A4 mRNA CTD PMID:17084830|PMID:27091632 CYP3A4 Human flavanone multiple interactions EXP 6480464 flavanone inhibits the reaction [[CYP3A4 protein results in increased oxidation of Midazolam] which results in more ... CTD PMID:21053930 CYP3A4 Human flavanone decreases activity EXP 6480464 flavanone results in decreased activity of CYP3A4 protein CTD PMID:21053930 CYP3A4 Human flavone multiple interactions EXP 6480464 [[flavone results in increased activity of CYP3A4 protein] which results in increased metabolism of Midazolam] more ... CTD PMID:21053930|PMID:31756459 CYP3A4 Human flavone increases activity EXP 6480464 flavone results in increased activity of CYP3A4 protein CTD PMID:31756459 CYP3A4 Human flavonol increases expression EXP 6480464 3-hydroxyflavone results in increased expression of CYP3A4 mRNA CTD PMID:26238175 CYP3A4 Human flavonol increases activity EXP 6480464 3-hydroxyflavone results in increased activity of CYP3A4 protein CTD PMID:31756459 CYP3A4 Human flavonol multiple interactions EXP 6480464 [3-hydroxyflavone results in increased activity of CYP3A4 protein] which results in increased metabolism of Midazolam; more ... CTD PMID:31756459 CYP3A4 Human flavonol decreases activity EXP 6480464 3-hydroxyflavone results in decreased activity of CYP3A4 protein CTD PMID:21053930 CYP3A4 Human flucloxacillin increases metabolic processing EXP 6480464 CYP3A4 results in increased metabolism of Floxacillin CTD PMID:11409940 CYP3A4 Human fluconazole decreases activity EXP 6480464 Fluconazole results in decreased activity of CYP3A4 protein CTD PMID:15784650|PMID:15843491 CYP3A4 Human flucythrinate affects binding EXP 6480464 flucythrinate binds to CYP3A4 protein CTD PMID:32278787 CYP3A4 Human fludioxonil multiple interactions EXP 6480464 [procymidone co-treated with iprodione co-treated with cyprodinil co-treated with fludioxonil co-treated with cyhalothrin] results in more ... CTD PMID:25028461 CYP3A4 Human fludioxonil decreases activity EXP 6480464 fludioxonil results in decreased activity of CYP3A4 protein CTD PMID:33575850 CYP3A4 Human flunitrazepam multiple interactions EXP 6480464 CYP3A4 protein affects the reaction [Flunitrazepam results in increased activity of CASP3 protein]; CYP3A4 protein more ... CTD PMID:19005028|PMID:19299527 CYP3A4 Human flunitrazepam increases hydroxylation EXP 6480464 CYP3A4 protein results in increased hydroxylation of Flunitrazepam CTD PMID:15383492 CYP3A4 Human fluoren-9-one increases expression ISO Cyp3a2 (Rattus norvegicus) 6480464 9-fluorenone results in increased expression of CYP3A2 protein CTD PMID:10445401 CYP3A4 Human fluorene increases expression ISO Cyp3a2 (Rattus norvegicus) 6480464 fluorene results in increased expression of CYP3A2 protein CTD PMID:10445401 CYP3A4 Human fluoxetine multiple interactions EXP 6480464 Fluoxetine inhibits the reaction [CYP3A4 protein results in increased oxidation of and results in increased more ... CTD PMID:11752104|PMID:12584149 CYP3A4 Human fluoxetine decreases activity EXP 6480464 Fluoxetine results in decreased activity of CYP3A4 protein CTD PMID:39023798 CYP3A4 Human fluoxetine increases metabolic processing EXP 6480464 CYP3A4 protein results in increased metabolism of Fluoxetine CTD PMID:11752104|PMID:16595712 CYP3A4 Human fluphenazine decreases activity EXP 6480464 Fluphenazine results in decreased activity of CYP3A4 protein CTD PMID:15135088 CYP3A4 Human flusilazole increases expression EXP 6480464 flusilazole results in increased expression of CYP3A4 protein CTD PMID:34273450 CYP3A4 Human flusilazole multiple interactions EXP 6480464 [Amiodarone co-treated with Benzoic Acid co-treated with cyproconazole co-treated with flusilazole co-treated with enilconazole co-treated more ... CTD PMID:34273450 CYP3A4 Human flutamide increases activity EXP 6480464 Flutamide results in increased activity of CYP3A4 protein CTD PMID:18839173 CYP3A4 Human flutamide decreases expression ISO Cyp3a2 (Rattus norvegicus) 6480464 Flutamide results in decreased expression of CYP3A2 mRNA CTD PMID:24136188 CYP3A4 Human flutamide multiple interactions ISO Cyp3a2 (Rattus norvegicus) 6480464 [SOD2 co-treated with CYP3A4] affects the susceptibility to Flutamide CTD PMID:19501153 CYP3A4 Human flutamide increases expression ISO Cyp3a2 (Rattus norvegicus) 6480464 Flutamide results in increased expression of CYP3A2 mRNA CTD PMID:24793618 CYP3A4 Human flutamide increases response to substance EXP 6480464 CYP3A4 protein results in increased susceptibility to Flutamide CTD PMID:28762043 CYP3A4 Human flutamide multiple interactions EXP 6480464 [CYP1A2 protein co-treated with CYP2C9 protein co-treated with CYP3A4 protein co-treated with CYP2D6 protein co-treated more ... CTD PMID:23397584|PMID:32682830 CYP3A4 Human flutamide increases expression EXP 6480464 Flutamide results in increased expression of CYP3A4 mRNA CTD PMID:18839173 CYP3A4 Human fluticasone decreases activity EXP 6480464 Fluticasone results in decreased activity of CYP3A4 protein CTD PMID:20707410 CYP3A4 Human flutolanil increases expression EXP 6480464 flutolanil results in increased expression of CYP3A4 mRNA CTD PMID:17293382 CYP3A4 Human flutriafol multiple interactions EXP 6480464 Acetylcysteine inhibits the reaction [flutriafol results in increased expression of CYP3A4 mRNA] CTD PMID:34200939 CYP3A4 Human flutriafol increases expression EXP 6480464 flutriafol results in increased expression of CYP3A4 mRNA CTD PMID:34200939 CYP3A4 Human flutriafol increases expression ISO Cyp3a2 (Rattus norvegicus) 6480464 flutriafol results in increased expression of CYP3A2 mRNA CTD PMID:34200939 CYP3A4 Human fluvalinate affects binding EXP 6480464 fluvalinate binds to CYP3A4 protein CTD PMID:32278787 CYP3A4 Human fluvastatin multiple interactions EXP 6480464 [fluvastatin co-treated with NR1I2 protein] results in increased expression of CYP3A4 mRNA; fluvastatin inhibits the more ... CTD PMID:16029222|PMID:24204015 CYP3A4 Human fluvastatin decreases activity EXP 6480464 fluvastatin results in decreased activity of CYP3A4 protein CTD PMID:16029222 CYP3A4 Human fluvoxamine multiple interactions EXP 6480464 Fluvoxamine inhibits the reaction [CYP3A4 protein results in increased oxidation of and results in increased more ... CTD PMID:12584149 CYP3A4 Human fluxapyroxad multiple interactions EXP 6480464 [fluxapyroxad co-treated with epoxiconazole] results in increased expression of CYP3A4 mRNA; [fluxapyroxad co-treated with epoxiconazole] more ... CTD PMID:29294346 CYP3A4 Human fluxapyroxad increases expression EXP 6480464 fluxapyroxad results in increased expression of CYP3A4 mRNA CTD PMID:29294346 CYP3A4 Human fonofos multiple interactions EXP 6480464 Fonofos inhibits the reaction [CYP3A4 protein results in increased chemical synthesis of 2-hydroxyestradiol]; Fonofos inhibits more ... CTD PMID:16790556 CYP3A4 Human fonofos decreases activity EXP 6480464 Fonofos results in decreased activity of CYP3A4 protein CTD PMID:16790556 CYP3A4 Human Fraxinellone increases glutathionylation EXP 6480464 CYP3A4 protein results in increased glutathionylation of fraxinellone CTD PMID:32484342 CYP3A4 Human fulvestrant increases expression ISO Cyp3a2 (Rattus norvegicus) 6480464 Fulvestrant results in increased expression of CYP3A2 mRNA CTD PMID:16837770 CYP3A4 Human Furafylline decreases activity ISO Cyp3a2 (Rattus norvegicus) 6480464 furafylline results in decreased activity of CYP3A2 protein CTD PMID:15879494 CYP3A4 Human furan decreases expression ISO Cyp3a2 (Rattus norvegicus) 6480464 furan results in decreased expression of CYP3A2 mRNA CTD PMID:25539665|PMID:26194646 CYP3A4 Human furathiocarb increases activity EXP 6480464 deltanit results in increased activity of CYP3A4 protein CTD PMID:22310298 CYP3A4 Human furathiocarb increases expression EXP 6480464 deltanit results in increased expression of CYP3A4 mRNA CTD PMID:22310298 CYP3A4 Human furosemide decreases activity EXP 6480464 Furosemide results in decreased activity of CYP3A4 protein CTD PMID:39023798 CYP3A4 Human fusidic acid multiple interactions EXP 6480464 Fusidic Acid inhibits the reaction [CYP3A4 protein results in increased hydroxylation of Midazolam] CTD PMID:26888941 CYP3A4 Human gadolinium trichloride multiple interactions ISO Cyp3a2 (Rattus norvegicus) 6480464 gadolinium chloride inhibits the reaction [Styrene results in increased expression of CYP3A2 mRNA]; gadolinium chloride more ... CTD PMID:18079364|PMID:18202523 CYP3A4 Human galangin increases expression EXP 6480464 galangin results in increased expression of CYP3A4 mRNA CTD PMID:26238175 CYP3A4 Human galangin increases activity EXP 6480464 galangin results in increased activity of CYP3A4 protein CTD PMID:31756459 CYP3A4 Human galangin multiple interactions EXP 6480464 [[galangin results in increased activity of CYP3A4 protein] which results in increased metabolism of Midazolam] more ... CTD PMID:21053930|PMID:31756459 CYP3A4 Human galangin decreases activity EXP 6480464 galangin results in decreased activity of CYP3A4 protein CTD PMID:21053930 CYP3A4 Human gamma-hexachlorocyclohexane increases expression EXP 6480464 Hexachlorocyclohexane results in increased expression of CYP3A4 protein CTD PMID:15548381 CYP3A4 Human gamma-hexachlorocyclohexane increases activity ISO Cyp3a2 (Rattus norvegicus) 6480464 Hexachlorocyclohexane results in increased activity of CYP3A11 protein; Hexachlorocyclohexane results in increased activity of CYP3A2 more ... CTD PMID:16641539|PMID:3569844 CYP3A4 Human gamma-hexachlorocyclohexane increases expression ISO Cyp3a2 (Rattus norvegicus) 6480464 Hexachlorocyclohexane results in increased expression of CYP3A2 mRNA; Hexachlorocyclohexane results in increased expression of CYP3A2 more ... CTD PMID:11684361|PMID:16837770 CYP3A4 Human gefitinib affects metabolic processing EXP 6480464 CYP3A4 protein affects the metabolism of gefitinib CTD PMID:15788367 CYP3A4 Human Gelsemine increases metabolic processing EXP 6480464 CYP3A4 protein results in increased metabolism of gelsemine CTD PMID:34627953 CYP3A4 Human Gelsemine decreases response to substance EXP 6480464 CYP3A4 protein results in decreased susceptibility to gelsemine CTD PMID:34627953 CYP3A4 Human gemfibrozil increases expression EXP 6480464 Gemfibrozil results in increased expression of CYP3A4 mRNA CTD PMID:15771232 CYP3A4 Human gemfibrozil increases activity EXP 6480464 Gemfibrozil results in increased activity of CYP3A4 protein CTD PMID:15771232 CYP3A4 Human genistein multiple interactions EXP 6480464 Genistein inhibits the reaction [Calcitriol results in increased activity of CYP3A4 protein] CTD PMID:19766177 CYP3A4 Human genistein multiple interactions ISO Cyp3a2 (Rattus norvegicus) 6480464 [bisphenol A co-treated with Genistein] results in decreased methylation of CYP3A2 gene CTD PMID:28505145 CYP3A4 Human genistein increases expression EXP 6480464 Genistein results in increased expression of CYP3A4 mRNA CTD PMID:29933105 CYP3A4 Human genistein decreases activity EXP 6480464 Genistein results in decreased activity of CYP3A4 protein CTD PMID:21053930 CYP3A4 Human gentamycin decreases expression ISO Cyp3a2 (Rattus norvegicus) 6480464 Gentamicins results in decreased expression of CYP3A2 mRNA CTD PMID:20849911 CYP3A4 Human gentamycin increases expression ISO Cyp3a2 (Rattus norvegicus) 6480464 Gentamicins results in increased expression of CYP3A2 mRNA CTD PMID:33387578 CYP3A4 Human gentamycin multiple interactions ISO Cyp3a2 (Rattus norvegicus) 6480464 [Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in more ... CTD PMID:30545405 CYP3A4 Human geranial multiple interactions EXP 6480464 citral inhibits the reaction [CYP3A4 protein results in increased hydroxylation of Midazolam] CTD PMID:18385293 CYP3A4 Human gestodene decreases activity EXP 6480464 Gestodene results in decreased activity of CYP3A4 protein CTD PMID:2271712 CYP3A4 Human gestodene multiple interactions EXP 6480464 Gestodene inhibits the reaction [CYP3A4 protein results in increased oxidation of Methylenebis(chloroaniline)] CTD PMID:1740010 CYP3A4 Human gingerol multiple interactions EXP 6480464 gingerol inhibits the reaction [CYP3A4 protein results in increased hydroxylation of Midazolam] CTD PMID:18385293 CYP3A4 Human Ginkgolide A increases expression EXP 6480464 ginkgolide A results in increased expression of CYP3A4 mRNA CTD PMID:19034627 CYP3A4 Human Ginkgolide A increases expression ISO Cyp3a2 (Rattus norvegicus) 6480464 ginkgolide A results in increased expression of CYP3A2 mRNA CTD PMID:16258077 CYP3A4 Human ginkgolide B multiple interactions EXP 6480464 NR1I2 protein affects the reaction [ginkgolide B results in increased expression of CYP3A4 mRNA]; sulforaphane more ... CTD PMID:26775663 CYP3A4 Human ginkgolide B increases expression EXP 6480464 ginkgolide B results in increased expression of CYP3A4 mRNA CTD PMID:19034627|PMID:26775663 CYP3A4 Human ginsenoside Rg1 multiple interactions ISO Cyp3a2 (Rattus norvegicus) 6480464 ginsenoside Rg1 inhibits the reaction [1-Naphthylisothiocyanate results in increased expression of CYP3A4 mRNA]; ginsenoside Rg1 more ... CTD PMID:32198087 CYP3A4 Human glafenine decreases expression ISO Cyp3a2 (Rattus norvegicus) 6480464 Glafenine results in decreased expression of CYP3A2 mRNA CTD PMID:24136188 CYP3A4 Human glimepiride multiple interactions EXP 6480464 [glimepiride results in increased activity of NR1I2 protein] which results in increased expression of CYP3A4 more ... CTD PMID:25455453 CYP3A4 Human glutathione multiple interactions EXP 6480464 [[CYP3A4 protein co-treated with GSTP1 protein co-treated with Glutathione] results in increased hydroxylation of Diclofenac] more ... CTD PMID:15523003|PMID:18206979|PMID:20825217|PMID:24246759|PMID:25451576|PMID:27485346|PMID:31102647|PMID:32198085 CYP3A4 Human glutathione multiple interactions ISO Cyp3a2 (Rattus norvegicus) 6480464 [CYP3A2 protein co-treated with NADP co-treated with Glutathione] results in increased glutathionylation of and results more ... CTD PMID:20825217 CYP3A4 Human glutathione affects binding EXP 6480464 Glutathione binds to CYP3A4 protein CTD PMID:18206979 CYP3A4 Human glycochenodeoxycholic acid multiple interactions EXP 6480464 [Atazanavir Sulfate co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated more ... CTD PMID:32152650|PMID:33819548 CYP3A4 Human glycochenodeoxycholic acid increases hydroxylation EXP 6480464 CYP3A4 protein results in increased hydroxylation of Glycochenodeoxycholic Acid CTD PMID:36473578 CYP3A4 Human glycocholic acid multiple interactions EXP 6480464 [Atazanavir Sulfate co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated more ... CTD PMID:32152650|PMID:33819548 CYP3A4 Human glycodeoxycholic acid multiple interactions EXP 6480464 [Atazanavir Sulfate co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated more ... CTD PMID:32152650|PMID:33819548 CYP3A4 Human glycodeoxycholic acid increases hydroxylation EXP 6480464 CYP3A4 protein results in increased hydroxylation of Glycodeoxycholic Acid CTD PMID:36473578 CYP3A4 Human Glycohyodeoxycholic acid multiple interactions EXP 6480464 [CYP3A4 protein results in increased hydroxylation of glycolithocholic acid] which results in increased abundance of more ... CTD PMID:36473578 CYP3A4 Human glycolithocholic acid increases hydroxylation EXP 6480464 CYP3A4 protein results in increased hydroxylation of glycolithocholic acid CTD PMID:36473578 CYP3A4 Human glycolithocholic acid multiple interactions EXP 6480464 [CYP3A4 protein results in increased hydroxylation of glycolithocholic acid] which results in increased abundance of more ... CTD PMID:36473578 CYP3A4 Human glycoursodeoxycholic acid increases hydroxylation EXP 6480464 CYP3A4 protein results in increased hydroxylation of glycoursodeoxycholic acid CTD PMID:36473578 CYP3A4 Human glycyrrhizinic acid increases expression EXP 6480464 Glycyrrhizic Acid results in increased expression of CYP3A4 mRNA; Glycyrrhizic Acid results in increased expression more ... CTD PMID:22982774 CYP3A4 Human glycyrrhizinic acid increases expression ISO Cyp3a2 (Rattus norvegicus) 6480464 Glycyrrhizic Acid results in increased expression of CYP3A2 mRNA; Glycyrrhizic Acid results in increased expression more ... CTD PMID:38448046 CYP3A4 Human glycyrrhizinic acid multiple interactions EXP 6480464 NR1I2 protein affects the reaction [Glycyrrhizic Acid results in increased expression of CYP3A4 mRNA] CTD PMID:22982774 CYP3A4 Human glyoxal multiple interactions EXP 6480464 [CYP3A4 protein results in increased metabolism of and results in increased susceptibility to sudoxicam] which more ... CTD PMID:33253783 CYP3A4 Human granisetron affects metabolic processing EXP 6480464 CYP3A4 protein affects the metabolism of Granisetron CTD PMID:15286053 CYP3A4 Human griseofulvin increases expression EXP 6480464 Griseofulvin results in increased expression of CYP3A4 mRNA; Griseofulvin results in increased expression of CYP3A4 more ... CTD PMID:18505790 CYP3A4 Human guggulsterone increases expression EXP 6480464 pregna-4,17-diene-3,16-dione results in increased expression of CYP3A4 mRNA CTD PMID:15075359 CYP3A4 Human GW 3965 multiple interactions EXP 6480464 [GW 3965 co-treated with NR1H3 protein] results in increased expression of CYP3A4 mRNA; GW 3965 more ... CTD PMID:23732298 CYP3A4 Human GW 3965 increases expression EXP 6480464 GW 3965 results in increased expression of CYP3A4 mRNA CTD PMID:23732298 CYP3A4 Human haloperidol multiple interactions EXP 6480464 CYP3A4 protein results in increased oxidation of and results in increased activity of Haloperidol; Fluoxetine more ... CTD PMID:12584149 CYP3A4 Human halothane increases metabolic processing EXP 6480464 CYP3A4 protein results in increased metabolism of Halothane CTD PMID:8886607 CYP3A4 Human helenalin decreases activity EXP 6480464 helenalin results in decreased activity of CYP3A4 protein CTD PMID:34989853 CYP3A4 Human helenalin increases oxidation EXP 6480464 CYP3A4 protein results in increased oxidation of helenalin CTD PMID:34989853 CYP3A4 Human Heliotrine increases response to substance EXP 6480464 CYP3A4 protein results in increased susceptibility to heliotrine CTD PMID:32910235 CYP3A4 Human heme b multiple interactions EXP 6480464 [CYB5A protein co-treated with Heme] promotes the reaction [[CYP3A4 protein co-treated with POR protein co-treated more ... CTD PMID:22390216 CYP3A4 Human HET0016 decreases activity EXP 6480464 HET0016 results in decreased activity of CYP3A4 protein CTD PMID:11375247 CYP3A4 Human Hexachloro-1,3-butadiene increases metabolic processing EXP 6480464 CYP3A4 protein results in increased metabolism of hexachlorobutadiene CTD PMID:8555406 CYP3A4 Human hexachlorobenzene increases expression ISO Cyp3a2 (Rattus norvegicus) 6480464 Hexachlorobenzene results in increased expression of CYP3A2 mRNA CTD PMID:15159207 CYP3A4 Human hexaflumuron increases expression EXP 6480464 hexafluoron results in increased expression of CYP3A4 mRNA CTD PMID:22310298 CYP3A4 Human hexobarbital multiple interactions EXP 6480464 Hexobarbital inhibits the reaction [CYP3A4 protein results in increased oxidation of 7-benzyloxy-4-trifluoromethylcoumarin] CTD PMID:19299527 CYP3A4 Human huperzine A increases metabolic processing ISO Cyp3a2 (Rattus norvegicus) 6480464 CYP3A2 protein results in increased metabolism of huperzine A CTD PMID:12586202 CYP3A4 Human hydrocortisone succinate multiple interactions EXP 6480464 [hydrocortisone hemisuccinate co-treated with Dimethyl Sulfoxide] results in increased expression of CYP3A4 CTD PMID:18347083 CYP3A4 Human hydrogen peroxide increases abundance EXP 6480464 CYP3A4 protein results in increased abundance of Hydrogen Peroxide CTD PMID:25061110 CYP3A4 Human hydrogen peroxide increases expression EXP 6480464 Hydrogen Peroxide results in increased expression of CYP3A4 mRNA; Hydrogen Peroxide results in increased expression more ... CTD PMID:15056853 CYP3A4 Human hydroquinone multiple interactions EXP 6480464 [CYP3A4 protein results in increased metabolism of bisphenol A] which results in increased chemical synthesis more ... CTD PMID:21402134 CYP3A4 Human hydroxynefazodone multiple interactions EXP 6480464 [CYP3A4 protein results in increased hydroxylation of nefazodone] which results in increased abundance of hydroxynefazodone CTD PMID:27485346 CYP3A4 Human hyodeoxycholic acid multiple interactions EXP 6480464 [CYP3A4 protein results in increased hydroxylation of Lithocholic Acid] which results in increased abundance of more ... CTD PMID:19487251|PMID:36473578 CYP3A4 Human Hypaconitine increases metabolic processing EXP 6480464 CYP3A4 protein results in increased metabolism of hypaconitine CTD PMID:21550385 CYP3A4 Human Hypaconitine increases expression EXP 6480464 hypaconitine results in increased expression of CYP3A4 mRNA CTD PMID:30303438 CYP3A4 Human Hypaconitine multiple interactions EXP 6480464 [Aconitine co-treated with mesaconitine co-treated with hypaconitine] results in increased expression of CYP3A4 mRNA CTD PMID:30303438 CYP3A4 Human hyperforin decreases activity EXP 6480464 hyperforin results in decreased activity of CYP3A4 protein CTD PMID:15100173 CYP3A4 Human hyperforin increases expression EXP 6480464 hyperforin results in increased expression of CYP3A4; hyperforin results in increased expression of CYP3A4 mRNA CTD PMID:15100173|PMID:15266218|PMID:16005588|PMID:16442130|PMID:17954527|PMID:24259679 CYP3A4 Human hyperforin multiple interactions EXP 6480464 hyperforin results in increased expression of and results in increased activity of CYP3A4 protein CTD PMID:15100173 CYP3A4 Human hypericin decreases activity EXP 6480464 hypericin results in decreased activity of CYP3A4 protein CTD PMID:15266218 CYP3A4 Human hypericin decreases expression EXP 6480464 hypericin results in decreased expression of CYP3A4 mRNA CTD PMID:15266218 CYP3A4 Human hypericin increases expression EXP 6480464 hypericin results in increased expression of CYP3A4 CTD PMID:16005588 CYP3A4 Human iberin decreases activity ISO Cyp3a2 (Rattus norvegicus) 6480464 iberin results in decreased activity of CYP3A2 protein CTD PMID:22664424 CYP3A4 Human iberin decreases expression ISO Cyp3a2 (Rattus norvegicus) 6480464 iberin results in decreased expression of CYP3A2 mRNA CTD PMID:22664424 CYP3A4 Human ibrutinib multiple interactions EXP 6480464 [CYP3A4 protein results in increased metabolism of ibrutinib] which results in increased abundance of PCI-45227 CTD PMID:34153224 CYP3A4 Human ibrutinib increases metabolic processing EXP 6480464 CYP3A4 protein results in increased metabolism of ibrutinib CTD PMID:34153224 CYP3A4 Human ibrutinib affects metabolic processing EXP 6480464 CYP3A4 protein alternative form affects the metabolism of ibrutinib CTD PMID:34153224 CYP3A4 Human Icaritin affects activity EXP 6480464 icaritin affects the activity of CYP3A4 protein CTD PMID:29753067 CYP3A4 Human Icaritin increases metabolic processing EXP 6480464 CYP3A4 protein results in increased metabolism of icaritin CTD PMID:30938510 CYP3A4 Human ifosfamide affects hydroxylation EXP 6480464 CYP3A4 protein affects the hydroxylation of Ifosfamide CTD PMID:12136253 CYP3A4 Human ifosfamide increases expression EXP 6480464 Ifosfamide results in increased expression of CYP3A4 mRNA CTD PMID:18839173 CYP3A4 Human ifosfamide increases response to substance EXP 6480464 CYP3A4 protein results in increased susceptibility to Ifosfamide; CYP3A4 results in increased susceptibility to Ifosfamide CTD PMID:20507880|PMID:9766669 CYP3A4 Human ifosfamide decreases ethylation EXP 6480464 CYP3A4 gene mutant form results in decreased ethylation of Ifosfamide; CYP3A4 protein results in decreased more ... CTD PMID:15821045 CYP3A4 Human ifosfamide affects metabolic processing EXP 6480464 CYP3A4 protein affects the metabolism of Ifosfamide CTD PMID:15875221 CYP3A4 Human ifosfamide affects degradation EXP 6480464 CYP3A4 protein affects the degradation of Ifosfamide CTD PMID:12136253 CYP3A4 Human iloperidone decreases expression EXP 6480464 iloperidone results in decreased expression of CYP3A4 mRNA CTD PMID:32941854 CYP3A4 Human iloperidone decreases activity EXP 6480464 iloperidone results in decreased activity of CYP3A4 protein CTD PMID:32941854 CYP3A4 Human imidacloprid multiple interactions EXP 6480464 [NADP co-treated with CYP3A4 protein] results in increased activity of imidacloprid analog CTD PMID:16153789 CYP3A4 Human imidazoles multiple interactions EXP 6480464 Imidazoles inhibits the reaction [6-(4-chlorophenyl)imidazo(2,1-b)(1,3)thiazole-5-carbaldehyde O-(3,4-dichlorobenzyl)oxime results in increased expression of CYP3A4 mRNA]; Imidazoles inhibits more ... CTD PMID:21778469 CYP3A4 Human imipramine multiple interactions EXP 6480464 CYP3A4 protein results in decreased methylation of and results in increased activity of Imipramine; Organophosphorus more ... CTD PMID:15922009 CYP3A4 Human imipramine decreases activity EXP 6480464 Imipramine results in decreased activity of CYP3A4 protein CTD PMID:39023798 CYP3A4 Human indicine increases metabolic processing EXP 6480464 CYP3A4 protein results in increased metabolism of indicine CTD PMID:33884520 CYP3A4 Human indicine increases response to substance EXP 6480464 CYP3A4 protein results in increased susceptibility to indicine CTD PMID:32910235 CYP3A4 Human indole-3-acetamide multiple interactions EXP 6480464 NR1I2 protein promotes the reaction [indoleacetamide results in increased expression of CYP3A4 mRNA] CTD PMID:33002526 CYP3A4 Human indole-3-acetamide increases expression EXP 6480464 indoleacetamide results in increased expression of CYP3A4 mRNA CTD PMID:33002526 CYP3A4 Human indoline increases metabolic processing EXP 6480464 CYP3A4 protein results in increased metabolism of indoline CTD PMID:17502430 CYP3A4 Human indometacin increases expression EXP 6480464 Indomethacin results in increased expression of CYP3A4 mRNA CTD PMID:29027214 CYP3A4 Human indometacin decreases expression ISO Cyp3a2 (Rattus norvegicus) 6480464 Indomethacin results in decreased expression of CYP3A7 mRNA CTD PMID:16771604 CYP3A4 Human iprodione multiple interactions EXP 6480464 [procymidone co-treated with iprodione co-treated with cyprodinil co-treated with fludioxonil co-treated with cyhalothrin] results in more ... CTD PMID:25028461 CYP3A4 Human irilone decreases activity EXP 6480464 irilone results in decreased activity of CYP3A4 protein CTD PMID:29753067 CYP3A4 Human irinotecan affects metabolic processing EXP 6480464 CYP3A4 protein affects the metabolism of Irinotecan CTD PMID:15523087|PMID:15655543 CYP3A4 Human irinotecan decreases activity EXP 6480464 Irinotecan metabolite results in decreased activity of CYP3A4 protein; Irinotecan results in decreased activity of more ... CTD PMID:11901092 CYP3A4 Human irinotecan increases oxidation EXP 6480464 CYP3A4 protein results in increased oxidation of Irinotecan CTD PMID:15100172 CYP3A4 Human irinotecan increases response to substance EXP 6480464 CYP3A4 mRNA results in increased susceptibility to Irinotecan CTD PMID:15239142 CYP3A4 Human iron(III) citrate multiple interactions EXP 6480464 Alcohols inhibits the reaction [ferric citrate results in increased expression of CYP3A4 mRNA]; Alcohols promotes more ... CTD PMID:24025710 CYP3A4 Human iron(III) citrate increases expression EXP 6480464 ferric citrate results in increased expression of CYP3A4 mRNA; ferric citrate results in increased expression more ... CTD PMID:24025710 CYP3A4 Human isobavachalcone multiple interactions ISO Cyp3a2 (Rattus norvegicus) 6480464 isobavachalcone inhibits the reaction [[CYP3A4 protein results in increased metabolism of Testosterone] which results in more ... CTD PMID:31870919 CYP3A4 Human isobavachalcone decreases activity ISO Cyp3a2 (Rattus norvegicus) 6480464 isobavachalcone results in decreased activity of CYP3A4 protein CTD PMID:31870919 CYP3A4 Human isocarbophos multiple interactions EXP 6480464 CYP3A4 protein results in increased metabolism of and results in decreased sulfation of and affects more ... CTD PMID:24752505 CYP3A4 Human isofenphos increases expression EXP 6480464 isofenphos results in increased expression of CYP3A4 mRNA CTD PMID:17293382 CYP3A4 Human isoliquiritigenin decreases activity EXP 6480464 isoliquiritigenin results in decreased activity of CYP3A4 protein CTD PMID:29753067 CYP3A4 Human isoniazide increases response to substance EXP 6480464 CYP3A4 protein results in increased susceptibility to Isoniazid CTD PMID:21540358 CYP3A4 Human isoniazide multiple interactions ISO Cyp3a2 (Rattus norvegicus) 6480464 [Isoniazid co-treated with Rifampin co-treated with Ethambutol co-treated with Pyrazinamide] results in increased expression of more ... CTD PMID:19501153|PMID:27919644 CYP3A4 Human isoniazide decreases activity EXP 6480464 Isoniazid results in decreased activity of CYP3A4 protein CTD PMID:15005856|PMID:15304522 CYP3A4 Human isoprothiolane increases expression EXP 6480464 isoprothiolane results in increased expression of CYP3A4 mRNA CTD PMID:17293382 CYP3A4 Human isoproturon increases activity EXP 6480464 isoproturon results in increased activity of CYP3A4 protein CTD PMID:22310298 CYP3A4 Human isoproturon decreases activity EXP 6480464 isoproturon results in decreased activity of CYP3A4 protein CTD PMID:18420780 CYP3A4 Human isoproturon increases expression EXP 6480464 isoproturon results in increased expression of CYP3A4 mRNA CTD PMID:22310298 CYP3A4 Human isorhamnetin increases expression EXP 6480464 3-methylquercetin results in increased expression of CYP3A4 mRNA CTD PMID:26238175 CYP3A4 Human Isosafrole increases expression EXP 6480464 isosafrole results in increased expression of CYP3A4 protein CTD PMID:8632764 CYP3A4 Human isotretinoin multiple interactions EXP 6480464 [Isotretinoin results in increased activity of NR1I2 protein] which results in increased expression of CYP3A4 more ... CTD PMID:16632523|PMID:25455453 CYP3A4 Human isotretinoin increases activity EXP 6480464 Isotretinoin results in increased activity of CYP3A4 protein CTD PMID:16632523 CYP3A4 Human isoxazoles decreases activity EXP 6480464 Isoxazoles analog results in decreased activity of CYP3A4 protein CTD PMID:21924250 CYP3A4 Human Isradipine multiple interactions EXP 6480464 Isradipine results in increased expression of and results in decreased activity of CYP3A4 protein CTD PMID:27732883 CYP3A4 Human Isradipine affects metabolic processing EXP 6480464 CYP3A4 protein affects the metabolism of Isradipine CTD PMID:15286053 CYP3A4 Human Isradipine increases expression EXP 6480464 Isradipine results in increased expression of CYP3A4 mRNA CTD PMID:27732883 CYP3A4 Human itraconazole affects metabolic processing EXP 6480464 CYP3A4 protein affects the metabolism of Itraconazole CTD PMID:15905803 CYP3A4 Human itraconazole decreases expression EXP 6480464 Itraconazole results in decreased expression of CYP3A4 mRNA; Itraconazole results in decreased expression of CYP3A4 more ... CTD PMID:28390928 CYP3A4 Human itraconazole decreases activity EXP 6480464 Itraconazole results in decreased activity of CYP3A4 protein CTD PMID:15328084|PMID:15447735|PMID:15684493|PMID:15784650|PMID:15905803|PMID:15963096|PMID:15969931|PMID:16041596 CYP3A4 Human itraconazole multiple interactions EXP 6480464 Itraconazole binds to and results in decreased activity of CYP3A4 protein CTD PMID:18218784 CYP3A4 Human itraconazole affects activity EXP 6480464 Itraconazole affects the activity of CYP3A4 protein CTD PMID:15964336 CYP3A4 Human itraconazole increases metabolic processing EXP 6480464 CYP3A4 protein results in increased metabolism of Itraconazole CTD PMID:18360572 CYP3A4 Human itraconazole increases hydroxylation EXP 6480464 CYP3A4 protein results in increased hydroxylation of Itraconazole CTD PMID:15383492 CYP3A4 Human ivermectin decreases activity EXP 6480464 Ivermectin results in decreased activity of CYP3A4 protein CTD PMID:11124226|PMID:18420780 CYP3A4 Human kaempferol increases expression EXP 6480464 kaempferol results in increased expression of CYP3A4 mRNA CTD PMID:16442130 CYP3A4 Human kaempferol decreases activity EXP 6480464 kaempferol results in decreased activity of CYP3A4 protein CTD PMID:15266218|PMID:21053930 CYP3A4 Human kaempferol multiple interactions EXP 6480464 [kaempferol results in increased activity of NR1I2 protein] which results in increased expression of CYP3A4 more ... CTD PMID:15266218|PMID:25455453 CYP3A4 Human kahweol multiple interactions ISO Cyp3a2 (Rattus norvegicus) 6480464 [cafestol co-treated with kahweol] results in decreased expression of CYP3A2; [cafestol co-treated with kahweol] results more ... CTD PMID:11346484|PMID:9744531 CYP3A4 Human ketamine multiple interactions EXP 6480464 Ketamine results in decreased expression of and results in decreased activity of CYP3A4 protein CTD PMID:18845661 CYP3A4 Human ketamine increases expression ISO Cyp3a2 (Rattus norvegicus) 6480464 Ketamine results in increased expression of CYP3A2 protein CTD PMID:16076768 CYP3A4 Human ketamine decreases expression EXP 6480464 Ketamine results in decreased expression of CYP3A4 mRNA CTD PMID:18845661 CYP3A4 Human ketoconazole increases metabolic processing EXP 6480464 CYP3A4 protein results in increased metabolism of Ketoconazole CTD PMID:17702393 CYP3A4 Human ketoconazole decreases activity ISO Cyp3a2 (Rattus norvegicus) 6480464 Ketoconazole results in decreased activity of CYP3A2 protein; Ketoconazole results in decreased activity of CYP3A4 more ... CTD PMID:12814958|PMID:15879494|PMID:31870919 CYP3A4 Human ketoconazole multiple interactions ISO Cyp3a2 (Rattus norvegicus) 6480464 Ketoconazole inhibits the reaction [CYP3A2 protein results in increased metabolism of 7-benzyloxyquinoline]; Ketoconazole inhibits the more ... CTD PMID:19226368|PMID:19858067 CYP3A4 Human ketoconazole decreases expression EXP 6480464 Ketoconazole results in decreased expression of CYP3A4 mRNA; Ketoconazole results in decreased expression of CYP3A4 more ... CTD PMID:31629065|PMID:36893891 CYP3A4 Human ketoconazole decreases activity EXP 6480464 Ketoconazole results in decreased activity of CYP3A2 protein; Ketoconazole results in decreased activity of CYP3A4 more ... CTD PMID:10997946|PMID:12814958|PMID:15005856|PMID:15135088|PMID:15279827|PMID:15306208|PMID:15328084|PMID:15466163|PMID:15557344|PMID:15560889|PMID:15618748|PMID:15731592|PMID:15784650|PMID:15860655|PMID:15869686|PMID:15896247|PMID:15969931|PMID:16012074|PMID:16204965|PMID:18799805|PMID:19328226|PMID:19593786|PMID:20233841|PMID:20307514|PMID:20507880|PMID:21336516|PMID:21349323|PMID:21915887|PMID:22447115|PMID:23146034|PMID:23274770|PMID:23850985|PMID:23876819|PMID:24799337|PMID:26038696|PMID:27871908|PMID:28119166|PMID:33253783|PMID:33438235|PMID:33775687|PMID:34780725 CYP3A4 Human ketoconazole increases expression EXP 6480464 Ketoconazole results in increased expression of CYP3A4 mRNA CTD PMID:17998298|PMID:25343516 CYP3A4 Human ketoconazole increases response to substance EXP 6480464 CYP3A4 protein results in increased susceptibility to Ketoconazole CTD PMID:12695342|PMID:18809730|PMID:26718876 CYP3A4 Human ketoconazole multiple interactions EXP 6480464 [Ketoconazole inhibits the reaction [CYP3A4 protein results in increased susceptibility to Amodiaquine]] which results in more ... CTD PMID:10952769|PMID:10997946|PMID:11377097|PMID:11502731|PMID:12072427|PMID:12237780|PMID:12569440|PMID:12675279|PMID:12695342|PMID:15560889|PMID:15764719|PMID:15869686|PMID:15896247|PMID:16146350|PMID:16207822|PMID:16390352|PMID:16608920|PMID:16819505|PMID:16855053|PMID:17438109|PMID:17998298|PMID:18809730|PMID:18846481|PMID:19230594|PMID:19299527|PMID:19358519|PMID:19593786|PMID:19812348|PMID:20233841|PMID:20307514|PMID:20507880|PMID:20863320|PMID:21402137|PMID:21566342|PMID:21915887|PMID:22178124|PMID:22447115|PMID:22651985|PMID:22785256|PMID:23146034|PMID:23707768|PMID:23850985|PMID:23876819|PMID:24120545|PMID:24246759|PMID:24819614|PMID:25343516|PMID:25542144|PMID:26038696|PMID:26286065|PMID:27485346|PMID:28119166|PMID:28238727|PMID:28887089|PMID:29782822|PMID:30087611|PMID:31102695|PMID:31293154|PMID:31629065|PMID:33775687|PMID:34153224|PMID:34189909|PMID:34648813|PMID:34780725|PMID:36332690|PMID:9600717 CYP3A4 Human L-methionine multiple interactions ISO Cyp3a2 (Rattus norvegicus) 6480464 [Choline deficiency co-treated with Methionine deficiency] results in decreased activity of CYP3A2 protein; [Choline deficiency more ... CTD PMID:27919644|PMID:38663832 CYP3A4 Human lactacystin multiple interactions EXP 6480464 lactacystin inhibits the reaction [6-(4-chlorophenyl)imidazo(2,1-b)(1,3)thiazole-5-carbaldehyde O-(3,4-dichlorobenzyl)oxime results in increased expression of CYP3A4 mRNA]; lactacystin inhibits more ... CTD PMID:24224465 CYP3A4 Human lamotrigine increases glutathionylation EXP 6480464 CYP3A4 protein results in increased glutathionylation of lamotrigine CTD PMID:19961160 CYP3A4 Human lansoprazole increases expression EXP 6480464 Lansoprazole results in increased expression of CYP3A4 mRNA; Lansoprazole results in increased expression of CYP3A4 more ... CTD PMID:10859152|PMID:9744552 CYP3A4 Human lansoprazole increases metabolic processing EXP 6480464 CYP3A4 protein results in increased metabolism of Lansoprazole CTD PMID:11829200|PMID:12975331|PMID:7870052|PMID:8930576 CYP3A4 Human lansoprazole affects metabolic processing EXP 6480464 CYP3A4 protein affects the metabolism of Lansoprazole CTD PMID:15010519 CYP3A4 Human lansoprazole increases hydroxylation EXP 6480464 CYP3A4 protein results in increased hydroxylation of Lansoprazole CTD PMID:12975331|PMID:8627562 CYP3A4 Human lapatinib increases metabolic processing EXP 6480464 CYP3A4 protein results in increased metabolism of Lapatinib CTD PMID:26958860|PMID:33259822|PMID:37788138 CYP3A4 Human lapatinib multiple interactions EXP 6480464 [CYP3A4 protein results in increased metabolism of lapatinib] which results in increased activity of NFE2L2 more ... CTD PMID:26958860 CYP3A4 Human laquinimod increases metabolic processing EXP 6480464 CYP3A4 protein results in increased metabolism of laquinimod CTD PMID:15764719 CYP3A4 Human laquinimod multiple interactions EXP 6480464 Ketoconazole inhibits the reaction [CYP3A4 protein results in increased metabolism of laquinimod]; Troleandomycin inhibits the more ... CTD PMID:15764719 CYP3A4 Human Lasiocarpine multiple interactions EXP 6480464 [CYP3A4 protein results in increased metabolism of lasiocarpine] which affects the expression of KIF23 mRNA; more ... CTD PMID:31103741|PMID:33884520 CYP3A4 Human Lasiocarpine increases response to substance EXP 6480464 CYP3A4 protein results in increased susceptibility to lasiocarpine CTD PMID:32910235 CYP3A4 Human Lasiocarpine increases metabolic processing ISO Cyp3a2 (Rattus norvegicus) 6480464 CYP3A2 protein results in increased metabolism of lasiocarpine CTD PMID:31103741 CYP3A4 Human Lasiocarpine increases metabolic processing EXP 6480464 CYP3A4 protein results in increased metabolism of lasiocarpine CTD PMID:31103741|PMID:33884520|PMID:35882637 CYP3A4 Human lead(0) increases expression EXP 6480464 Lead results in increased expression of CYP3A4 mRNA CTD PMID:19921347 CYP3A4 Human lefetamine decreases alkylation EXP 6480464 CYP3A4 protein results in decreased alkylation of lephetamine CTD PMID:26276083 CYP3A4 Human leflunomide multiple interactions EXP 6480464 [leflunomide results in increased activity of NR1I2 protein] which results in increased expression of CYP3A4 more ... CTD PMID:25455453|PMID:25860621 CYP3A4 Human leflunomide increases response to substance EXP 6480464 CYP3A4 protein results in increased susceptibility to leflunomide CTD PMID:21540358 CYP3A4 Human leptomycin B multiple interactions EXP 6480464 [epigallocatechin gallate co-treated with leptomycin B] results in increased expression of CYP3A4 mRNA CTD PMID:25922640 CYP3A4 Human leptomycin B increases expression EXP 6480464 leptomycin B results in increased expression of CYP3A4 mRNA CTD PMID:25922640 CYP3A4 Human letrozole increases oxidation EXP 6480464 CYP3A4 protein results in increased oxidation of letrozole CTD PMID:19845430 CYP3A4 Human levofloxacin decreases activity EXP 6480464 Levofloxacin results in decreased activity of CYP3A4 protein CTD PMID:39023798 CYP3A4 Human Licochalcone A decreases activity EXP 6480464 licochalcone A results in decreased activity of CYP3A4 protein CTD PMID:26100226 CYP3A4 Human lidocaine affects metabolic processing EXP 6480464 CYP3A4 protein affects the metabolism of Lidocaine CTD PMID:15447735 CYP3A4 Human lidocaine increases metabolic processing EXP 6480464 CYP3A4 protein results in increased metabolism of Lidocaine CTD PMID:18846481 CYP3A4 Human lidocaine multiple interactions EXP 6480464 Rifampin promotes the reaction [CYP3A4 protein results in increased metabolism of Lidocaine] CTD PMID:9298257 CYP3A4 Human lidocaine decreases methylation EXP 6480464 CYP3A4 protein results in decreased methylation of Lidocaine CTD PMID:15383492 CYP3A4 Human lidocaine decreases ethylation EXP 6480464 CYP3A4 protein results in decreased ethylation of Lidocaine CTD PMID:15887009 CYP3A4 Human Liensinine increases chemical synthesis EXP 6480464 CYP3A4 protein results in increased chemical synthesis of liensinine CTD PMID:25451576 CYP3A4 Human limonene multiple interactions EXP 6480464 limonene inhibits the reaction [CYP3A4 protein results in increased hydroxylation of Midazolam] CTD PMID:18385293 CYP3A4 Human limonin decreases activity EXP 6480464 limonin results in decreased activity of CYP3A4 protein CTD PMID:22001672 CYP3A4 Human linoleic acid decreases activity EXP 6480464 Linoleic Acid results in decreased activity of CYP3A4 protein CTD PMID:16978661 CYP3A4 Human linuron multiple interactions EXP 6480464 [Chlorfenvinphos co-treated with ethion co-treated with Linuron] results in increased expression of CYP3A4 mRNA CTD PMID:25028461 CYP3A4 Human lipoic acid multiple interactions EXP 6480464 Thioctic Acid inhibits the reaction [[NADP co-treated with CYP1A2 protein co-treated with CYP2C8 protein co-treated more ... CTD PMID:24120545 CYP3A4 Human lithocholic acid affects metabolic processing EXP 6480464 CYP3A4 protein affects the metabolism of Lithocholic Acid CTD PMID:15708356 CYP3A4 Human lithocholic acid increases hydroxylation EXP 6480464 CYP3A4 protein results in increased hydroxylation of Lithocholic Acid CTD PMID:36473578 CYP3A4 Human lithocholic acid increases expression ISO Cyp3a2 (Rattus norvegicus) 6480464 Lithocholic Acid results in increased expression of CYP3A11 mRNA; Lithocholic Acid results in increased expression more ... CTD PMID:19965603|PMID:20006981|PMID:20888898 CYP3A4 Human lithocholic acid multiple interactions ISO Cyp3a2 (Rattus norvegicus) 6480464 [CYP3A2 protein results in increased metabolism of Lithocholic Acid] which results in increased chemical synthesis more ... CTD PMID:18039809|PMID:19965603|PMID:34461081 CYP3A4 Human lithocholic acid decreases activity ISO Cyp3a2 (Rattus norvegicus) 6480464 Lithocholic Acid results in decreased activity of CYP3A2 protein CTD PMID:8889968 CYP3A4 Human lithocholic acid increases metabolic processing ISO Cyp3a2 (Rattus norvegicus) 6480464 CYP3A2 protein results in increased metabolism of Lithocholic Acid CTD PMID:18039809 CYP3A4 Human lithocholic acid increases oxidation EXP 6480464 CYP3A4 protein results in increased oxidation of Lithocholic Acid CTD PMID:31102695 CYP3A4 Human lithocholic acid increases expression EXP 6480464 Lithocholic Acid results in increased expression of CYP3A4 mRNA CTD PMID:17965521|PMID:18645036|PMID:19562681|PMID:20888898 CYP3A4 Human lithocholic acid increases activity EXP 6480464 Lithocholic Acid results in increased activity of CYP3A4 protein mutant form CTD PMID:19299527 CYP3A4 Human lithocholic acid multiple interactions EXP 6480464 [CYP3A4 protein results in increased hydroxylation of Lithocholic Acid] which results in increased abundance of more ... CTD PMID:15489543|PMID:15578590|PMID:18645036|PMID:19299527|PMID:19487251|PMID:31102695|PMID:36473578 CYP3A4 Human lithocholic acid increases metabolic processing EXP 6480464 CYP3A4 protein results in increased metabolism of Lithocholic Acid CTD PMID:19487251 CYP3A4 Human loperamide multiple interactions EXP 6480464 [Axitinib results in decreased activity of CYP3A4 protein] which results in decreased metabolism of Loperamide CTD PMID:31299239 CYP3A4 Human lopinavir multiple interactions EXP 6480464 CAT protein inhibits the reaction [Lopinavir results in decreased activity of CYP3A4 protein] CTD PMID:15523003 CYP3A4 Human lopinavir decreases activity EXP 6480464 Lopinavir results in decreased activity of CYP3A4 protein CTD PMID:15523003 CYP3A4 Human loratadine decreases activity EXP 6480464 Loratadine analog results in decreased activity of CYP3A4 protein; Loratadine results in decreased activity of more ... CTD PMID:15482930 CYP3A4 Human lorlatinib multiple interactions EXP 6480464 lorlatinib inhibits the reaction [Rifampin results in increased activity of CYP3A4 protein] CTD PMID:34021354 CYP3A4 Human lovastatin multiple interactions EXP 6480464 [Lovastatin results in increased activity of NR1I2 protein] which results in increased expression of CYP3A4 more ... CTD PMID:17041008 CYP3A4 Human lovastatin increases expression EXP 6480464 Lovastatin results in increased expression of CYP3A4 mRNA CTD PMID:12505310 CYP3A4 Human loxapine increases metabolic processing EXP 6480464 CYP3A4 results in increased metabolism of Loxapine CTD PMID:21826677 CYP3A4 Human luteolin multiple interactions EXP 6480464 Luteolin inhibits the reaction [CYP3A4 protein results in increased chemical synthesis of 1-hydroxymethylmidazolam]; Luteolin inhibits more ... CTD PMID:18191104 CYP3A4 Human lycopene increases activity EXP 6480464 lycopene results in increased activity of CYP3A4 protein CTD PMID:16632523 CYP3A4 Human madecassoside decreases activity EXP 6480464 madecassoside results in decreased activity of CYP3A4 protein CTD PMID:21349323 CYP3A4 Human malathion affects metabolic processing EXP 6480464 CYP3A4 protein affects the metabolism of Malathion CTD PMID:15557345|PMID:17110060 CYP3A4 Human malathion multiple interactions EXP 6480464 [Malathion co-treated with isomalathion] results in increased expression of CYP3A4 mRNA CTD PMID:24333466 CYP3A4 Human malathion increases expression EXP 6480464 Malathion results in increased expression of CYP3A4 mRNA CTD PMID:22310298 CYP3A4 Human Maleic hydrazide multiple interactions EXP 6480464 [Maleic Hydrazide co-treated with Chlorpropham] results in increased expression of CYP3A4 mRNA CTD PMID:25028461 CYP3A4 Human mancozeb decreases expression EXP 6480464 mancozeb results in decreased expression of CYP3A4 mRNA; mancozeb results in decreased expression of CYP3A4 more ... CTD PMID:31096615 CYP3A4 Human mangiferin decreases activity EXP 6480464 mangiferin results in decreased activity of CYP3A4 protein CTD PMID:22815239 CYP3A4 Human Marrubiin increases metabolic processing EXP 6480464 CYP3A4 protein results in increased metabolism of marrubiin CTD PMID:34431289 CYP3A4 Human masitinib increases metabolic processing EXP 6480464 CYP3A4 protein results in increased metabolism of masitinib CTD PMID:36048877 CYP3A4 Human Meclizine multiple interactions EXP 6480464 [Meclizine results in decreased activity of CYP3A4 protein] which results in decreased chemical synthesis of more ... CTD PMID:26239802 CYP3A4 Human Meclizine decreases activity EXP 6480464 Meclizine results in decreased activity of CYP3A4 protein CTD PMID:26239802 CYP3A4 Human Meclizine increases expression EXP 6480464 Meclizine results in increased expression of CYP3A4 mRNA CTD PMID:26239802 CYP3A4 Human Medazepam increases expression EXP 6480464 Medazepam results in increased expression of CYP3A4 mRNA CTD PMID:20080160 CYP3A4 Human medroxyprogesterone acetate increases expression EXP 6480464 Medroxyprogesterone Acetate results in increased expression of CYP3A4 mRNA; Medroxyprogesterone Acetate results in increased expression more ... CTD PMID:15650019 CYP3A4 Human mefenamic acid increases hydroxylation EXP 6480464 CYP3A4 protein results in increased hydroxylation of Mefenamic Acid CTD PMID:25372302 CYP3A4 Human mefenamic acid increases glutathionylation EXP 6480464 CYP3A4 protein results in increased glutathionylation of Mefenamic Acid analog CTD PMID:25372302 CYP3A4 Human mefloquine multiple interactions EXP 6480464 Ketoconazole inhibits the reaction [CYP3A4 protein affects the metabolism of Mefloquine] CTD PMID:15896247 CYP3A4 Human MeIQ affects activity EXP 6480464 CYP3A4 affects the activity of 2-amino-3,4-dimethylimidazo(4,5-f)quinoline CTD PMID:8844805 CYP3A4 Human Melarsoprol decreases activity EXP 6480464 Melarsoprol results in decreased activity of CYP3A4 protein CTD PMID:11124226 CYP3A4 Human Mesaconitine multiple interactions EXP 6480464 [Aconitine co-treated with mesaconitine co-treated with hypaconitine] results in increased expression of CYP3A4 mRNA CTD PMID:30303438 CYP3A4 Human Mesaconitine increases expression EXP 6480464 mesaconitine results in increased expression of CYP3A4 mRNA CTD PMID:30303438 CYP3A4 Human metazachlor increases expression EXP 6480464 metazachlor results in increased expression of CYP3A4 mRNA CTD PMID:31465819 CYP3A4 Human metformin increases expression EXP 6480464 Metformin results in increased expression of CYP3A4 mRNA CTD PMID:19022234 CYP3A4 Human metformin decreases expression EXP 6480464 Metformin results in decreased expression of CYP3A4 mRNA CTD PMID:21920351 CYP3A4 Human metformin multiple interactions EXP 6480464 Metformin inhibits the reaction [Rifampin results in increased expression of CYP3A4 mRNA]; Metformin inhibits the more ... CTD PMID:21920351 CYP3A4 Human methadone increases metabolic processing EXP 6480464 CYP3A4 protein results in increased metabolism of Methadone CTD PMID:16595712 CYP3A4 Human methadone affects metabolic processing EXP 6480464 CYP3A4 protein affects the metabolism of Methadone CTD PMID:15986265 CYP3A4 Human methamphetamine affects metabolic processing EXP 6480464 CYP3A4 protein affects the metabolism of Methamphetamine metabolite CTD PMID:16038959 CYP3A4 Human methamphetamine multiple interactions EXP 6480464 [Methamphetamine binds to CYP3A4 promoter] which results in increased expression of CYP3A4 mRNA CTD PMID:12851153 CYP3A4 Human methidathion multiple interactions EXP 6480464 [enilconazole co-treated with methidathion] results in increased expression of CYP3A4 mRNA CTD PMID:25028461 CYP3A4 Human methotrexate decreases expression EXP 6480464 Methotrexate results in decreased expression of CYP3A4 mRNA CTD PMID:16837568 CYP3A4 Human methotrexate increases expression EXP 6480464 Methotrexate results in increased expression of CYP3A4 mRNA CTD PMID:29027214 CYP3A4 Human methoxsalen multiple interactions EXP 6480464 Dichlororibofuranosylbenzimidazole inhibits the reaction [Methoxsalen results in increased expression of CYP3A4 mRNA]; NR1I2 protein promotes more ... CTD PMID:17003103 CYP3A4 Human methoxsalen decreases activity ISO Cyp3a2 (Rattus norvegicus) 6480464 Methoxsalen results in decreased activity of CYP3A2 protein CTD PMID:15879494 CYP3A4 Human methoxsalen decreases activity EXP 6480464 Methoxsalen results in decreased activity of CYP3A4 protein CTD PMID:18420780 CYP3A4 Human methoxsalen increases expression EXP 6480464 Methoxsalen results in increased expression of CYP3A4 mRNA; Methoxsalen results in increased expression of CYP3A4 more ... CTD PMID:17003103 CYP3A4 Human methoxychlor increases expression EXP 6480464 Methoxychlor results in increased expression of CYP3A4 mRNA; Methoxychlor results in increased expression of CYP3A4 more ... CTD PMID:15466163|PMID:15548381|PMID:24832206 CYP3A4 Human methoxychlor decreases methylation ISO Cyp3a2 (Rattus norvegicus) 6480464 CYP3A4 protein results in decreased methylation of Methoxychlor CTD PMID:12433799 CYP3A4 Human methoxychlor increases expression ISO Cyp3a2 (Rattus norvegicus) 6480464 Methoxychlor results in increased expression of CYP3A2 protein CTD PMID:12919727 CYP3A4 Human methoxychlor increases activity EXP 6480464 Methoxychlor results in increased activity of CYP3A4 protein CTD PMID:24832206 CYP3A4 Human methoxychlor multiple interactions EXP 6480464 [Endosulfan co-treated with Methoxychlor] results in increased activity of CYP3A4 protein; Endosulfan promotes the reaction more ... CTD PMID:24832206 CYP3A4 Human methoxychlor decreases activity EXP 6480464 Methoxychlor results in decreased activity of CYP3A4 protein CTD PMID:18420780 CYP3A4 Human methoxyflurane increases metabolic processing EXP 6480464 CYP3A4 protein results in increased metabolism of Methoxyflurane CTD PMID:7879937 CYP3A4 Human metolachlor increases metabolic processing EXP 6480464 CYP3A4 protein results in increased metabolism of metolachlor CTD PMID:11133395 CYP3A4 Human metolachlor increases expression EXP 6480464 metolachlor results in increased expression of CYP3A4 mRNA CTD PMID:16565514 CYP3A4 Human metolazone multiple interactions EXP 6480464 [Metolazone results in increased activity of NR1I2 protein] which results in increased expression of CYP3A4 more ... CTD PMID:25455453 CYP3A4 Human metoprolol multiple interactions EXP 6480464 Ketoconazole inhibits the reaction [CYP3A4 protein results in increased hydroxylation of Metoprolol] CTD PMID:30087611 CYP3A4 Human metoprolol increases hydroxylation EXP 6480464 CYP3A4 protein results in increased hydroxylation of Metoprolol CTD PMID:30087611 CYP3A4 Human metronidazole multiple interactions EXP 6480464 Metronidazole inhibits the reaction [CYP3A4 protein results in increased metabolism of Amiodarone]; Metronidazole inhibits the more ... CTD PMID:15855244|PMID:15869686|PMID:19299527 CYP3A4 Human metronidazole multiple interactions ISO Cyp3a2 (Rattus norvegicus) 6480464 [Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in more ... CTD PMID:30545405 CYP3A4 Human metyrapone multiple interactions EXP 6480464 [Metyrapone results in increased activity of NR1I2 protein] which results in increased expression of CYP3A4 more ... CTD PMID:17041008 CYP3A4 Human metyrapone increases expression EXP 6480464 Metyrapone results in increased expression of CYP3A4 mRNA CTD PMID:10219967|PMID:12505310 CYP3A4 Human mevastatin increases expression EXP 6480464 mevastatin results in increased expression of CYP3A4 mRNA CTD PMID:12235278|PMID:15466163 CYP3A4 Human mevastatin multiple interactions EXP 6480464 [mevastatin results in increased activity of NR1I2 protein] which results in increased expression of CYP3A4 more ... CTD PMID:12235278|PMID:17041008 CYP3A4 Human Mibefradil decreases activity EXP 6480464 Mibefradil results in decreased activity of CYP3A4 protein CTD PMID:15860655 CYP3A4 Human miconazole decreases activity EXP 6480464 Miconazole results in decreased activity of CYP3A4 protein CTD PMID:15135088|PMID:15969931 CYP3A4 Human miconazole increases expression EXP 6480464 Miconazole results in increased expression of CYP3A4 mRNA CTD PMID:17998298 CYP3A4 Human miconazole multiple interactions EXP 6480464 Miconazole inhibits the reaction [CYP3A4 protein results in increased oxidation of 7-benzyloxy-4-trifluoromethylcoumarin]; Miconazole promotes the more ... CTD PMID:17998298|PMID:19299527 CYP3A4 Human midazolam increases metabolic processing EXP 6480464 CYP3A4 protein results in increased metabolism of Midazolam CTD PMID:12401345|PMID:12467917|PMID:15043991|PMID:15370959|PMID:16049126|PMID:16124035|PMID:17267297|PMID:17418993|PMID:17565714|PMID:17702393|PMID:19230594|PMID:19255940|PMID:21915887|PMID:23850985|PMID:26958860|PMID:28119166 CYP3A4 Human midazolam affects metabolic processing ISO Cyp3a2 (Rattus norvegicus) 6480464 CYP3A4 protein affects the metabolism of Midazolam CTD PMID:15801540 CYP3A4 Human midazolam multiple interactions ISO Cyp3a2 (Rattus norvegicus) 6480464 shikonin inhibits the reaction [CYP3A2 protein results in increased hydroxylation of Midazolam] CTD PMID:28941798 CYP3A4 Human midazolam increases hydroxylation ISO Cyp3a2 (Rattus norvegicus) 6480464 CYP3A2 protein results in increased hydroxylation of Midazolam CTD PMID:11911841|PMID:28941798 CYP3A4 Human midazolam increases glucuronidation EXP 6480464 CYP3A4 protein results in increased glucuronidation of Midazolam CTD PMID:27485346 CYP3A4 Human midazolam multiple interactions EXP 6480464 [3-hydroxyflavone results in increased activity of CYP3A4 protein] which results in increased metabolism of Midazolam; more ... CTD PMID:10997946|PMID:12695342|PMID:15043991|PMID:15258107|PMID:15370959|PMID:16029222|PMID:16049126|PMID:18385293|PMID:19230594|PMID:19299527|PMID:19557931|PMID:20233841|PMID:21053930|PMID:21915887|PMID:22178124|PMID:22524704|PMID:22652334|PMID:23850985|PMID:23876819|PMID:25343516|PMID:26888941|PMID:27485346|PMID:28119166|PMID:30087611|PMID:31756459|PMID:34189909|PMID:8114683 CYP3A4 Human midazolam increases hydroxylation EXP 6480464 CYP3A4 protein results in increased hydroxylation of Midazolam CTD PMID:12433797|PMID:12695342|PMID:15258107|PMID:15383492|PMID:15499178|PMID:15618748|PMID:15860655|PMID:18385293|PMID:20233841|PMID:22634058|PMID:22652334|PMID:23876819|PMID:26888941|PMID:27485346|PMID:28762043|PMID:29445054|PMID:30087611|PMID:34189909|PMID:8114683 CYP3A4 Human midazolam increases expression EXP 6480464 Midazolam results in increased expression of CYP3A4 mRNA CTD PMID:20080160 CYP3A4 Human midazolam increases oxidation EXP 6480464 CYP3A4 protein results in increased oxidation of Midazolam CTD PMID:21053930 CYP3A4 Human midazolam affects metabolic processing EXP 6480464 CYP3A4 gene polymorphism affects the metabolism of Midazolam; CYP3A4 protein affects the metabolism of Midazolam CTD PMID:15286053|PMID:15626586|PMID:15784650|PMID:15801540|PMID:15900284|PMID:15948934|PMID:16029222|PMID:16042670|PMID:19557931 CYP3A4 Human midazolam decreases abundance EXP 6480464 CYP3A4 protein results in decreased abundance of Midazolam CTD PMID:12695342 CYP3A4 Human mifepristone multiple interactions EXP 6480464 [Mifepristone results in increased activity of NR1I2 protein] which results in increased expression of CYP3A4 more ... CTD PMID:10219967|PMID:12235278|PMID:16049126|PMID:17041008|PMID:19299527|PMID:22652334 CYP3A4 Human mifepristone increases expression EXP 6480464 Mifepristone results in increased expression of CYP3A4 mRNA CTD PMID:12235278|PMID:15466163|PMID:16837568 CYP3A4 Human mifepristone decreases activity EXP 6480464 Mifepristone results in decreased activity of CYP3A4 protein CTD PMID:15860655|PMID:16049126|PMID:22652334 CYP3A4 Human Mitotane increases activity EXP 6480464 Mitotane results in increased activity of CYP3A4 protein CTD PMID:23179081 CYP3A4 Human Mitotane multiple interactions EXP 6480464 [Mitotane results in increased activity of NR1I2 protein] which results in increased expression of CYP3A4 more ... CTD PMID:23179081|PMID:31312845 CYP3A4 Human Mitotane increases expression EXP 6480464 Mitotane results in increased expression of CYP3A4 mRNA CTD PMID:23179081|PMID:31312845 CYP3A4 Human Mitragynine increases expression EXP 6480464 mitragynine results in increased expression of CYP3A4 mRNA; mitragynine results in increased expression of CYP3A4 more ... CTD PMID:23274770 CYP3A4 Human Mitragynine increases activity EXP 6480464 mitragynine results in increased activity of CYP3A4 protein CTD PMID:23274770 CYP3A4 Human mono(2-ethyl-5-hydroxyhexyl) phthalate multiple interactions EXP 6480464 [CYP3A4 protein results in increased metabolism of mono-(2-ethylhexyl)phthalate] which results in increased chemical synthesis of more ... CTD PMID:23545481 CYP3A4 Human mono(2-ethyl-5-hydroxyhexyl) phthalate multiple interactions ISO Cyp3a2 (Rattus norvegicus) 6480464 [CYP3A2 protein results in increased metabolism of mono-(2-ethylhexyl)phthalate] which results in increased chemical synthesis of more ... CTD PMID:23545481 CYP3A4 Human mono(2-ethyl-5-oxohexyl) phthalate multiple interactions EXP 6480464 [CYP3A4 protein results in increased metabolism of mono-(2-ethylhexyl)phthalate] which results in increased chemical synthesis of more ... CTD PMID:23545481 CYP3A4 Human mono(2-ethyl-5-oxohexyl) phthalate multiple interactions ISO Cyp3a2 (Rattus norvegicus) 6480464 [CYP3A2 protein results in increased metabolism of mono-(2-ethylhexyl)phthalate] which results in increased chemical synthesis of more ... CTD PMID:23545481 CYP3A4 Human mono(2-ethylhexyl) phthalate multiple interactions EXP 6480464 [CYP3A4 protein results in increased metabolism of mono-(2-ethylhexyl)phthalate] which results in increased chemical synthesis of more ... CTD PMID:18332045|PMID:22186153|PMID:23545481 CYP3A4 Human mono(2-ethylhexyl) phthalate multiple interactions ISO Cyp3a2 (Rattus norvegicus) 6480464 [CYP3A2 protein results in increased metabolism of mono-(2-ethylhexyl)phthalate] which results in increased chemical synthesis of more ... CTD PMID:22186153|PMID:23545481 CYP3A4 Human mono(2-ethylhexyl) phthalate increases metabolic processing ISO Cyp3a2 (Rattus norvegicus) 6480464 CYP3A2 protein results in increased metabolism of mono-(2-ethylhexyl)phthalate CTD PMID:22186153|PMID:23545481 CYP3A4 Human mono(2-ethylhexyl) phthalate increases expression EXP 6480464 mono-(2-ethylhexyl)phthalate results in increased expression of CYP3A4 mRNA CTD PMID:27551952|PMID:39341470 CYP3A4 Human mono(2-ethylhexyl) phthalate increases metabolic processing EXP 6480464 CYP3A4 protein results in increased metabolism of mono-(2-ethylhexyl)phthalate CTD PMID:22186153|PMID:23545481 CYP3A4 Human mono-isopropyl-disopyramide increases chemical synthesis EXP 6480464 CYP3A4 protein results in increased chemical synthesis of 4-(isopropylamino)-2-(2-pyridyl)-2-phenylbutyramide CTD PMID:10901704 CYP3A4 Human monobenzone multiple interactions EXP 6480464 [monobenzone results in increased activity of NR1I2 protein] which results in increased expression of CYP3A4 more ... CTD PMID:25455453 CYP3A4 Human monocrotaline multiple interactions EXP 6480464 [CYP3A4 protein results in increased metabolism of Monocrotaline] which affects the expression of BRCA2 mRNA; more ... CTD PMID:19818743|PMID:32682830|PMID:33884520 CYP3A4 Human monocrotaline increases response to substance EXP 6480464 CYP3A4 protein results in increased susceptibility to Monocrotaline CTD PMID:32910235 CYP3A4 Human monocrotaline increases expression EXP 6480464 Monocrotaline results in increased expression of CYP3A4 mRNA CTD PMID:32682830 CYP3A4 Human monocrotaline increases metabolic processing EXP 6480464 CYP3A4 protein results in increased metabolism of Monocrotaline CTD PMID:33884520 CYP3A4 Human monocrotophos increases activity EXP 6480464 Monocrotophos results in increased activity of CYP3A4 protein CTD PMID:22733800 CYP3A4 Human monocrotophos increases expression EXP 6480464 Monocrotophos results in increased expression of CYP3A4 mRNA; Monocrotophos results in increased expression of CYP3A4 more ... CTD PMID:22733800 CYP3A4 Human monocrotophos multiple interactions EXP 6480464 [Monocrotophos co-treated with Cimetidine] results in increased expression of CYP3A4 protein; [Rifampin co-treated with Monocrotophos] more ... CTD PMID:22733800 CYP3A4 Human monoethylglycinexylidide affects chemical synthesis EXP 6480464 CYP3A4 protein affects the chemical synthesis of monoethylglycinexylidide CTD PMID:15887009 CYP3A4 Human monosodium L-glutamate multiple interactions ISO Cyp3a2 (Rattus norvegicus) 6480464 GH1 protein inhibits the reaction [Sodium Glutamate results in decreased expression of and results in more ... CTD PMID:7476908 CYP3A4 Human moricizine increases expression EXP 6480464 Moricizine results in increased expression of CYP3A4 mRNA CTD PMID:18332078 CYP3A4 Human Muscone increases activity EXP 6480464 muscone results in increased activity of CYP3A4 protein CTD PMID:22178124 CYP3A4 Human Muscone multiple interactions EXP 6480464 muscone promotes the reaction [CYP3A4 protein results in increased metabolism of Midazolam] CTD PMID:22178124 CYP3A4 Human musk xylene increases activity ISO Cyp3a2 (Rattus norvegicus) 6480464 musk xylene results in increased activity of CYP3A2 protein CTD PMID:10630706 CYP3A4 Human musk xylene increases expression ISO Cyp3a2 (Rattus norvegicus) 6480464 musk xylene results in increased expression of CYP3A2 protein CTD PMID:10630706 CYP3A4 Human mycophenolic acid increases methylation EXP 6480464 CYP3A4 protein results in increased methylation of Mycophenolic Acid CTD PMID:15570183 CYP3A4 Human mycophenolic acid multiple interactions EXP 6480464 [Mycophenolic Acid results in increased activity of NR1I2 protein] which results in increased expression of more ... CTD PMID:25455453 CYP3A4 Human myricetin decreases activity EXP 6480464 myricetin results in decreased activity of CYP3A4 protein CTD PMID:29753067 CYP3A4 Human myristicin affects oxidation EXP 6480464 CYP3A4 protein affects the oxidation of myristicin CTD PMID:12523956 CYP3A4 Human N'-Nitrosoanabasine multiple interactions EXP 6480464 CYP3A4 protein affects the metabolism of and results in increased activity of N'-nitrosoanabasine CTD PMID:11774366 CYP3A4 Human N,N-Didesmethyltamoxifen increases metabolic processing EXP 6480464 CYP3A4 protein results in increased metabolism of N,N-didesmethyltamoxifen CTD PMID:29285606 CYP3A4 Human N,N-Didesmethyltamoxifen multiple interactions EXP 6480464 [CYP3A4 protein results in increased metabolism of N,N-didesmethyltamoxifen] which results in increased abundance of 1-(4-hydroxyphenyl)-1,2-diphenyl-1-butene CTD PMID:29285606 CYP3A4 Human N,N-diethyl-m-toluamide increases metabolic processing EXP 6480464 CYP3A4 protein results in increased metabolism of DEET CTD PMID:11854147 CYP3A4 Human N,N-diethyl-m-toluamide increases expression EXP 6480464 DEET results in increased expression of CYP3A4 mRNA CTD PMID:19326769|PMID:27091632|PMID:36356836 CYP3A4 Human N,N-diethyl-m-toluamide multiple interactions EXP 6480464 [fipronil co-treated with DEET] results in increased expression of CYP3A4 mRNA CTD PMID:27091632 CYP3A4 Human N-(2,6-diethylphenyl)-2-chloroacetamide multiple interactions EXP 6480464 [CYP3A4 protein results in increased metabolism of alachlor] which results in increased abundance of 2-chloro-N-(2,6-diethylphenyl)acetamide CTD PMID:18273908 CYP3A4 Human N-(2,6-diethylphenyl)-2-chloroacetamide increases chemical synthesis EXP 6480464 CYP3A4 protein results in increased chemical synthesis of 2-chloro-N-(2,6-diethylphenyl)acetamide CTD PMID:10475613 CYP3A4 Human N-(2,6-diethylphenyl)-2-chloroacetamide increases abundance EXP 6480464 CYP3A4 protein results in increased abundance of 2-chloro-N-(2,6-diethylphenyl)acetamide CTD PMID:18273908 CYP3A4 Human N-acetyl-1,4-benzoquinone imine increases abundance EXP 6480464 CYP3A4 protein results in increased abundance of N-acetyl-4-benzoquinoneimine CTD PMID:24661219 CYP3A4 Human N-acetyl-L-cysteine multiple interactions EXP 6480464 [CYP3A4 protein co-treated with Acetylcysteine] results in increased metabolism of Emodin metabolite; Acetylcysteine inhibits the more ... CTD PMID:25451576|PMID:27989148|PMID:34200939 CYP3A4 Human N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal multiple interactions EXP 6480464 benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [6-(4-chlorophenyl)imidazo(2,1-b)(1,3)thiazole-5-carbaldehyde O-(3,4-dichlorobenzyl)oxime results in increased expression of CYP3A4 mRNA]; benzyloxycarbonylleucyl-leucyl-leucine more ... CTD PMID:24224465 CYP3A4 Human N-desethylamiodarone increases metabolic processing EXP 6480464 CYP3A4 protein results in increased metabolism of desethylamiodarone CTD PMID:22785256 CYP3A4 Human N-desethylamiodarone multiple interactions EXP 6480464 [desethylamiodarone co-treated with CYP3A4 protein] results in increased expression of CXCL8 mRNA; [desethylamiodarone co-treated with more ... CTD PMID:22785256 CYP3A4 Human N-desethylamiodarone increases chemical synthesis EXP 6480464 CYP3A4 protein results in increased chemical synthesis of desethylamiodarone CTD PMID:8445979 CYP3A4 Human N-desmethylclozapine increases chemical synthesis EXP 6480464 CYP3A4 protein results in increased chemical synthesis of norclozapine CTD PMID:18809730 CYP3A4 Human N-desmethylclozapine multiple interactions EXP 6480464 Ketoconazole inhibits the reaction [CYP3A4 protein results in increased chemical synthesis of norclozapine] CTD PMID:18809730 CYP3A4 Human N-Desmethyltamoxifen multiple interactions EXP 6480464 [CYP3A4 protein results in increased metabolism of N-desmethyltamoxifen] which results in increased abundance of 1-(4-hydroxyphenyl)-1,2-diphenyl-1-butene; more ... CTD PMID:14652237|PMID:29285606 CYP3A4 Human N-Desmethyltamoxifen increases metabolic processing EXP 6480464 CYP3A4 protein results in increased metabolism of N-desmethyltamoxifen CTD PMID:29285606 CYP3A4 Human N-Desmethyltamoxifen decreases activity EXP 6480464 N-desmethyltamoxifen results in decreased activity of CYP3A4 protein CTD PMID:12419016 CYP3A4 Human N-Nitrosodi-n-propylamine affects metabolic processing EXP 6480464 CYP3A4 protein affects the metabolism of N-nitroso(di-n-propyl)amine CTD PMID:10910959 CYP3A4 Human N-Nitrosodi-n-propylamine decreases nitrosation EXP 6480464 CYP3A4 protein results in decreased nitrosation of N-nitroso(di-n-propyl)amine CTD PMID:10910959 CYP3A4 Human N-nitrosodiethylamine multiple interactions ISO Cyp3a2 (Rattus norvegicus) 6480464 [DDT co-treated with Diethylnitrosamine] results in decreased expression of CYP3A2 mRNA; [DDT co-treated with Diethylnitrosamine] more ... CTD PMID:11165752|PMID:15885732|PMID:16246485|PMID:18164116|PMID:18977376|PMID:28943392|PMID:29698782|PMID:9744545 CYP3A4 Human N-nitrosodiethylamine decreases expression ISO Cyp3a2 (Rattus norvegicus) 6480464 Diethylnitrosamine results in decreased expression of CYP3A11 mRNA CTD PMID:19638242 CYP3A4 Human N-nitrosodimethylamine decreases expression ISO Cyp3a2 (Rattus norvegicus) 6480464 Dimethylnitrosamine results in decreased expression of CYP3A11 mRNA CTD PMID:17072980 CYP3A4 Human NADP zwitterion multiple interactions EXP 6480464 [2,3,5,4'-tetrahydroxystilbene-2-O-beta-D-glucopyranoside co-treated with NADP] results in decreased activity of CYP3A4 protein; [[CYP3A4 protein co-treated with more ... CTD PMID:16153789|PMID:19818743|PMID:20825217|PMID:21766881|PMID:22390216|PMID:24120545|PMID:30914192|PMID:34189909|PMID:36332690 CYP3A4 Human NADP zwitterion multiple interactions ISO Cyp3a2 (Rattus norvegicus) 6480464 [CYP3A2 protein co-treated with NADP co-treated with Glutathione] results in increased glutathionylation of and results more ... CTD PMID:20825217 CYP3A4 Human NADP(+) multiple interactions EXP 6480464 [2,3,5,4'-tetrahydroxystilbene-2-O-beta-D-glucopyranoside co-treated with NADP] results in decreased activity of CYP3A4 protein; [[CYP3A4 protein co-treated with more ... CTD PMID:16153789|PMID:19818743|PMID:20825217|PMID:21766881|PMID:22390216|PMID:24120545|PMID:30914192|PMID:34189909|PMID:36332690 CYP3A4 Human NADP(+) multiple interactions ISO Cyp3a2 (Rattus norvegicus) 6480464 [CYP3A2 protein co-treated with NADP co-treated with Glutathione] results in increased glutathionylation of and results more ... CTD PMID:20825217 CYP3A4 Human nafcillin increases expression EXP 6480464 Nafcillin results in increased expression of CYP3A4 mRNA; Nafcillin results in increased expression of CYP3A4 more ... CTD PMID:18505790 CYP3A4 Human naphthalene increases expression EXP 6480464 naphthalene results in increased expression of CYP3A4 mRNA CTD PMID:20500019 CYP3A4 Human naringin multiple interactions EXP 6480464 naringin inhibits the reaction [CYP3A4 protein affects the metabolism of Verapamil] CTD PMID:16013069 CYP3A4 Human naringin decreases activity EXP 6480464 naringin results in decreased activity of CYP3A4 protein CTD PMID:16013069|PMID:21053930 CYP3A4 Human nefazodone increases response to substance EXP 6480464 CYP3A4 protein results in increased susceptibility to nefazodone CTD PMID:21540358 CYP3A4 Human nefazodone decreases expression EXP 6480464 nefazodone results in decreased expression of CYP3A4 mRNA CTD PMID:32152650 CYP3A4 Human nefazodone increases hydroxylation EXP 6480464 CYP3A4 protein results in increased hydroxylation of nefazodone CTD PMID:27485346 CYP3A4 Human nefazodone multiple interactions EXP 6480464 [CYP3A4 protein results in increased hydroxylation of nefazodone] which results in increased abundance of hydroxynefazodone; more ... CTD PMID:12584149|PMID:27485346|PMID:32152650 CYP3A4 Human Neferine multiple interactions EXP 6480464 [CYP3A4 protein co-treated with neferine] results in decreased abundance of Glutathione; Acetylcysteine inhibits the reaction more ... CTD PMID:25451576 CYP3A4 Human Neferine increases glutathionylation EXP 6480464 CYP3A4 protein results in increased glutathionylation of neferine metabolite CTD PMID:25451576 CYP3A4 Human nelfinavir decreases activity EXP 6480464 Nelfinavir results in decreased activity of CYP3A4 protein CTD PMID:15523003 CYP3A4 Human nemorubicin multiple interactions EXP 6480464 [CYP3A4 protein co-treated with POR protein] results in increased metabolism of methoxy-morpholinyl-doxorubicin CTD PMID:15465924 CYP3A4 Human nemorubicin increases metabolic processing ISO Cyp3a2 (Rattus norvegicus) 6480464 CYP3A2 protein results in increased metabolism of methoxy-morpholinyl-doxorubicin CTD PMID:15465924 CYP3A4 Human nemorubicin increases metabolic processing EXP 6480464 CYP3A4 protein results in increased metabolism of methoxy-morpholinyl-doxorubicin CTD PMID:15465924 CYP3A4 Human neobavaisoflavone increases expression ISO Cyp3a2 (Rattus norvegicus) 6480464 neobavaisoflavone results in increased expression of CYP3A4 mRNA CTD PMID:31870919 CYP3A4 Human neomycin multiple interactions ISO Cyp3a2 (Rattus norvegicus) 6480464 [Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in more ... CTD PMID:30545405 CYP3A4 Human nevirapine affects binding EXP 6480464 Nevirapine binds to CYP3A4 protein CTD PMID:22793666 CYP3A4 Human nevirapine decreases activity EXP 6480464 Nevirapine results in decreased activity of CYP3A4 protein CTD PMID:39023798 CYP3A4 Human nicardipine decreases activity EXP 6480464 Nicardipine results in decreased activity of CYP3A4 protein CTD PMID:10805063|PMID:15860655|PMID:15863898 CYP3A4 Human nicardipine affects metabolic processing EXP 6480464 CYP3A4 protein affects the metabolism of Nicardipine CTD PMID:15863898 CYP3A4 Human nicardipine multiple interactions EXP 6480464 [Nicardipine results in increased activity of NR1I2 protein] which results in increased expression of CYP3A4 more ... CTD PMID:15863898|PMID:17041008 CYP3A4 Human nickel atom decreases expression EXP 6480464 Nickel results in decreased expression of CYP3A4 mRNA CTD PMID:24768652 CYP3A4 Human niclosamide decreases activity EXP 6480464 Niclosamide results in decreased activity of CYP3A4 protein CTD PMID:11124226 CYP3A4 Human nicotinamide multiple interactions ISO Cyp3a2 (Rattus norvegicus) 6480464 [Methionine co-treated with Thiamine co-treated with Niacinamide co-treated with alpha-Tocopherol co-treated with Zinc] inhibits the more ... CTD PMID:27919644 CYP3A4 Human nicotine multiple interactions EXP 6480464 [Nicotine binds to CYP3A4 promoter] which results in increased expression of CYP3A4 mRNA CTD PMID:12851153 CYP3A4 Human nicotine multiple interactions ISO Cyp3a2 (Rattus norvegicus) 6480464 [Nicotine co-treated with 2,2',3,5',6-pentachlorobiphenyl] results in increased expression of CYP3A2 mRNA CTD PMID:26463278 CYP3A4 Human nifedipine multiple interactions EXP 6480464 6',7'-dihydroxybergamottin inhibits the reaction [CYP3A4 protein results in increased oxidation of Nifedipine]; [Nifedipine binds to more ... CTD PMID:12851153|PMID:17041008|PMID:18846481|PMID:19230594|PMID:19299527|PMID:20863320|PMID:23146034|PMID:25069801 CYP3A4 Human nifedipine multiple interactions ISO Cyp3a2 (Rattus norvegicus) 6480464 [SOD2 co-treated with CYP3A4] affects the susceptibility to Nifedipine; Nifedipine inhibits the reaction [CYP3A2 protein more ... CTD PMID:19501153|PMID:19858067 CYP3A4 Human nifedipine increases hydroxylation EXP 6480464 CYP3A4 protein results in increased hydroxylation of Nifedipine CTD PMID:18846481 CYP3A4 Human nifedipine increases oxidation EXP 6480464 CYP3A4 protein results in increased oxidation of Nifedipine CTD PMID:15618748|PMID:15937564|PMID:20863320|PMID:23146034 CYP3A4 Human nifedipine affects metabolic processing EXP 6480464 CYP3A4 protein affects the metabolism of Nifedipine CTD PMID:15286053|PMID:15634941|PMID:15784650 CYP3A4 Human nifedipine increases expression EXP 6480464 Nifedipine results in increased expression of CYP3A4 mRNA; Nifedipine results in increased expression of CYP3A4 more ... CTD PMID:16837568|PMID:17954527|PMID:22524704|PMID:25069801 CYP3A4 Human nifedipine increases metabolic processing EXP 6480464 CYP3A4 protein results in increased metabolism of Nifedipine CTD PMID:16712844|PMID:19230594 CYP3A4 Human nifedipine affects oxidation EXP 6480464 CYP3A4 protein affects the oxidation of Nifedipine CTD PMID:2271712 CYP3A4 Human nimesulide increases glutathionylation EXP 6480464 CYP3A4 protein results in increased glutathionylation of nimesulide CTD PMID:26524229 CYP3A4 Human nimesulide multiple interactions ISO Cyp3a2 (Rattus norvegicus) 6480464 nimesulide inhibits the reaction [Trinitrobenzenesulfonic Acid results in decreased activity of and results in decreased more ... CTD PMID:18079364 CYP3A4 Human nimetazepam multiple interactions EXP 6480464 CYP3A4 protein affects the reaction [nimetazepam results in increased activity of CASP3 protein]; CYP3A4 protein more ... CTD PMID:19005028 CYP3A4 Human nitrazepam multiple interactions EXP 6480464 CYP3A4 protein affects the reaction [Nitrazepam results in increased activity of CASP3 protein]; CYP3A4 protein more ... CTD PMID:19005028 CYP3A4 Human nitrendipine affects metabolic processing EXP 6480464 CYP3A4 protein affects the metabolism of Nitrendipine CTD PMID:15286053 CYP3A4 Human nobiletin increases activity EXP 6480464 nobiletin results in increased activity of CYP3A4 protein CTD PMID:31756459 CYP3A4 Human nobiletin multiple interactions EXP 6480464 [[nobiletin results in increased activity of CYP3A4 protein] which results in increased metabolism of Midazolam] more ... CTD PMID:31756459 CYP3A4 Human Norbuprenorphine decreases activity EXP 6480464 norbuprenorphine results in decreased activity of CYP3A4 protein CTD PMID:12756210 CYP3A4 Human Norbuprenorphine affects chemical synthesis EXP 6480464 CYP3A4 protein affects the chemical synthesis of norbuprenorphine CTD PMID:15966752 CYP3A4 Human norcisapride affects metabolic processing EXP 6480464 CYP3A4 protein affects the metabolism of norcisapride CTD PMID:11717173 CYP3A4 Human norcisapride affects chemical synthesis EXP 6480464 CYP3A4 protein affects the chemical synthesis of norcisapride CTD PMID:11717173 CYP3A4 Human norcodeine multiple interactions EXP 6480464 [CYP3A4 protein results in increased metabolism of Codeine] which results in increased chemical synthesis of more ... CTD PMID:16595712 CYP3A4 Human nordazepam increases metabolic processing EXP 6480464 CYP3A4 protein results in increased metabolism of Nordazepam CTD PMID:18846481 CYP3A4 Human Norfluoxetine multiple interactions EXP 6480464 norfluoxetine inhibits the reaction [CYP3A4 protein results in increased oxidation of and results in increased more ... CTD PMID:12584149 CYP3A4 Human Noroxycodone multiple interactions EXP 6480464 telithromycin inhibits the reaction [CYP3A4 protein results in increased chemical synthesis of noroxycodone] CTD PMID:19755414 CYP3A4 Human nortriptyline increases metabolic processing EXP 6480464 Nortriptyline results in increased metabolism of CYP3A4 protein CTD PMID:18359012 CYP3A4 Human notoginsenoside R1 increases expression EXP 6480464 notoginsenoside R1 results in increased expression of CYP3A4 mRNA CTD PMID:25472953 CYP3A4 Human Notopterol increases metabolic processing EXP 6480464 CYP3A4 protein results in increased metabolism of notopterol CTD PMID:32198085 CYP3A4 Human Notopterol decreases activity EXP 6480464 notopterol results in decreased activity of CYP3A4 protein CTD PMID:32198085 CYP3A4 Human Notopterol multiple interactions EXP 6480464 [CYP3A4 protein results in increased metabolism of notopterol] promotes the reaction [Glutathione binds to notopterol]; more ... CTD PMID:32198085 CYP3A4 Human o-anisidine increases oxidation EXP 6480464 CYP3A4 protein results in increased oxidation of 2-anisidine CTD PMID:15828049 CYP3A4 Human o-toluidine increases expression EXP 6480464 2-toluidine results in increased expression of CYP3A4 mRNA; 2-toluidine results in increased expression of CYP3A4 more ... CTD PMID:36870411 CYP3A4 Human obeticholic acid decreases activity EXP 6480464 obeticholic acid results in decreased activity of CYP3A4 protein CTD PMID:27939613 CYP3A4 Human obeticholic acid decreases expression ISO Cyp3a2 (Rattus norvegicus) 6480464 obeticholic acid results in decreased expression of CYP3A2 mRNA CTD PMID:35267068 CYP3A4 Human obeticholic acid multiple interactions EXP 6480464 obeticholic acid inhibits the reaction [CYP3A4 protein results in increased chemical synthesis of 6 beta-hydroxytestosterone]; more ... CTD PMID:27939613 CYP3A4 Human obeticholic acid decreases expression EXP 6480464 obeticholic acid results in decreased expression of CYP3A4 mRNA CTD PMID:27939613 CYP3A4 Human ochratoxin A increases expression EXP 6480464 ochratoxin A results in increased expression of CYP3A4 mRNA; ochratoxin A results in increased expression more ... CTD PMID:21834667|PMID:30291945 CYP3A4 Human ochratoxin A decreases expression EXP 6480464 ochratoxin A results in decreased expression of CYP3A4 mRNA CTD PMID:26505656 CYP3A4 Human ochratoxin A multiple interactions EXP 6480464 ochratoxin A inhibits the reaction [Rifampin results in increased expression of CYP3A4 mRNA]; ochratoxin A more ... CTD PMID:26341324 CYP3A4 Human ochratoxin A increases response to substance EXP 6480464 CYP3A4 protein results in increased susceptibility to ochratoxin A CTD PMID:21781659|PMID:8542584 CYP3A4 Human octadecanoic acid decreases expression EXP 6480464 stearic acid results in decreased expression of CYP3A4 mRNA; stearic acid results in decreased expression more ... CTD PMID:26739624 CYP3A4 Human octadecanoic acid multiple interactions EXP 6480464 INS protein inhibits the reaction [stearic acid results in decreased expression of CYP3A4 mRNA] CTD PMID:26739624 CYP3A4 Human octamethylcyclotetrasiloxane increases expression ISO Cyp3a2 (Rattus norvegicus) 6480464 octamethylcyclotetrasiloxane results in increased expression of CYP3A2 protein CTD PMID:15849718 CYP3A4 Human octamethylcyclotetrasiloxane multiple interactions ISO Cyp3a2 (Rattus norvegicus) 6480464 octamethylcyclotetrasiloxane results in increased expression of and results in increased activity of CYP3A2 protein CTD PMID:36100151 CYP3A4 Human ofloxacin multiple interactions EXP 6480464 [Ofloxacin co-treated with Clarithromycin] inhibits the reaction [CYP3A4 protein results in increased metabolism of Theophylline] CTD PMID:11408986 CYP3A4 Human okadaic acid decreases response to substance EXP 6480464 CYP3A4 protein results in decreased susceptibility to Okadaic Acid CTD PMID:24504163 CYP3A4 Human okadaic acid decreases expression EXP 6480464 Okadaic Acid results in decreased expression of CYP3A4 mRNA CTD PMID:38832940 CYP3A4 Human okadaic acid multiple interactions ISO Cyp3a2 (Rattus norvegicus) 6480464 CYP3A2 protein results in increased metabolism of and results in increased hydroxylation of and results more ... CTD PMID:26374342 CYP3A4 Human okadaic acid multiple interactions EXP 6480464 CYP3A4 protein results in increased metabolism of and results in increased hydroxylation of and results more ... CTD PMID:26374342 CYP3A4 Human olanzapine decreases activity EXP 6480464 Olanzapine results in decreased activity of CYP3A4 protein CTD PMID:39023798 CYP3A4 Human oleanolic acid decreases activity EXP 6480464 Oleanolic Acid results in decreased activity of CYP3A4 protein CTD PMID:15043991 CYP3A4 Human oleanolic acid increases expression EXP 6480464 Oleanolic Acid results in increased expression of CYP3A4 protein CTD PMID:38513930 CYP3A4 Human oleanolic acid multiple interactions EXP 6480464 Oleanolic Acid inhibits the reaction [CYP3A4 protein results in increased metabolism of Midazolam] CTD PMID:15043991 CYP3A4 Human oleic acid decreases expression EXP 6480464 Oleic Acid results in decreased expression of CYP3A4 mRNA; Oleic Acid results in decreased expression more ... CTD PMID:26739624|PMID:30611723 CYP3A4 Human oleic acid multiple interactions EXP 6480464 Farnesol analog inhibits the reaction [Oleic Acid results in decreased expression of CYP3A4 mRNA] CTD PMID:30611723 CYP3A4 Human olmesartan decreases activity EXP 6480464 olmesartan results in decreased activity of CYP3A4 protein CTD PMID:39023798 CYP3A4 Human oltipraz decreases activity EXP 6480464 oltipraz metabolite results in decreased activity of CYP3A4 protein; oltipraz results in decreased activity of more ... CTD PMID:10775323|PMID:19833192 CYP3A4 Human oltipraz affects metabolic processing ISO Cyp3a2 (Rattus norvegicus) 6480464 CYP3A2 protein affects the metabolism of oltipraz CTD PMID:15831204|PMID:15920769 CYP3A4 Human oltipraz affects activity EXP 6480464 oltipraz affects the activity of CYP3A4 protein CTD PMID:10775323 CYP3A4 Human omeprazole multiple interactions EXP 6480464 [Omeprazole results in increased activity of NR1I2 protein] which results in increased expression of CYP3A4 more ... CTD PMID:12695340|PMID:15802389|PMID:17041008|PMID:19299527 CYP3A4 Human omeprazole increases metabolic processing EXP 6480464 CYP3A4 protein results in increased metabolism of Omeprazole CTD PMID:12485723|PMID:17565714|PMID:22634058|PMID:7870052|PMID:8930576 CYP3A4 Human omeprazole affects metabolic processing EXP 6480464 CYP3A4 protein affects the metabolism of Omeprazole CTD PMID:15286053|PMID:15626586 CYP3A4 Human omeprazole increases expression EXP 6480464 Omeprazole results in increased expression of CYP3A4 mRNA; Omeprazole results in increased expression of CYP3A4 more ... CTD PMID:12235278|PMID:12695340|PMID:15466163|PMID:15802389|PMID:17954527|PMID:19118567|PMID:9744552 CYP3A4 Human Omeprazole sulfide increases metabolic processing EXP 6480464 CYP3A4 protein results in increased metabolism of omeprazole sulfide CTD PMID:16109480 CYP3A4 Human Ondansetron affects metabolic processing EXP 6480464 CYP3A4 protein affects the metabolism of Ondansetron CTD PMID:15286053 CYP3A4 Human organophosphorus compound multiple interactions EXP 6480464 Organophosphorus Compounds inhibits the reaction [CYP3A4 protein results in decreased methylation of and results in more ... CTD PMID:15922009 CYP3A4 Human orlistat increases expression EXP 6480464 orlistat results in increased expression of CYP3A4 mRNA; orlistat results in increased expression of CYP3A4 more ... CTD PMID:20599501 CYP3A4 Human osthole increases metabolic processing EXP 6480464 CYP3A4 protein results in increased metabolism of osthol CTD PMID:39793773 CYP3A4 Human Oxadiazon increases expression EXP 6480464 oxadiazon results in increased expression of CYP3A4 mRNA CTD PMID:16565514 CYP3A4 Human oxatomide decreases activity EXP 6480464 oxatomide results in decreased activity of CYP3A4 protein CTD PMID:15684493 CYP3A4 Human oxatomide increases metabolic processing EXP 6480464 CYP3A4 protein results in increased metabolism of oxatomide CTD PMID:15684493 CYP3A4 Human oxiconazole multiple interactions EXP 6480464 oxiconazole inhibits the reaction [Rifampin promotes the reaction [NR1I2 results in increased expression of CYP3A4 more ... CTD PMID:17998298 CYP3A4 Human oxiconazole increases expression EXP 6480464 oxiconazole results in increased expression of CYP3A4 mRNA CTD PMID:17998298 CYP3A4 Human oxycodone multiple interactions EXP 6480464 telithromycin inhibits the reaction [CYP3A4 protein results in decreased methylation of Oxycodone] CTD PMID:19755414 CYP3A4 Human oxycodone multiple interactions ISO Cyp3a2 (Rattus norvegicus) 6480464 Oxycodone inhibits the reaction [CYP3A2 protein results in increased hydroxylation of Testosterone] CTD PMID:20487198 CYP3A4 Human oxycodone decreases expression ISO Cyp3a2 (Rattus norvegicus) 6480464 Oxycodone results in decreased expression of CYP3A2 mRNA; Oxycodone results in decreased expression of CYP3A2 more ... CTD PMID:20487198 CYP3A4 Human oxycodone affects metabolic processing EXP 6480464 CYP3A4 protein alternative form affects the metabolism of Oxycodone CTD PMID:33393779 CYP3A4 Human p-menthan-3-ol increases expression EXP 6480464 Menthol results in increased expression of CYP3A4 mRNA CTD PMID:24594507 CYP3A4 Human p-toluidine decreases expression ISO Cyp3a2 (Rattus norvegicus) 6480464 4-toluidine results in decreased expression of CYP3A2 mRNA CTD PMID:27638505 CYP3A4 Human paclitaxel multiple interactions EXP 6480464 Ketoconazole inhibits the reaction [CYP3A4 protein results in increased oxidation of Paclitaxel]; Ketoconazole inhibits the more ... CTD PMID:12237780|PMID:16819505|PMID:17438109|PMID:19695866 CYP3A4 Human paclitaxel multiple interactions ISO Cyp3a2 (Rattus norvegicus) 6480464 Plant Extracts inhibits the reaction [Paclitaxel results in increased expression of CYP3A4 protein] CTD PMID:15918522 CYP3A4 Human paclitaxel increases expression ISO Cyp3a2 (Rattus norvegicus) 6480464 Paclitaxel results in increased expression of CYP3A4 protein CTD PMID:15918522 CYP3A4 Human paclitaxel increases activity EXP 6480464 Paclitaxel results in increased activity of CYP3A4 protein CTD PMID:12065438|PMID:18839173 CYP3A4 Human paclitaxel increases expression EXP 6480464 Paclitaxel results in increased expression of CYP3A4 mRNA; Paclitaxel results in increased expression of CYP3A4 more ... CTD PMID:15650019|PMID:16819505|PMID:17438109|PMID:18839173|PMID:23707768 CYP3A4 Human paclitaxel affects metabolic processing EXP 6480464 CYP3A4 protein affects the metabolism of Paclitaxel CTD PMID:15901749 CYP3A4 Human paclitaxel increases hydroxylation EXP 6480464 CYP3A4 protein results in increased hydroxylation of Paclitaxel CTD PMID:19695866 CYP3A4 Human paclitaxel decreases activity EXP 6480464 Paclitaxel results in decreased activity of CYP3A4 protein CTD PMID:19909766 CYP3A4 Human paclitaxel increases oxidation EXP 6480464 CYP3A4 protein results in increased oxidation of Paclitaxel CTD PMID:12237780 CYP3A4 Human Panaxytriol multiple interactions EXP 6480464 NR1I3 protein inhibits the reaction [panaxytriol results in increased expression of CYP3A4 mRNA]; panaxytriol promotes more ... CTD PMID:30414935|PMID:36948264 CYP3A4 Human Panaxytriol decreases expression ISO Cyp3a2 (Rattus norvegicus) 6480464 panaxytriol results in decreased expression of CYP3A2 mRNA CTD PMID:26424012 CYP3A4 Human Panaxytriol increases expression EXP 6480464 panaxytriol results in increased expression of CYP3A4 mRNA; panaxytriol results in increased expression of CYP3A4 more ... CTD PMID:30414935|PMID:30653754|PMID:35417848|PMID:36948264 CYP3A4 Human pantoprazole increases metabolic processing EXP 6480464 CYP3A4 protein results in increased metabolism of pantoprazole CTD PMID:8930576 CYP3A4 Human pantoprazole increases expression EXP 6480464 pantoprazole results in increased expression of CYP3A4 protein CTD PMID:9744552 CYP3A4 Human pantoprazole multiple interactions EXP 6480464 pantoprazole inhibits the reaction [CYP3A4 protein results in increased hydroxylation of Midazolam] CTD PMID:15258107 CYP3A4 Human paracetamol increases response to substance EXP 6480464 CYP3A4 protein results in increased susceptibility to Acetaminophen CTD PMID:26706816|PMID:26718876|PMID:27485346 CYP3A4 Human paracetamol affects expression ISO Cyp3a2 (Rattus norvegicus) 6480464 Acetaminophen affects the expression of CYP3A11 mRNA CTD PMID:17366322 CYP3A4 Human paracetamol multiple interactions ISO Cyp3a2 (Rattus norvegicus) 6480464 [Acetaminophen co-treated with Uranium analog] results in decreased expression of CYP3A2 mRNA; Arsenic inhibits the more ... CTD PMID:17126469|PMID:19932728 CYP3A4 Human paracetamol decreases expression ISO Cyp3a2 (Rattus norvegicus) 6480464 Acetaminophen results in decreased expression of CYP3A2 mRNA CTD PMID:17126469|PMID:21807079|PMID:30723492 CYP3A4 Human paracetamol increases activity ISO Cyp3a2 (Rattus norvegicus) 6480464 Acetaminophen results in increased activity of CYP3A4 protein CTD PMID:19932728 CYP3A4 Human paracetamol decreases expression EXP 6480464 Acetaminophen results in decreased expression of CYP3A4 mRNA; Acetaminophen results in decreased expression of CYP3A4 more ... CTD PMID:29067470|PMID:32112222 CYP3A4 Human paracetamol increases expression EXP 6480464 Acetaminophen results in increased expression of CYP3A4 mRNA CTD PMID:26497421|PMID:30008028 CYP3A4 Human paracetamol increases metabolic processing EXP 6480464 CYP3A4 protein results in increased metabolism of Acetaminophen; CYP3A4 results in increased metabolism of Acetaminophen CTD PMID:19460945|PMID:20566340|PMID:33259822 CYP3A4 Human paracetamol multiple interactions EXP 6480464 [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated more ... CTD PMID:11811955|PMID:19460945|PMID:27485346|PMID:33819548 CYP3A4 Human paraquat multiple interactions ISO Cyp3a2 (Rattus norvegicus) 6480464 betanin inhibits the reaction [Paraquat results in increased expression of CYP3A2 mRNA] CTD PMID:24799198 CYP3A4 Human paraquat increases expression ISO Cyp3a2 (Rattus norvegicus) 6480464 Paraquat results in increased expression of CYP3A2 mRNA CTD PMID:24799198 CYP3A4 Human parathion affects metabolic processing EXP 6480464 CYP3A4 protein affects the metabolism of Parathion CTD PMID:12669189|PMID:17079358|PMID:17110060 CYP3A4 Human parathion increases expression EXP 6480464 Parathion results in increased expression of CYP3A4 mRNA; Parathion results in increased expression of CYP3A4 more ... CTD PMID:26196221 CYP3A4 Human paricalcitol increases expression EXP 6480464 paricalcitol results in increased expression of CYP3A4 mRNA CTD PMID:11723248 CYP3A4 Human pazopanib increases expression EXP 6480464 pazopanib results in increased expression of CYP3A4 mRNA CTD PMID:29356861 CYP3A4 Human PD 0325901 increases expression EXP 6480464 mirdametinib results in increased expression of CYP3A4 mRNA CTD PMID:24819614 CYP3A4 Human pedalitin decreases activity EXP 6480464 pedalitin results in decreased activity of CYP3A4 protein CTD PMID:29753067 CYP3A4 Human penconazole multiple interactions EXP 6480464 [N-(2,3-dichloro-4-hydroxyphenyl)-1-methylcyclohexanecarboxamide co-treated with pyrimethanil co-treated with Fenitrothion co-treated with triadimefon co-treated with quinoxyfen co-treated with more ... CTD PMID:25028461 CYP3A4 Human pentachlorobenzene increases oxidation EXP 6480464 CYP3A4 protein results in increased oxidation of pentachlorobenzene CTD PMID:7747284 CYP3A4 Human pentachlorophenol increases expression EXP 6480464 Pentachlorophenol results in increased expression of CYP3A4 protein CTD PMID:15548381 CYP3A4 Human pentamidine decreases activity EXP 6480464 Pentamidine results in decreased activity of CYP3A4 protein CTD PMID:11124226 CYP3A4 Human perazine decreases methylation EXP 6480464 CYP3A4 protein results in decreased methylation of Perazine CTD PMID:11026737 CYP3A4 Human perfluorobutanesulfonic acid increases expression EXP 6480464 perfluorobutanesulfonic acid results in increased expression of CYP3A4 mRNA CTD PMID:33772556 CYP3A4 Human perfluorodecanoic acid increases expression EXP 6480464 perfluorodecanoic acid results in increased expression of CYP3A4 mRNA CTD PMID:23567314 CYP3A4 Human perfluorodecanoic acid decreases activity EXP 6480464 perfluorodecanoic acid results in decreased activity of CYP3A4 protein CTD PMID:35121066 CYP3A4 Human perfluorododecanoic acid decreases expression EXP 6480464 perfluorododecanoic acid results in decreased expression of CYP3A4 mRNA CTD PMID:23567314 CYP3A4 Human perfluoroheptanoic acid increases expression EXP 6480464 perfluoro-n-heptanoic acid results in increased expression of CYP3A4 mRNA CTD PMID:23567314 CYP3A4 Human perfluorohexanesulfonic acid increases expression EXP 6480464 perfluorohexanesulfonic acid results in increased expression of CYP3A4 mRNA CTD PMID:23567314|PMID:38117326 CYP3A4 Human perfluorohexanesulfonic acid increases expression ISO Cyp3a2 (Rattus norvegicus) 6480464 perfluorohexanesulfonic acid results in increased expression of CYP3A11 mRNA CTD PMID:34460931 CYP3A4 Human perfluorohexanesulfonic acid multiple interactions EXP 6480464 [perfluorooctane sulfonic acid co-treated with perfluorooctanoic acid co-treated with perfluoro-n-nonanoic acid co-treated with perfluorohexanesulfonic acid] more ... CTD PMID:38117326 CYP3A4 Human perfluorohexanesulfonic acid decreases activity EXP 6480464 perfluorohexanesulfonic acid results in decreased activity of CYP3A4 protein CTD PMID:35121066 CYP3A4 Human perfluorohexanoic acid increases expression EXP 6480464 perfluorohexanoic acid results in increased expression of CYP3A4 mRNA CTD PMID:38117326 CYP3A4 Human perfluorononanoic acid increases expression EXP 6480464 perfluoro-n-nonanoic acid results in increased expression of CYP3A4 mRNA CTD PMID:32588087 CYP3A4 Human perfluorononanoic acid multiple interactions EXP 6480464 [perfluorooctane sulfonic acid co-treated with perfluorooctanoic acid co-treated with perfluoro-n-nonanoic acid co-treated with perfluorohexanesulfonic acid] more ... CTD PMID:38117326 CYP3A4 Human perfluorononanoic acid affects expression EXP 6480464 perfluoro-n-nonanoic acid affects the expression of CYP3A4 mRNA CTD PMID:38117326 CYP3A4 Human perfluorooctane-1-sulfonic acid multiple interactions EXP 6480464 [perfluorooctane sulfonic acid co-treated with perfluorooctanoic acid co-treated with perfluoro-n-nonanoic acid co-treated with perfluorohexanesulfonic acid] more ... CTD PMID:21964418|PMID:38117326 CYP3A4 Human perfluorooctane-1-sulfonic acid increases expression ISO Cyp3a2 (Rattus norvegicus) 6480464 perfluorooctane sulfonic acid results in increased expression of CYP3A2 mRNA CTD PMID:16221955|PMID:18692542|PMID:19162173 CYP3A4 Human perfluorooctane-1-sulfonic acid increases expression EXP 6480464 perfluorooctane sulfonic acid results in increased expression of CYP3A4 mRNA CTD PMID:21723365|PMID:23567314|PMID:27153767|PMID:32253466|PMID:32588087|PMID:33772556 CYP3A4 Human perfluorooctane-1-sulfonic acid decreases activity EXP 6480464 perfluorooctane sulfonic acid results in decreased activity of CYP3A4 protein CTD PMID:31809754|PMID:35121066 CYP3A4 Human perfluorooctane-1-sulfonic acid decreases expression EXP 6480464 perfluorooctane sulfonic acid results in decreased expression of CYP3A4 mRNA CTD PMID:31809754 CYP3A4 Human perfluorooctanoic acid increases expression EXP 6480464 perfluorooctanoic acid results in increased expression of CYP3A4 mRNA CTD PMID:23567314|PMID:32253466|PMID:32588087|PMID:33772556|PMID:37302725|PMID:38117326 CYP3A4 Human perfluorooctanoic acid multiple interactions EXP 6480464 [perfluorooctane sulfonic acid co-treated with perfluorooctanoic acid co-treated with perfluoro-n-nonanoic acid co-treated with perfluorohexanesulfonic acid] more ... CTD PMID:38117326 CYP3A4 Human perfluorooctanoic acid increases expression ISO Cyp3a2 (Rattus norvegicus) 6480464 perfluorooctanoic acid results in increased expression of CYP3A2 mRNA; perfluorooctanoic acid results in increased expression more ... CTD PMID:28511854|PMID:34958885 CYP3A4 Human perfluorooctanoic acid decreases activity EXP 6480464 perfluorooctanoic acid results in decreased activity of CYP3A4 protein CTD PMID:31809754|PMID:35121066 CYP3A4 Human perfluorooctanoic acid decreases expression EXP 6480464 perfluorooctanoic acid results in decreased expression of CYP3A4 mRNA CTD PMID:31809754 CYP3A4 Human perhexiline multiple interactions EXP 6480464 CYP3A4 protein results in increased hydroxylation of [perhexiline maleate results in increased abundance of Perhexiline]; more ... CTD PMID:36083301 CYP3A4 Human Perhexiline maleate multiple interactions EXP 6480464 CYP3A4 protein results in increased hydroxylation of [perhexiline maleate results in increased abundance of Perhexiline]; more ... CTD PMID:36083301 CYP3A4 Human permethrin multiple interactions EXP 6480464 [Permethrin results in increased activity of NR1I2 protein] which results in increased expression of CYP3A4 more ... CTD PMID:16790556|PMID:31312845 CYP3A4 Human permethrin increases metabolic processing EXP 6480464 CYP3A4 protein results in increased metabolism of Permethrin CTD PMID:24548679 CYP3A4 Human permethrin decreases activity EXP 6480464 Permethrin results in decreased activity of CYP3A4 protein CTD PMID:16790556|PMID:21924250 CYP3A4 Human permethrin increases expression EXP 6480464 Permethrin results in increased expression of CYP3A4 mRNA CTD PMID:19249324|PMID:19326768 CYP3A4 Human phenacetin affects metabolic processing ISO Cyp3a2 (Rattus norvegicus) 6480464 CYP3A2 protein affects the metabolism of Phenacetin CTD PMID:15879494 CYP3A4 Human phencyclidine affects metabolic processing EXP 6480464 CYP3A4 protein affects the metabolism of Phencyclidine CTD PMID:16782764 CYP3A4 Human Phenelzine decreases activity EXP 6480464 Phenelzine results in decreased activity of CYP3A4 protein CTD PMID:15304522 CYP3A4 Human phenethyl isothiocyanate decreases expression EXP 6480464 phenethyl isothiocyanate results in decreased expression of CYP3A4 mRNA CTD PMID:20442190 CYP3A4 Human phenethyl isothiocyanate increases expression ISO Cyp3a2 (Rattus norvegicus) 6480464 phenethyl isothiocyanate results in increased expression of CYP3A4 protein CTD PMID:20025923 CYP3A4 Human phenethyl isothiocyanate decreases activity ISO Cyp3a2 (Rattus norvegicus) 6480464 phenethyl isothiocyanate results in decreased activity of CYP3A2 protein CTD PMID:22664424 CYP3A4 Human phenethyl isothiocyanate decreases expression ISO Cyp3a2 (Rattus norvegicus) 6480464 phenethyl isothiocyanate results in decreased expression of CYP3A2 mRNA CTD PMID:22664424 CYP3A4 Human phenethyl isothiocyanate decreases activity EXP 6480464 phenethyl isothiocyanate results in decreased activity of CYP3A4 mRNA CTD PMID:20442190 CYP3A4 Human phenobarbital multiple interactions EXP 6480464 [Celsior co-treated with Phenobarbital] results in increased expression of CYP3A4 mRNA; [Methylcholanthrene co-treated with Rifampin more ... CTD PMID:10219967|PMID:12695340|PMID:15448115|PMID:15802389|PMID:15833926|PMID:16608920|PMID:22524704|PMID:24224465|PMID:24999631 CYP3A4 Human phenobarbital multiple interactions ISO Cyp3a2 (Rattus norvegicus) 6480464 [Dehydroepiandrosterone Sulfate co-treated with Phenobarbital] results in increased expression of CYP3A2 protein; [Diethylnitrosamine co-treated with more ... CTD PMID:11181506|PMID:25786523|PMID:30842367|PMID:9744545 CYP3A4 Human phenobarbital decreases expression ISO Cyp3a2 (Rattus norvegicus) 6480464 Phenobarbital results in decreased expression of CYP3A2 CTD PMID:15975961 CYP3A4 Human phenobarbital increases expression ISO Cyp3a2 (Rattus norvegicus) 6480464 Phenobarbital results in increased expression of CYP3A11 mRNA; Phenobarbital results in increased expression of CYP3A2 more ... CTD PMID:10506011|PMID:11181506|PMID:14965361|PMID:15588932|PMID:16940010|PMID:17505019|PMID:19118567|PMID:19162173|PMID:19695238|PMID:19850644|PMID:20607812|PMID:24090815|PMID:24449422|PMID:25786523|PMID:25929820|PMID:30842367|PMID:9152597 CYP3A4 Human phenobarbital increases activity EXP 6480464 Phenobarbital results in increased activity of CYP3A4 mRNA; Phenobarbital results in increased activity of CYP3A4 more ... CTD PMID:12065438|PMID:14977870|PMID:18094037|PMID:19118567|PMID:19202563|PMID:19328226|PMID:22258563|PMID:22310298|PMID:22843569|PMID:30364229 CYP3A4 Human phenobarbital affects expression EXP 6480464 Phenobarbital affects the expression of CYP3A4 mRNA CTD PMID:19159669 CYP3A4 Human phenobarbital decreases activity EXP 6480464 Phenobarbital results in decreased activity of CYP3A4 protein CTD PMID:19909766 CYP3A4 Human phenobarbital increases expression EXP 6480464 Phenobarbital results in increased expression of CYP3A4; Phenobarbital results in increased expression of CYP3A4 mRNA; more ... CTD PMID:10219967|PMID:10640517|PMID:12505310|PMID:12584154|PMID:12673034|PMID:12695340|PMID:15466163|PMID:15548381|PMID:15629111|PMID:15802389|PMID:15833926|PMID:16608920|PMID:16837568|PMID:17954527|PMID:18094037|PMID:18468591|PMID:19084549|PMID:19118567|PMID:19135037|PMID:20035023|PMID:20361990|PMID:20686338|PMID:21227907|PMID:21315811|PMID:21778469|PMID:21924250|PMID:21998292|PMID:22258563|PMID:22310298|PMID:22524704|PMID:22664347|PMID:24224465|PMID:24343343|PMID:27530964|PMID:31096615|PMID:31465819|PMID:33263786|PMID:35881160|PMID:36549901|PMID:39909212|PMID:8632764 CYP3A4 Human Phenoxybenzamine multiple interactions EXP 6480464 [Phenoxybenzamine results in increased activity of NR1I2 protein] which results in increased expression of CYP3A4 more ... CTD PMID:31312845 CYP3A4 Human phenoxymethylpenicillin increases expression EXP 6480464 Penicillin V results in increased expression of CYP3A4 mRNA; Penicillin V results in increased expression more ... CTD PMID:18505790 CYP3A4 Human phenthoate increases expression EXP 6480464 phenthoate results in increased expression of CYP3A4 mRNA CTD PMID:22310298 CYP3A4 Human phenthoate decreases activity EXP 6480464 phenthoate results in decreased activity of CYP3A4 protein CTD PMID:20183062 CYP3A4 Human phenthoate increases activity EXP 6480464 phenthoate results in increased activity of CYP3A4 protein CTD PMID:22310298 CYP3A4 Human phenylbutazone multiple interactions EXP 6480464 NR3C1 protein promotes the reaction [Phenylbutazone results in increased expression of CYP3A4 mRNA] CTD PMID:10219967 CYP3A4 Human phenylbutazone increases activity EXP 6480464 Phenylbutazone results in increased activity of CYP3A4 protein CTD PMID:9512926 CYP3A4 Human phenylbutazone increases expression EXP 6480464 Phenylbutazone results in increased expression of CYP3A4 mRNA CTD PMID:10219967 CYP3A4 Human phenytoin multiple interactions EXP 6480464 [CYP1A2 protein co-treated with CYP2C9 protein co-treated with CYP3A4 protein co-treated with CYP2D6 protein co-treated more ... CTD PMID:10219967|PMID:12695340|PMID:16207822|PMID:18206661|PMID:21402137|PMID:23397584 CYP3A4 Human phenytoin increases expression ISO Cyp3a2 (Rattus norvegicus) 6480464 Phenytoin results in increased expression of CYP3A2 mRNA; Phenytoin results in increased expression of CYP3A2 more ... CTD PMID:17505019|PMID:19226368 CYP3A4 Human phenytoin multiple interactions ISO Cyp3a2 (Rattus norvegicus) 6480464 Ketoconazole inhibits the reaction [Phenytoin results in increased expression of CYP3A2 protein] CTD PMID:19226368 CYP3A4 Human phenytoin increases activity EXP 6480464 Phenytoin results in increased activity of CYP3A4 protein CTD PMID:12065438|PMID:14977870|PMID:21742782|PMID:9512926 CYP3A4 Human phenytoin increases expression EXP 6480464 Phenytoin results in increased expression of CYP3A4 mRNA; Phenytoin results in increased expression of CYP3A4 more ... CTD PMID:10219967|PMID:12505310|PMID:12673034|PMID:12695340|PMID:15466163|PMID:16837568|PMID:17954527|PMID:18206661|PMID:18332078|PMID:28289823 CYP3A4 Human PhIP increases expression EXP 6480464 2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine results in increased expression of CYP3A4 mRNA CTD PMID:29549414|PMID:31542801 CYP3A4 Human PhIP multiple interactions ISO Cyp3a2 (Rattus norvegicus) 6480464 CYP3A4 protein results in increased metabolism of and results in increased activity of 2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine CTD PMID:1913651 CYP3A4 Human phosalone multiple interactions EXP 6480464 [Omite co-treated with Diphenylamine co-treated with phosalone co-treated with Captan co-treated with N-dichlorofluoromethylthio-N',N'-dimethyl-N-p-tolylsulfamide] results in more ... CTD PMID:25028461 CYP3A4 Human phthalic acid increases expression EXP 6480464 phthalic acid results in increased expression of CYP3A4 mRNA; phthalic acid results in increased expression more ... CTD PMID:15650019 CYP3A4 Human phthalic acid multiple interactions ISO Cyp3a2 (Rattus norvegicus) 6480464 [CYP3A2 protein results in increased metabolism of mono-(2-ethylhexyl)phthalate] which results in increased chemical synthesis of more ... CTD PMID:22186153|PMID:23545481 CYP3A4 Human phthalic acid multiple interactions EXP 6480464 [CYP3A4 protein results in increased metabolism of mono-(2-ethylhexyl)phthalate] which results in increased chemical synthesis of more ... CTD PMID:22186153|PMID:23545481 CYP3A4 Human physcion increases hydroxylation EXP 6480464 CYP3A4 protein results in increased hydroxylation of physcione CTD PMID:29667811 CYP3A4 Human pimecrolimus increases expression EXP 6480464 pimecrolimus results in increased expression of CYP3A4 mRNA CTD PMID:29356861 CYP3A4 Human pimobendan decreases methylation EXP 6480464 CYP3A4 protein results in decreased methylation of pimobendan CTD PMID:10611143 CYP3A4 Human pinocembrin affects activity EXP 6480464 pinocembrin affects the activity of CYP3A4 protein CTD PMID:29753067 CYP3A4 Human pioglitazone affects metabolic processing EXP 6480464 CYP3A4 protein affects the metabolism of pioglitazone CTD PMID:15900286 CYP3A4 Human pioglitazone multiple interactions ISO Cyp3a2 (Rattus norvegicus) 6480464 Pioglitazone inhibits the reaction [Endotoxins results in decreased expression of CYP3A2 protein] CTD PMID:15364003 CYP3A4 Human pioglitazone decreases activity EXP 6480464 Pioglitazone results in decreased activity of CYP3A4 protein CTD PMID:12642470|PMID:15860655|PMID:39023798 CYP3A4 Human pioglitazone increases expression EXP 6480464 Pioglitazone results in increased expression of CYP3A4 mRNA; Pioglitazone results in increased expression of CYP3A4 more ... CTD PMID:12642470|PMID:16837568|PMID:22524704|PMID:31233785 CYP3A4 Human pioglitazone multiple interactions EXP 6480464 [pioglitazone results in increased expression of CYP3A4 protein] which results in decreased abundance of Ethinyl more ... CTD PMID:12642470|PMID:22524704 CYP3A4 Human piperine increases expression EXP 6480464 piperine results in increased expression of CYP3A4 mRNA; piperine results in increased expression of CYP3A4 more ... CTD PMID:23707768 CYP3A4 Human piperine multiple interactions EXP 6480464 [piperine co-treated with NR1I2 protein] results in increased expression of CYP3A4 mRNA; Ketoconazole inhibits the more ... CTD PMID:23707768 CYP3A4 Human pirinixic acid multiple interactions EXP 6480464 [pirinixic acid binds to and results in increased activity of PPARA protein] which results in more ... CTD PMID:19710929 CYP3A4 Human pirinixic acid increases expression EXP 6480464 pirinixic acid results in increased expression of CYP3A4 mRNA CTD PMID:27551952 CYP3A4 Human PK-11195 increases expression EXP 6480464 PK 11195 results in increased expression of CYP3A4 mRNA CTD PMID:21315811 CYP3A4 Human poly(styrene) decreases activity EXP 6480464 styrofoam analog results in decreased activity of CYP3A4 protein CTD PMID:19909766 CYP3A4 Human poly(styrene) multiple interactions EXP 6480464 styrofoam analog promotes the reaction [Cimetidine results in decreased activity of CYP3A4 protein] CTD PMID:19909766 CYP3A4 Human polymyxin B2 multiple interactions ISO Cyp3a2 (Rattus norvegicus) 6480464 Polymyxin B inhibits the reaction [Trinitrobenzenesulfonic Acid results in decreased activity of and results in more ... CTD PMID:18079364 CYP3A4 Human pomalidomide increases oxidation EXP 6480464 CYP3A4 protein results in increased oxidation of pomalidomide CTD PMID:24350712 CYP3A4 Human posaconazole decreases activity EXP 6480464 posaconazole results in decreased activity of CYP3A4 protein CTD PMID:19346885 CYP3A4 Human potassium bromate decreases expression EXP 6480464 potassium bromate results in decreased expression of CYP3A4 mRNA CTD PMID:30008028 CYP3A4 Human potassium hexacyanoferrate(3-) multiple interactions EXP 6480464 potassium ferricyanide inhibits the reaction [Diltiazem inhibits the reaction [CYP3A4 protein results in increased hydroxylation more ... CTD PMID:22652334 CYP3A4 Human Pramiconazole decreases activity EXP 6480464 pramiconazole results in decreased activity of CYP3A4 protein CTD PMID:15328084 CYP3A4 Human pravastatin decreases activity EXP 6480464 Pravastatin results in decreased activity of CYP3A4 protein CTD PMID:39023798 CYP3A4 Human prednisolone increases expression EXP 6480464 Prednisolone results in increased expression of CYP3A4 mRNA CTD PMID:12673034 CYP3A4 Human pregnenolone increases expression EXP 6480464 Pregnenolone results in increased expression of CYP3A4 mRNA; Pregnenolone results in increased expression of CYP3A4 more ... CTD PMID:15650019 CYP3A4 Human pregnenolone 16alpha-carbonitrile multiple interactions EXP 6480464 [Pregnenolone Carbonitrile results in increased activity of NR1I2 protein] which results in increased expression of more ... CTD PMID:10219967|PMID:18799805|PMID:25542144 CYP3A4 Human pregnenolone 16alpha-carbonitrile increases activity ISO Cyp3a2 (Rattus norvegicus) 6480464 Pregnenolone Carbonitrile results in increased activity of CYP3A2 protein CTD PMID:12458634|PMID:29366910 CYP3A4 Human pregnenolone 16alpha-carbonitrile increases expression ISO Cyp3a2 (Rattus norvegicus) 6480464 Pregnenolone Carbonitrile results in increased expression of CYP3A11 mRNA; Pregnenolone Carbonitrile results in increased expression more ... CTD PMID:15588932|PMID:15596064|PMID:16673044|PMID:19118567|PMID:19162173|PMID:19850644|PMID:29366910 CYP3A4 Human pregnenolone 16alpha-carbonitrile multiple interactions ISO Cyp3a2 (Rattus norvegicus) 6480464 [NR1I2 protein co-treated with Pregnenolone Carbonitrile] results in increased expression of CYP3A4 mRNA; allyl isothiocyanate more ... CTD PMID:15946133|PMID:25069801 CYP3A4 Human pregnenolone 16alpha-carbonitrile increases expression EXP 6480464 Pregnenolone Carbonitrile results in increased expression of CYP3A4 mRNA; Pregnenolone Carbonitrile results in increased expression more ... CTD PMID:10219967|PMID:12505310|PMID:15541768|PMID:18799805|PMID:25542144|PMID:36549901 CYP3A4 Human Pretilachlor increases expression EXP 6480464 pretilachlor results in increased expression of CYP3A4 mRNA CTD PMID:16565514 CYP3A4 Human primaquine increases metabolic processing EXP 6480464 CYP3A4 protein results in increased metabolism of Primaquine CTD PMID:19616568 CYP3A4 Human primaquine multiple interactions EXP 6480464 [CYP3A4 protein results in increased expression of HBG2 protein] which affects the susceptibility to Primaquine CTD PMID:19616568 CYP3A4 Human primidone decreases activity EXP 6480464 Primidone results in decreased activity of CYP3A4 protein CTD PMID:39023798 CYP3A4 Human probenecid decreases expression EXP 6480464 Probenecid results in decreased expression of CYP3A4 mRNA CTD PMID:16837568 CYP3A4 Human probenecid multiple interactions EXP 6480464 Probenecid promotes the reaction [CYP3A4 protein affects the chemical synthesis of carbamazepine epoxide]; Probenecid promotes more ... CTD PMID:15915352 CYP3A4 Human prochloraz multiple interactions ISO Cyp3a2 (Rattus norvegicus) 6480464 [cyproconazole co-treated with epoxiconazole co-treated with prochloraz] results in increased expression of CYP3A2 mRNA CTD PMID:29038839 CYP3A4 Human prochloraz multiple interactions EXP 6480464 [Amiodarone co-treated with Benzoic Acid co-treated with cyproconazole co-treated with flusilazole co-treated with enilconazole co-treated more ... CTD PMID:34273450 CYP3A4 Human prochloraz increases expression EXP 6480464 prochloraz results in increased expression of CYP3A4 protein CTD PMID:33150952|PMID:34273450 CYP3A4 Human procymidone multiple interactions EXP 6480464 [procymidone co-treated with iprodione co-treated with cyprodinil co-treated with fludioxonil co-treated with cyhalothrin] results in more ... CTD PMID:25028461 CYP3A4 Human profenofos increases activity EXP 6480464 profenofos results in increased activity of CYP3A4 protein CTD PMID:22310298 CYP3A4 Human profenofos decreases expression ISO Cyp3a2 (Rattus norvegicus) 6480464 profenofos results in decreased expression of CYP3A2 mRNA; profenofos results in decreased expression of CYP3A2 more ... CTD PMID:18828448 CYP3A4 Human profenofos increases metabolic processing EXP 6480464 CYP3A4 protein results in increased metabolism of profenofos CTD PMID:23415833 CYP3A4 Human profenofos multiple interactions EXP 6480464 [CYP3A4 protein results in increased metabolism of profenofos] which results in increased abundance of 4-bromo-2-chlorophenol CTD PMID:23415833 CYP3A4 Human profenofos increases expression EXP 6480464 profenofos results in increased expression of CYP3A4 mRNA CTD PMID:22310298 CYP3A4 Human progesterone increases expression EXP 6480464 Progesterone results in increased expression of CYP3A4 mRNA CTD PMID:22837389 CYP3A4 Human progesterone multiple interactions EXP 6480464 Progesterone promotes the reaction [CYP3A4 protein results in increased oxidation of 7-benzyloxy-4-trifluoromethylcoumarin] CTD PMID:19299527 CYP3A4 Human progesterone increases hydroxylation EXP 6480464 CYP3A4 protein results in increased hydroxylation of Progesterone CTD PMID:18957504 CYP3A4 Human proguanil decreases activity EXP 6480464 Proguanil results in decreased activity of CYP3A4 protein CTD PMID:11124226 CYP3A4 Human propargite multiple interactions EXP 6480464 [Omite co-treated with Diphenylamine co-treated with phosalone co-treated with Captan co-treated with N-dichlorofluoromethylthio-N',N'-dimethyl-N-p-tolylsulfamide] results in more ... CTD PMID:25028461 CYP3A4 Human propiconazole increases expression EXP 6480464 propiconazole results in increased expression of CYP3A4 mRNA; propiconazole results in increased expression of CYP3A4 more ... CTD PMID:30293151|PMID:33575850|PMID:34273450 CYP3A4 Human propiconazole increases expression ISO Cyp3a2 (Rattus norvegicus) 6480464 propiconazole results in increased expression of CYP3A2 mRNA CTD PMID:15603923 CYP3A4 Human propiconazole decreases activity EXP 6480464 propiconazole results in decreased activity of CYP3A4 protein CTD PMID:29420809 CYP3A4 Human propiconazole multiple interactions EXP 6480464 [Amiodarone co-treated with Benzoic Acid co-treated with cyproconazole co-treated with flusilazole co-treated with enilconazole co-treated more ... CTD PMID:29420809|PMID:34273450 CYP3A4 Human propranolol increases oxidation EXP 6480464 CYP3A4 protein results in increased oxidation of Propranolol CTD PMID:19853591 CYP3A4 Human propyzamide increases expression EXP 6480464 pronamide results in increased expression of CYP3A4 mRNA CTD PMID:17293382 CYP3A4 Human psoralidin increases expression ISO Cyp3a2 (Rattus norvegicus) 6480464 psoralidin results in increased expression of CYP3A4 mRNA CTD PMID:31870919 CYP3A4 Human pyrantel decreases activity EXP 6480464 Pyrantel results in decreased activity of CYP3A4 protein CTD PMID:11124226 CYP3A4 Human pyrazinecarboxamide multiple interactions ISO Cyp3a2 (Rattus norvegicus) 6480464 [Isoniazid co-treated with Rifampin co-treated with Ethambutol co-treated with Pyrazinamide] results in increased expression of more ... CTD PMID:27919644 CYP3A4 Human pyrethrins increases expression EXP 6480464 Pyrethrins results in increased expression of CYP3A4 mRNA CTD PMID:18022748 CYP3A4 Human pyridine multiple interactions ISO Cyp3a2 (Rattus norvegicus) 6480464 cordycepin inhibits the reaction [pyridine results in increased expression of CYP3A2 mRNA]; Cycloheximide inhibits the more ... CTD PMID:11181506 CYP3A4 Human pyridine increases activity ISO Cyp3a2 (Rattus norvegicus) 6480464 pyridine results in increased activity of CYP3A2 protein CTD PMID:11181506 CYP3A4 Human pyridine increases expression ISO Cyp3a2 (Rattus norvegicus) 6480464 pyridine results in increased expression of CYP3A2 mRNA; pyridine results in increased expression of CYP3A2 more ... CTD PMID:11181506 CYP3A4 Human pyrimethanil multiple interactions EXP 6480464 [N-(2,3-dichloro-4-hydroxyphenyl)-1-methylcyclohexanecarboxamide co-treated with pyrimethanil co-treated with Fenitrothion co-treated with triadimefon co-treated with quinoxyfen co-treated with more ... CTD PMID:25028461 CYP3A4 Human pyrimidin-2-amine decreases activity EXP 6480464 2-aminopyrimidine analog results in decreased activity of CYP3A4 protein CTD PMID:19317514 CYP3A4 Human pyrrolidines decreases expression ISO Cyp3a2 (Rattus norvegicus) 6480464 Pyrrolidines analog results in decreased expression of CYP3A2 mRNA CTD PMID:26365562 CYP3A4 Human quercetin decreases activity EXP 6480464 Quercetin results in decreased activity of CYP3A4 protein CTD PMID:15266218|PMID:18420780|PMID:19766177|PMID:21053930|PMID:28232125|PMID:29753067 CYP3A4 Human quercetin increases expression EXP 6480464 Quercetin results in increased expression of CYP3A4 mRNA; Quercetin results in increased expression of CYP3A4 more ... CTD PMID:12695340|PMID:15266218|PMID:16442130|PMID:26238175|PMID:26366751 CYP3A4 Human quercetin multiple interactions EXP 6480464 [Quercetin results in decreased activity of CYP3A4 protein] which results in decreased degradation of vanoxerine; more ... CTD PMID:11502731|PMID:15266218|PMID:19766177|PMID:24120545|PMID:26366751 CYP3A4 Human quetiapine fumarate multiple interactions EXP 6480464 Carbamazepine promotes the reaction [CYP3A4 protein results in increased metabolism of and results in decreased more ... CTD PMID:16390352 CYP3A4 Human quinacrine increases metabolic processing EXP 6480464 CYP3A4 protein results in increased metabolism of Quinacrine CTD PMID:16581945 CYP3A4 Human quinidine affects metabolic processing EXP 6480464 CYP3A4 protein affects the metabolism of Quinidine CTD PMID:15784650|PMID:2271712 CYP3A4 Human quinidine multiple interactions EXP 6480464 Quinidine inhibits the reaction [CYP3A4 protein results in increased metabolism of YM 758]; Quinidine inhibits more ... CTD PMID:19230594|PMID:19299527 CYP3A4 Human quinine decreases activity EXP 6480464 Quinine results in decreased activity of CYP3A4 protein CTD PMID:11124226 CYP3A4 Human quinine affects metabolic processing EXP 6480464 CYP3A4 protein affects the metabolism of Quinine CTD PMID:12920490|PMID:15896247 CYP3A4 Human quinoxyfen multiple interactions EXP 6480464 [N-(2,3-dichloro-4-hydroxyphenyl)-1-methylcyclohexanecarboxamide co-treated with pyrimethanil co-treated with Fenitrothion co-treated with triadimefon co-treated with quinoxyfen co-treated with more ... CTD PMID:25028461 CYP3A4 Human raloxifene multiple interactions EXP 6480464 Raloxifene Hydrochloride inhibits the reaction [CYP3A4 protein results in increased oxidation of 7-benzyloxy-4-trifluoromethylcoumarin] CTD PMID:19299527 CYP3A4 Human raloxifene decreases activity EXP 6480464 Raloxifene Hydrochloride results in decreased activity of CYP3A4 protein CTD PMID:15860655|PMID:23721565 CYP3A4 Human reactive oxygen species multiple interactions EXP 6480464 CAT protein inhibits the reaction [CYP3A4 protein results in increased abundance of Reactive Oxygen Species] CTD PMID:21566342 CYP3A4 Human reactive oxygen species increases abundance EXP 6480464 CYP3A4 protein results in increased abundance of Reactive Oxygen Species CTD PMID:21566342 CYP3A4 Human regorafenib increases metabolic processing EXP 6480464 CYP3A4 protein results in increased metabolism of regorafenib CTD PMID:31293154 CYP3A4 Human regorafenib affects metabolic processing EXP 6480464 CYP3A4 polymorphism affects the metabolism of regorafenib CTD PMID:31293154 CYP3A4 Human reserpic acid multiple interactions EXP 6480464 reserpic acid inhibits the reaction [Calcitriol results in increased expression of CYP3A4 protein] CTD PMID:29782822 CYP3A4 Human reserpine increases expression EXP 6480464 Reserpine results in increased expression of CYP3A4 mRNA; Reserpine results in increased expression of CYP3A4 more ... CTD PMID:16837568|PMID:8632764 CYP3A4 Human reserpine multiple interactions EXP 6480464 [Reserpine results in increased activity of NR1I2 protein] which results in increased expression of CYP3A4 more ... CTD PMID:17041008|PMID:29782822 CYP3A4 Human resveratrol multiple interactions EXP 6480464 [resveratrol results in increased activity of NR1I2 protein] which results in increased expression of CYP3A4 more ... CTD PMID:12569440|PMID:20716633|PMID:21524698 CYP3A4 Human resveratrol decreases activity EXP 6480464 resveratrol results in decreased activity of CYP3A4 protein CTD PMID:12569440|PMID:18420780 CYP3A4 Human resveratrol increases expression EXP 6480464 Resveratrol results in increased expression of CYP3A4 mRNA CTD PMID:17210444|PMID:29933105 CYP3A4 Human Retrorsine multiple interactions EXP 6480464 [retrorsine co-treated with NADP] results in decreased activity of CYP3A4 protein; CYP3A4 protein results in more ... CTD PMID:19818743|PMID:24799337 CYP3A4 Human Retrorsine increases response to substance EXP 6480464 CYP3A4 protein results in increased susceptibility to retrorsine CTD PMID:24799337|PMID:32910235 CYP3A4 Human riddelliine multiple interactions EXP 6480464 [CYP3A4 protein results in increased metabolism of riddelliine] which results in decreased expression of ANAPC1 more ... CTD PMID:33884520 CYP3A4 Human riddelliine increases response to substance EXP 6480464 CYP3A4 protein results in increased susceptibility to riddelliine CTD PMID:32910235 CYP3A4 Human riddelliine decreases expression ISO Cyp3a2 (Rattus norvegicus) 6480464 riddelliine results in decreased expression of CYP3A2 mRNA CTD PMID:18047727 CYP3A4 Human riddelliine increases metabolic processing EXP 6480464 CYP3A4 protein results in increased metabolism of riddelliine CTD PMID:33884520 CYP3A4 Human rifabutin multiple interactions EXP 6480464 AADAC mRNA affects the reaction [Rifabutin results in increased expression of CYP3A4 mRNA] CTD PMID:21856291 CYP3A4 Human rifabutin affects activity EXP 6480464 Rifabutin affects the activity of CYP3A4 protein CTD PMID:37285043 CYP3A4 Human rifabutin increases expression EXP 6480464 Rifabutin results in increased expression of CYP3A4 mRNA CTD PMID:16837568|PMID:21856291|PMID:37285043|PMID:38713375 CYP3A4 Human rifampicin multiple interactions EXP 6480464 [[Rifampin results in increased activity of NR1I2 protein] which results in increased activity of CYP3A4 more ... CTD PMID:10219967|PMID:11581012|PMID:12072427|PMID:12417264|PMID:12695340|PMID:12695342|PMID:12851153|PMID:14709624|PMID:15769886|PMID:15802389|PMID:15833926|PMID:16146350|PMID:16184197|PMID:16608920|PMID:16632523|PMID:16819505|PMID:17003103|PMID:17041008|PMID:17438109|PMID:17936189|PMID:17998298|PMID:18332045|PMID:18505790|PMID:18799805|PMID:20233841|PMID:20361990|PMID:21127053|PMID:21292004|PMID:21402137|PMID:21641981|PMID:21742782|PMID:21764778|PMID:21856291|PMID:21920351|PMID:22093699|PMID:22310326|PMID:22314385|PMID:22524704|PMID:22687401|PMID:22733800|PMID:23153560|PMID:23707768|PMID:23732298|PMID:23845848|PMID:23899473|PMID:24204015|PMID:24999631|PMID:25069801|PMID:25313206|PMID:25455453|PMID:25542144|PMID:25616597|PMID:26341324|PMID:27180241|PMID:28289823|PMID:28571685|PMID:29162470|PMID:29356861|PMID:30071242|PMID:31877331|PMID:32092453|PMID:33002526|PMID:33629115|PMID:34021354|PMID:38713375|PMID:9298257 CYP3A4 Human rifampicin multiple interactions ISO Cyp3a2 (Rattus norvegicus) 6480464 [Isoniazid co-treated with Rifampin co-treated with Ethambutol co-treated with Pyrazinamide] results in increased expression of more ... CTD PMID:22159698|PMID:27919644 CYP3A4 Human rifampicin increases expression ISO Cyp3a2 (Rattus norvegicus) 6480464 Rifampin results in increased expression of CYP3A2 mRNA; Rifampin results in increased expression of CYP3A4 more ... CTD PMID:22159698|PMID:31870919 CYP3A4 Human rifampicin decreases response to substance EXP 6480464 CYP3A4 protein results in decreased susceptibility to Rifampin CTD PMID:12695342 CYP3A4 Human rifampicin increases expression EXP 6480464 Rifampin results in increased expression of CYP3A4; Rifampin results in increased expression of CYP3A4 mRNA; more ... CTD PMID:10219967|PMID:10640517|PMID:10859152|PMID:12040753|PMID:12072427|PMID:12235278|PMID:12505310|PMID:12584154|PMID:12642470|PMID:12673034|PMID:12695340|PMID:14600250|PMID:14636322|PMID:14722322|PMID:15075359|PMID:15466163|PMID:15548381|PMID:15554232|PMID:15629111|PMID:15681896|PMID:15710169|PMID:15769886|PMID:15771232|PMID:15802389|PMID:15833926|PMID:15855724|PMID:15977188|PMID:16184197|PMID:16565514|PMID:16608920|PMID:16819505|PMID:16837568|PMID:17003103|PMID:17270371|PMID:17293382|PMID:17438109|PMID:17590308|PMID:17936189|PMID:17954527|PMID:17998298|PMID:18094037|PMID:18332078|PMID:18505790|PMID:18799805|PMID:18839173|PMID:19041297|PMID:19118567|PMID:19135037|PMID:19202563|PMID:19230594|PMID:19686824|PMID:19854261|PMID:20035023|PMID:20035846|PMID:20361990|PMID:20599501|PMID:21127053|PMID:21315811|PMID:21641981|PMID:21742782|PMID:21856291|PMID:21920351|PMID:21924250|PMID:21998292|PMID:22126990|PMID:22178124|PMID:22258563|PMID:22310298|PMID:22310326|PMID:22314385|PMID:22524704|PMID:22664347|PMID:22733800|PMID:22982774|PMID:23153560|PMID:23707768|PMID:23732298|PMID:23850985|PMID:24038852|PMID:24146111|PMID:24204015|PMID:24259679|PMID:24552687|PMID:24685772|PMID:24752503|PMID:25069801|PMID:25084468|PMID:25313206|PMID:25512232|PMID:25542144|PMID:25616597|PMID:25929522|PMID:26196221|PMID:26201057|PMID:26301745|PMID:26341324|PMID:26616219|PMID:27177772|PMID:27180241|PMID:27507784|PMID:27794450|PMID:27871908|PMID:27917125|PMID:28289823|PMID:28571685|PMID:28887089|PMID:28916285|PMID:29356861|PMID:29933105|PMID:30044681|PMID:30071242|PMID:30087611|PMID:31132328|PMID:31233785|PMID:31877331|PMID:32092453|PMID:32682830|PMID:33002526|PMID:33263786|PMID:33844597|PMID:34689256|PMID:36288780|PMID:36893891|PMID:37285043|PMID:38713375|PMID:38823534|PMID:39909212|PMID:8632764 CYP3A4 Human rifampicin increases activity EXP 6480464 [Rifampin results in increased activity of NR1I2 protein] which results in increased activity of CYP3A4 more ... CTD PMID:12065438|PMID:14636322|PMID:14722322|PMID:14977870|PMID:15771232|PMID:16146350|PMID:17270371|PMID:18094037|PMID:18332045|PMID:18332078|PMID:18839173|PMID:19135037|PMID:19202563|PMID:21742782|PMID:22126990|PMID:22258563|PMID:22310298|PMID:22733800|PMID:22843569|PMID:25069801|PMID:26201057|PMID:27590069|PMID:30044681|PMID:33263786|PMID:33629115|PMID:33844597|PMID:34021354|PMID:36288780|PMID:9298257|PMID:9512926 CYP3A4 Human rifampicin affects activity EXP 6480464 Rifampin affects the activity of CYP3A4 protein CTD PMID:15964336|PMID:37285043 CYP3A4 Human rifapentine multiple interactions EXP 6480464 AADAC mRNA affects the reaction [rifapentine results in increased expression of CYP3A4 mRNA] CTD PMID:21856291 CYP3A4 Human rifapentine increases expression EXP 6480464 rifapentine results in increased expression of CYP3A4 mRNA CTD PMID:16837568|PMID:21856291 CYP3A4 Human rifaximin increases expression EXP 6480464 rifaximin results in increased expression of CYP3A4 mRNA CTD PMID:21141967|PMID:27506419 CYP3A4 Human risperidone affects response to substance EXP 6480464 CYP3A4 gene polymorphism affects the susceptibility to Risperidone; CYP3A4 protein affects the susceptibility to Risperidone CTD PMID:19395426 CYP3A4 Human risperidone multiple interactions EXP 6480464 N-Methyl-3,4-methylenedioxyamphetamine inhibits the reaction [Risperidone promotes the reaction [NR1I2 protein results in increased expression of more ... CTD PMID:21402137 CYP3A4 Human ritonavir increases expression EXP 6480464 Ritonavir results in increased expression of CYP3A4 mRNA CTD PMID:16837568 CYP3A4 Human ritonavir affects binding EXP 6480464 CYP3A4 protein binds to Ritonavir analog CTD PMID:27966929 CYP3A4 Human ritonavir decreases activity EXP 6480464 Ritonavir results in decreased activity of CYP3A4 protein CTD PMID:15523003|PMID:15860655|PMID:26626330|PMID:39023798 CYP3A4 Human ritonavir affects metabolic processing EXP 6480464 CYP3A4 protein affects the metabolism of Ritonavir CTD PMID:15286053 CYP3A4 Human rivaroxaban increases hydroxylation EXP 6480464 CYP3A4 protein results in increased hydroxylation of Rivaroxaban CTD PMID:34189909 CYP3A4 Human rivaroxaban multiple interactions EXP 6480464 erdafitinib inhibits the reaction [CYP3A4 protein results in increased hydroxylation of Rivaroxaban] CTD PMID:34189909 CYP3A4 Human romidepsin affects metabolic processing EXP 6480464 CYP3A4 protein affects the metabolism of romidepsin CTD PMID:15635176 CYP3A4 Human rose bengal decreases activity EXP 6480464 Rose Bengal results in decreased activity of CYP3A4 protein CTD PMID:20041016 CYP3A4 Human rubiarbonone C affects activity EXP 6480464 rubiarbonone C affects the activity of CYP3A4 protein CTD PMID:30259074 CYP3A4 Human Rutaevin increases metabolic processing EXP 6480464 CYP3A4 protein results in increased metabolism of rutaevin CTD PMID:33305580 CYP3A4 Human Rutaevin decreases activity EXP 6480464 rutaevin results in decreased activity of CYP3A4 protein CTD PMID:33305580 CYP3A4 Human S-(1,2-dichlorovinyl)-L-cysteine increases expression EXP 6480464 S-(1,2-dichlorovinyl)cysteine results in increased expression of CYP3A4 mRNA CTD PMID:37544576 CYP3A4 Human S-(1,2-dichlorovinyl)-L-cysteine multiple interactions EXP 6480464 [S-(1,2-dichlorovinyl)cysteine co-treated with Colforsin] results in increased expression of CYP3A4 mRNA CTD PMID:37544576 CYP3A4 Human S-allylcysteine increases expression ISO Cyp3a2 (Rattus norvegicus) 6480464 S-allylcysteine results in increased expression of CYP3A2 protein CTD PMID:16000231 CYP3A4 Human S-butyl-DL-homocysteine (S,R)-sulfoximine multiple interactions EXP 6480464 [CYP3A4 protein co-treated with Buthionine Sulfoximine] results in decreased abundance of Glutathione; Buthionine Sulfoximine promotes more ... CTD PMID:25451576 CYP3A4 Human safrole decreases activity EXP 6480464 Safrole results in decreased activity of CYP3A4 protein CTD PMID:15778010 CYP3A4 Human Salinomycin decreases activity EXP 6480464 salinomycin results in decreased activity of CYP3A4 protein CTD PMID:26282489 CYP3A4 Human Salinomycin decreases expression EXP 6480464 salinomycin results in decreased expression of CYP3A4 mRNA CTD PMID:34806536 CYP3A4 Human Salinomycin increases metabolic processing EXP 6480464 CYP3A4 protein results in increased metabolism of salinomycin CTD PMID:26282489 CYP3A4 Human saquinavir multiple interactions EXP 6480464 Glutathione inhibits the reaction [Saquinavir results in decreased activity of CYP3A4 protein] CTD PMID:15523003 CYP3A4 Human saquinavir increases metabolic processing EXP 6480464 CYP3A4 protein results in increased metabolism of Saquinavir CTD PMID:11824416 CYP3A4 Human saquinavir decreases activity EXP 6480464 Saquinavir results in decreased activity of CYP3A4 protein CTD PMID:15523003 CYP3A4 Human saracatinib increases oxidation EXP 6480464 CYP3A4 protein results in increased oxidation of saracatinib CTD PMID:27769111 CYP3A4 Human satraplatin decreases activity EXP 6480464 satraplatin results in decreased activity of CYP3A4 protein CTD PMID:24882083 CYP3A4 Human secobarbital multiple interactions EXP 6480464 Secobarbital inhibits the reaction [CYP3A4 protein results in increased oxidation of 7-benzyloxy-4-trifluoromethylcoumarin] CTD PMID:19299527 CYP3A4 Human selenium atom decreases expression EXP 6480464 Selenium results in decreased expression of CYP3A4 mRNA CTD PMID:19244175 CYP3A4 Human semicarbazide increases activity ISO Cyp3a2 (Rattus norvegicus) 6480464 carbamylhydrazine results in increased activity of CYP3A2 protein CTD PMID:19788891 CYP3A4 Human semicarbazide multiple interactions ISO Cyp3a2 (Rattus norvegicus) 6480464 [carbamylhydrazine results in increased activity of CYP3A2 protein] which results in increased abundance of Testosterone more ... CTD PMID:19788891 CYP3A4 Human senecionine increases expression EXP 6480464 senecionine results in increased expression of CYP3A4 mRNA CTD PMID:26100227 CYP3A4 Human senecionine increases response to substance EXP 6480464 CYP3A4 protein results in increased susceptibility to senecionine CTD PMID:32910235 CYP3A4 Human seneciphylline increases response to substance EXP 6480464 CYP3A4 protein results in increased susceptibility to seneciphylline CTD PMID:32910235 CYP3A4 Human Senkirkine increases expression EXP 6480464 senkirkine results in increased expression of CYP3A4 mRNA CTD PMID:26100227 CYP3A4 Human sertraline multiple interactions EXP 6480464 CYP3A4 protein results in decreased amination of and results in increased metabolism of Sertraline; CYP3A4 more ... CTD PMID:15547048|PMID:19299527 CYP3A4 Human sevoflurane increases metabolic processing EXP 6480464 CYP3A4 protein results in increased metabolism of sevoflurane CTD PMID:7879937 CYP3A4 Human Shikonin decreases activity ISO Cyp3a2 (Rattus norvegicus) 6480464 shikonin results in decreased activity of CYP3A2 protein CTD PMID:28941798 CYP3A4 Human Shikonin decreases activity EXP 6480464 shikonin results in decreased activity of CYP3A4 protein CTD PMID:28941798 CYP3A4 Human Shikonin multiple interactions ISO Cyp3a2 (Rattus norvegicus) 6480464 shikonin inhibits the reaction [CYP3A2 protein results in increased hydroxylation of Midazolam] CTD PMID:28941798 CYP3A4 Human sibutramine affects response to substance EXP 6480464 CYP3A4 protein affects the susceptibility to sibutramine CTD PMID:27838152 CYP3A4 Human sibutramine affects metabolic processing EXP 6480464 CYP3A4 protein affects the metabolism of sibutramine CTD PMID:27838152 CYP3A4 Human silibinin decreases activity EXP 6480464 Silybin results in decreased activity of CYP3A4 protein CTD PMID:15155549 CYP3A4 Human silibinin multiple interactions EXP 6480464 Silybin inhibits the reaction [CYP3A4 protein results in increased hydroxylation of Testosterone] CTD PMID:15155549 CYP3A4 Human silicon dioxide decreases expression EXP 6480464 Silicon Dioxide results in decreased expression of CYP3A4 mRNA CTD PMID:25351596 CYP3A4 Human simvastatin affects metabolic processing EXP 6480464 CYP3A4 protein affects the metabolism of Simvastatin CTD PMID:16011971 CYP3A4 Human simvastatin multiple interactions ISO Cyp3a2 (Rattus norvegicus) 6480464 Berberine promotes the reaction [Simvastatin results in decreased activity of CYP3A4 protein]; Berberine promotes the more ... CTD PMID:30086269 CYP3A4 Human simvastatin decreases activity ISO Cyp3a2 (Rattus norvegicus) 6480464 Simvastatin results in decreased activity of CYP3A4 protein CTD PMID:30086269 CYP3A4 Human simvastatin decreases expression ISO Cyp3a2 (Rattus norvegicus) 6480464 Simvastatin results in decreased expression of CYP3A4 mRNA; Simvastatin results in decreased expression of CYP3A4 more ... CTD PMID:30086269 CYP3A4 Human simvastatin increases metabolic processing EXP 6480464 CYP3A4 protein results in increased metabolism of Simvastatin CTD PMID:24927617 CYP3A4 Human simvastatin affects response to substance EXP 6480464 CYP3A4 polymorphism affects the susceptibility to Simvastatin CTD PMID:15650881|PMID:19802823 CYP3A4 Human simvastatin increases expression EXP 6480464 Simvastatin results in increased expression of CYP3A4 mRNA CTD PMID:12505310 CYP3A4 Human simvastatin multiple interactions EXP 6480464 [Simvastatin co-treated with NR1I2 protein] results in increased expression of CYP3A4 mRNA; [Simvastatin results in more ... CTD PMID:17041008|PMID:19802823|PMID:24204015|PMID:24927617 CYP3A4 Human sinensetin increases activity EXP 6480464 sinensetin analog results in increased activity of CYP3A4 protein; sinensetin results in increased activity of more ... CTD PMID:31756459 CYP3A4 Human sinensetin multiple interactions EXP 6480464 [[sinensetin analog results in increased activity of CYP3A4 protein] which results in increased metabolism of more ... CTD PMID:31756459 CYP3A4 Human sirolimus affects metabolic processing EXP 6480464 CYP3A4 protein affects the metabolism of Sirolimus; CYP3A4 protein polymorphism affects the metabolism of Sirolimus CTD PMID:15707415|PMID:15964407 CYP3A4 Human skatole decreases expression EXP 6480464 Skatole results in decreased expression of CYP3A4 mRNA CTD PMID:28571685 CYP3A4 Human skatole multiple interactions EXP 6480464 Skatole inhibits the reaction [Rifampin results in increased expression of CYP3A4 mRNA]; Skatole inhibits the more ... CTD PMID:28571685 CYP3A4 Human sodium arsenite multiple interactions EXP 6480464 [Estradiol co-treated with [sodium arsenite results in increased abundance of Arsenic]] results in increased expression more ... CTD PMID:15833926|PMID:22310326|PMID:35747940 CYP3A4 Human sodium arsenite increases activity EXP 6480464 sodium arsenite results in increased activity of CYP3A4 protein CTD PMID:19084030 CYP3A4 Human sodium arsenite increases expression EXP 6480464 sodium arsenite results in increased expression of CYP3A4 mRNA; sodium arsenite results in increased expression more ... CTD PMID:19084030 CYP3A4 Human sodium arsenite decreases expression EXP 6480464 sodium arsenite results in decreased expression of CYP3A4 mRNA CTD PMID:15833926|PMID:29301061 CYP3A4 Human sodium cholate multiple interactions EXP 6480464 [1,2-dilauroylphosphatidylcholine co-treated with 1,2-oleoylphosphatidylcholine co-treated with Phosphatidylserines co-treated with Sodium Cholate] results in increased activity more ... CTD PMID:1627548 CYP3A4 Human sodium cholate multiple interactions ISO Cyp3a2 (Rattus norvegicus) 6480464 [1,2-dilauroylphosphatidylcholine co-treated with 1,2-oleoylphosphatidylcholine co-treated with Phosphatidylserines co-treated with Sodium Cholate] results in increased activity more ... CTD PMID:1627548 CYP3A4 Human sophoraflavanone B decreases activity EXP 6480464 8-prenylnaringenin results in decreased activity of CYP3A4 protein CTD PMID:19770484 CYP3A4 Human sophoranone decreases activity EXP 6480464 sophoranone results in decreased activity of CYP3A4 protein CTD PMID:29753067 CYP3A4 Human spironolactone increases expression EXP 6480464 Spironolactone results in increased expression of CYP3A4 mRNA CTD PMID:12505310 CYP3A4 Human staurosporine multiple interactions EXP 6480464 Staurosporine inhibits the reaction [Calcitriol results in increased expression of CYP3A4 mRNA] CTD PMID:17965521 CYP3A4 Human stavudine increases expression ISO Cyp3a2 (Rattus norvegicus) 6480464 Stavudine results in increased expression of CYP3A11 mRNA CTD PMID:18299183 CYP3A4 Human sterigmatocystin affects metabolic processing EXP 6480464 CYP3A4 protein affects the metabolism of Sterigmatocystin CTD PMID:2271712|PMID:2655891 CYP3A4 Human sterigmatocystin increases glutathionylation EXP 6480464 CYP3A4 protein results in increased glutathionylation of Sterigmatocystin CTD PMID:20929267 CYP3A4 Human sterigmatocystin multiple interactions EXP 6480464 [CYP3A4 protein results in increased glutathionylation of and results in increased hydroxylation of Sterigmatocystin] which more ... CTD PMID:20929267 CYP3A4 Human steviol multiple interactions EXP 6480464 steviol binds to and results in decreased activity of CYP3A4 protein CTD PMID:28887089 CYP3A4 Human steviol increases expression EXP 6480464 steviol results in increased expression of CYP3A4 mRNA; steviol results in increased expression of CYP3A4 more ... CTD PMID:28887089 CYP3A4 Human stevioside increases expression EXP 6480464 stevioside results in increased expression of CYP3A4 mRNA; stevioside results in increased expression of CYP3A4 more ... CTD PMID:28887089 CYP3A4 Human stevioside multiple interactions EXP 6480464 stevioside binds to and results in decreased activity of CYP3A4 protein CTD PMID:28887089 CYP3A4 Human styrene increases expression ISO Cyp3a2 (Rattus norvegicus) 6480464 Styrene results in increased expression of CYP3A2 protein CTD PMID:18202523 CYP3A4 Human styrene multiple interactions ISO Cyp3a2 (Rattus norvegicus) 6480464 gadolinium chloride inhibits the reaction [Styrene results in increased expression of CYP3A2 mRNA]; gadolinium chloride more ... CTD PMID:18202523 CYP3A4 Human Sudan I increases oxidation EXP 6480464 CYP3A4 protein results in increased oxidation of 1-phenylazo-2-naphthol CTD PMID:17159775|PMID:19358889 CYP3A4 Human Sudan I multiple interactions EXP 6480464 CYB5A protein promotes the reaction [CYP3A4 protein results in increased oxidation of 1-phenylazo-2-naphthol] CTD PMID:17159775|PMID:19358889 CYP3A4 Human Sudan III multiple interactions ISO Cyp3a2 (Rattus norvegicus) 6480464 [sudan III binds to AHR protein] inhibits the reaction [[Clofibric Acid binds to PPARA protein] more ... CTD PMID:15788368 CYP3A4 Human Sudan III decreases expression ISO Cyp3a2 (Rattus norvegicus) 6480464 sudan III results in decreased expression of CYP3A2 mRNA CTD PMID:15788368 CYP3A4 Human sulconazole increases expression EXP 6480464 sulconazole results in increased expression of CYP3A4 mRNA CTD PMID:31312845 CYP3A4 Human sulconazole multiple interactions EXP 6480464 [sulconazole results in increased activity of NR1I2 protein] which results in increased expression of CYP3A4 more ... CTD PMID:31312845 CYP3A4 Human sulfamethazine increases activity EXP 6480464 Sulfamethazine results in increased activity of CYP3A4 protein CTD PMID:12065438 CYP3A4 Human sulfamethoxazole multiple interactions ISO Cyp3a2 (Rattus norvegicus) 6480464 [SOD2 co-treated with CYP3A4] affects the susceptibility to Sulfamethoxazole CTD PMID:19501153 CYP3A4 Human sulfaphenazole multiple interactions EXP 6480464 Sulfaphenazole inhibits the reaction [CYP3A4 protein results in increased hydroxylation of Testosterone] CTD PMID:31102695 CYP3A4 Human sulfinpyrazone increases expression EXP 6480464 Sulfinpyrazone results in increased expression of CYP3A4 mRNA CTD PMID:10219967|PMID:16837568|PMID:17954527 CYP3A4 Human sulfinpyrazone increases activity EXP 6480464 Sulfinpyrazone results in increased activity of CYP3A4 protein CTD PMID:12065438|PMID:9512926 CYP3A4 Human sulfisoxazole multiple interactions EXP 6480464 Sulfisoxazole results in increased expression of and results in increased activity of CYP3A4 protein CTD PMID:18505790 CYP3A4 Human sulfisoxazole increases expression EXP 6480464 Sulfisoxazole results in increased expression of CYP3A4 mRNA CTD PMID:18505790 CYP3A4 Human sulforaphane decreases expression EXP 6480464 sulforaphane results in decreased expression of CYP3A4 mRNA CTD PMID:20442190|PMID:26775663 CYP3A4 Human sulforaphane increases expression ISO Cyp3a2 (Rattus norvegicus) 6480464 sulforaphane results in increased expression of CYP3A2 protein CTD PMID:18823965 CYP3A4 Human sulforaphane decreases activity ISO Cyp3a2 (Rattus norvegicus) 6480464 sulforaphane results in decreased activity of CYP3A2 protein CTD PMID:22664424 CYP3A4 Human sulforaphane multiple interactions ISO Cyp3a2 (Rattus norvegicus) 6480464 sulforaphane results in decreased expression of and results in decreased activity of CYP3A2 protein CTD PMID:15906351 CYP3A4 Human sulforaphane multiple interactions EXP 6480464 sulforaphane inhibits the reaction [ginkgolide B results in increased expression of CYP3A4 mRNA]; sulforaphane inhibits more ... CTD PMID:23153560|PMID:26775663 CYP3A4 Human sunitinib multiple interactions EXP 6480464 [CYP3A4 protein results in increased metabolism of Sunitinib] which results in increased chemical synthesis of more ... CTD PMID:29847931 CYP3A4 Human sunitinib increases expression ISO Cyp3a2 (Rattus norvegicus) 6480464 Sunitinib results in increased expression of CYP3A2 mRNA CTD PMID:26797788 CYP3A4 Human sunitinib increases metabolic processing EXP 6480464 CYP3A4 protein results in increased metabolism of Sunitinib CTD PMID:29847931 CYP3A4 Human tacrine increases response to substance EXP 6480464 CYP3A4 protein results in increased susceptibility to Tacrine CTD PMID:21540358 CYP3A4 Human tacrine decreases activity EXP 6480464 Tacrine results in decreased activity of CYP3A4 protein CTD PMID:39023798 CYP3A4 Human tacrine increases expression ISO Cyp3a2 (Rattus norvegicus) 6480464 Tacrine analog results in increased expression of CYP3A2 protein; Tacrine results in increased expression of more ... CTD PMID:20533758 CYP3A4 Human tacrolimus hydrate affects metabolic processing EXP 6480464 CYP3A4 protein affects the metabolism of Tacrolimus CTD PMID:15010519|PMID:15919446|PMID:15964336 CYP3A4 Human tacrolimus hydrate decreases methylation EXP 6480464 CYP3A4 protein results in decreased methylation of Tacrolimus CTD PMID:15951320 CYP3A4 Human tacrolimus hydrate increases metabolic processing EXP 6480464 CYP3A4 protein results in increased metabolism of Tacrolimus CTD PMID:15855244 CYP3A4 Human tacrolimus hydrate multiple interactions EXP 6480464 Metronidazole inhibits the reaction [CYP3A4 protein results in increased metabolism of Tacrolimus] CTD PMID:15855244 CYP3A4 Human tamarixetin increases expression EXP 6480464 tamarixetin results in increased expression of CYP3A4 mRNA CTD PMID:26238175 CYP3A4 Human tamoxifen increases metabolic processing EXP 6480464 CYP3A4 protein results in increased metabolism of Tamoxifen CTD PMID:20507880|PMID:29285606 CYP3A4 Human tamoxifen increases hydroxylation ISO Cyp3a2 (Rattus norvegicus) 6480464 CYP3A2 protein results in increased hydroxylation of Tamoxifen CTD PMID:15587933 CYP3A4 Human tamoxifen multiple interactions ISO Cyp3a2 (Rattus norvegicus) 6480464 [Bexarotene co-treated with Tamoxifen] results in increased expression of CYP3A11 mRNA; Tamoxifen promotes the reaction more ... CTD PMID:17630414|PMID:8573203 CYP3A4 Human tamoxifen increases activity EXP 6480464 Tamoxifen metabolite results in increased activity of CYP3A4 protein; Tamoxifen results in increased activity of more ... CTD PMID:29285606 CYP3A4 Human tamoxifen increases response to substance EXP 6480464 CYP3A4 protein results in increased susceptibility to Tamoxifen CTD PMID:26718876 CYP3A4 Human tamoxifen increases expression EXP 6480464 Tamoxifen metabolite results in increased expression of CYP3A4 mRNA; Tamoxifen results in increased expression of more ... CTD PMID:18839173|PMID:29285606 CYP3A4 Human tamoxifen decreases activity EXP 6480464 Tamoxifen results in decreased activity of CYP3A4 protein CTD PMID:12419016 CYP3A4 Human tamoxifen multiple interactions EXP 6480464 [CYP1A2 protein co-treated with CYP2C9 protein co-treated with CYP3A4 protein co-treated with CYP2D6 protein co-treated more ... CTD PMID:14652237|PMID:19299527|PMID:20507880|PMID:23397584|PMID:29285606 CYP3A4 Human tangeretin multiple interactions EXP 6480464 [[tangeretin results in increased activity of CYP3A4 protein] which results in increased metabolism of Midazolam] more ... CTD PMID:31756459 CYP3A4 Human tangeretin increases activity EXP 6480464 tangeretin results in increased activity of CYP3A4 protein CTD PMID:31756459 CYP3A4 Human Tanshinone I multiple interactions EXP 6480464 NR1I2 protein promotes the reaction [tanshinone results in increased expression of CYP3A4 protein]; NR1I3 protein more ... CTD PMID:18805405 CYP3A4 Human Tanshinone I increases expression EXP 6480464 tanshinone results in increased expression of CYP3A4 protein CTD PMID:18805405 CYP3A4 Human tartrazine multiple interactions EXP 6480464 [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated more ... CTD PMID:33819548 CYP3A4 Human taurochenodeoxycholic acid increases hydroxylation EXP 6480464 CYP3A4 protein results in increased hydroxylation of Taurochenodeoxycholic Acid CTD PMID:36473578 CYP3A4 Human taurocholic acid decreases activity ISO Cyp3a2 (Rattus norvegicus) 6480464 Taurocholic Acid results in decreased activity of CYP3A2 protein CTD PMID:8889968 CYP3A4 Human taurocholic acid multiple interactions ISO Cyp3a2 (Rattus norvegicus) 6480464 [CYP3A23-3A1 gene mutant form co-treated with CYP3A2 gene mutant form] results in increased abundance of more ... CTD PMID:34461081 CYP3A4 Human taurodeoxycholic acid increases hydroxylation EXP 6480464 CYP3A4 protein results in increased hydroxylation of Taurodeoxycholic Acid CTD PMID:36473578 CYP3A4 Human taurolithocholic acid increases hydroxylation EXP 6480464 CYP3A4 protein results in increased hydroxylation of Taurolithocholic Acid CTD PMID:36473578 CYP3A4 Human tauroursodeoxycholic acid increases hydroxylation EXP 6480464 CYP3A4 protein results in increased hydroxylation of ursodoxicoltaurine CTD PMID:36473578 CYP3A4 Human tebuconazole multiple interactions EXP 6480464 [Amiodarone co-treated with Benzoic Acid co-treated with cyproconazole co-treated with flusilazole co-treated with enilconazole co-treated more ... CTD PMID:29420809|PMID:34273450 CYP3A4 Human tebuconazole decreases activity EXP 6480464 tebuconazole results in decreased activity of CYP3A4 protein CTD PMID:37422065 CYP3A4 Human tebuconazole increases expression EXP 6480464 tebuconazole results in increased expression of CYP3A4 mRNA CTD PMID:30458266|PMID:33575850 CYP3A4 Human tebufenozide increases expression EXP 6480464 tebufenozide results in increased expression of CYP3A4 mRNA CTD PMID:22310298 CYP3A4 Human telaprevir multiple interactions EXP 6480464 telaprevir inhibits the reaction [CYP3A4 protein results in increased metabolism of Simvastatin] CTD PMID:24927617 CYP3A4 Human telithromycin multiple interactions EXP 6480464 telithromycin inhibits the reaction [CYP3A4 protein results in decreased methylation of Oxycodone]; telithromycin inhibits the more ... CTD PMID:19755414 CYP3A4 Human Temazepam multiple interactions EXP 6480464 Temazepam promotes the reaction [CYP3A4 protein results in increased oxidation of 7-benzyloxy-4-trifluoromethylcoumarin] CTD PMID:19299527 CYP3A4 Human teniposide multiple interactions EXP 6480464 Cyclosporine inhibits the reaction [CYP3A4 protein results in decreased methylation of Teniposide]; Dexamethasone inhibits the more ... CTD PMID:8114683 CYP3A4 Human teniposide decreases methylation EXP 6480464 CYP3A4 protein results in decreased methylation of Teniposide CTD PMID:8114683 CYP3A4 Human terbinafine increases response to substance EXP 6480464 CYP3A4 protein results in increased susceptibility to terbinafine CTD PMID:21540358 CYP3A4 Human terbinafine increases expression EXP 6480464 Terbinafine results in increased expression of CYP3A4 mRNA CTD PMID:36356836 CYP3A4 Human Terfenadine increases metabolic processing EXP 6480464 CYP3A4 protein results in increased metabolism of Terfenadine CTD PMID:15869686 CYP3A4 Human Terfenadine increases expression EXP 6480464 Terfenadine analog results in increased expression of CYP3A4 mRNA CTD PMID:12505310 CYP3A4 Human Terfenadine multiple interactions EXP 6480464 Ketoconazole inhibits the reaction [CYP3A4 protein results in increased metabolism of Terfenadine]; Terfenadine promotes the more ... CTD PMID:15869686|PMID:19299527 CYP3A4 Human Terfenadine increases degradation EXP 6480464 CYP3A4 protein results in increased degradation of Terfenadine CTD PMID:15684493 CYP3A4 Human Terfenadine affects metabolic processing EXP 6480464 CYP3A4 protein affects the metabolism of Terfenadine CTD PMID:15383492 CYP3A4 Human teriflunomide increases activity EXP 6480464 teriflunomide results in increased activity of CYP3A4 protein CTD PMID:30364229 CYP3A4 Human teriflunomide increases expression EXP 6480464 teriflunomide results in increased expression of CYP3A4 mRNA CTD PMID:30364229 CYP3A4 Human Territrem B affects metabolic processing ISO Cyp3a2 (Rattus norvegicus) 6480464 CYP3A2 protein affects the metabolism of territrem B CTD PMID:15799453 CYP3A4 Human tert-butyl ethyl ether increases expression ISO Cyp3a2 (Rattus norvegicus) 6480464 ethyl tert-butyl ether results in increased expression of CYP3A2 protein CTD PMID:24090815 CYP3A4 Human testosterone multiple interactions EXP 6480464 [[CYP3A4 protein co-treated with NADP] results in increased oxidation of Testosterone] which results in increased more ... CTD PMID:11377097|PMID:11907170|PMID:12569440|PMID:15155549|PMID:15560889|PMID:16416302|PMID:16595712|PMID:17084830|PMID:19135037|PMID:19299527|PMID:19695866|PMID:20233841|PMID:20863320|PMID:21915887|PMID:21964418|PMID:22524704|PMID:22652334|PMID:23850985|PMID:23876819|PMID:25343516|PMID:26239802|PMID:27939613|PMID:28119166|PMID:28238727|PMID:29555536|PMID:30914192|PMID:31102695|PMID:32198085|PMID:34189909|PMID:35366062|PMID:35748891 CYP3A4 Human testosterone increases metabolic processing ISO Cyp3a2 (Rattus norvegicus) 6480464 CYP3A4 protein results in increased metabolism of Testosterone CTD PMID:31870919 CYP3A4 Human testosterone multiple interactions ISO Cyp3a2 (Rattus norvegicus) 6480464 [carbamylhydrazine results in increased activity of CYP3A2 protein] which results in increased abundance of Testosterone more ... CTD PMID:19788891|PMID:20487198|PMID:31870919 CYP3A4 Human testosterone increases hydroxylation ISO Cyp3a2 (Rattus norvegicus) 6480464 CYP3A2 protein results in increased hydroxylation of Testosterone CTD PMID:20487198 CYP3A4 Human testosterone increases hydroxylation EXP 6480464 CYP3A4 protein results in increased hydroxylation of Testosterone CTD PMID:12433797|PMID:15155549|PMID:15383492|PMID:15499178|PMID:15618748|PMID:15802389|PMID:15845858|PMID:15860655|PMID:16012074|PMID:16416302|PMID:16595712|PMID:19695866|PMID:20233841|PMID:20863320|PMID:22652334|PMID:23876819|PMID:26239802|PMID:26739624|PMID:31102695|PMID:34189909|PMID:35748891|PMID:9047321 CYP3A4 Human testosterone increases metabolic processing EXP 6480464 CYP3A4 mRNA results in increased metabolism of Testosterone; CYP3A4 protein results in increased metabolism of more ... CTD PMID:12401345|PMID:12569440|PMID:17084830|PMID:17418993|PMID:17565714|PMID:19135037|PMID:21915887|PMID:23850985|PMID:27939613|PMID:28119166|PMID:29555536|PMID:32198085|PMID:35366062 CYP3A4 Human testosterone increases hydrolysis EXP 6480464 CYP3A4 protein results in increased hydrolysis of Testosterone CTD PMID:11377097|PMID:19299527 CYP3A4 Human testosterone affects metabolic processing EXP 6480464 CYP3A4 protein affects the metabolism of Testosterone CTD PMID:12818727|PMID:15548719|PMID:15626586|PMID:15784650 CYP3A4 Human testosterone increases oxidation EXP 6480464 CYP3A4 protein results in increased oxidation of Testosterone CTD PMID:21964418 CYP3A4 Human testosterone affects hydroxylation EXP 6480464 CYP3A4 protein affects the hydroxylation of Testosterone CTD PMID:2271712 CYP3A4 Human testosterone enanthate increases expression ISO Cyp3a2 (Rattus norvegicus) 6480464 testosterone enanthate results in increased expression of CYP3A2 protein CTD PMID:8573203 CYP3A4 Human testosterone enanthate multiple interactions ISO Cyp3a2 (Rattus norvegicus) 6480464 Tamoxifen promotes the reaction [testosterone enanthate results in increased expression of CYP3A2 protein] CTD PMID:8573203 CYP3A4 Human tetrachloromethane increases metabolic processing ISO Cyp3a2 (Rattus norvegicus) 6480464 CYP3A2 protein results in increased metabolism of Carbon Tetrachloride CTD PMID:15988118 CYP3A4 Human tetrachloromethane decreases activity ISO Cyp3a2 (Rattus norvegicus) 6480464 Carbon Tetrachloride results in decreased activity of CYP3A2 protein CTD PMID:14706259 CYP3A4 Human tetrachloromethane increases expression ISO Cyp3a2 (Rattus norvegicus) 6480464 Carbon Tetrachloride results in increased expression of CYP3A2 mRNA CTD PMID:31150632 CYP3A4 Human tetrachloromethane decreases expression ISO Cyp3a2 (Rattus norvegicus) 6480464 Carbon Tetrachloride results in decreased expression of CYP3A2 mRNA; Carbon Tetrachloride results in decreased expression more ... CTD PMID:10445401|PMID:14706259|PMID:17606319|PMID:19224547|PMID:30723492 CYP3A4 Human tetracycline multiple interactions EXP 6480464 Tetracycline results in increased expression of and results in increased activity of CYP3A4 protein CTD PMID:18505790 CYP3A4 Human tetracycline decreases expression ISO Cyp3a2 (Rattus norvegicus) 6480464 Tetracycline results in decreased expression of CYP3A4 mRNA CTD PMID:19224547 CYP3A4 Human tetracycline increases expression EXP 6480464 Tetracycline results in increased expression of CYP3A4 mRNA CTD PMID:18505790 CYP3A4 Human tetramethrin increases metabolic processing EXP 6480464 CYP3A4 protein results in increased metabolism of tetramethrin CTD PMID:19249324 CYP3A4 Human thalidomide multiple interactions EXP 6480464 [CYP3A4 protein results in increased hydroxylation of Thalidomide] which results in increased chemical synthesis of more ... CTD PMID:20443640 CYP3A4 Human thalidomide increases metabolic processing EXP 6480464 CYP3A4 protein results in increased metabolism of Thalidomide CTD PMID:28745489 CYP3A4 Human thalidomide increases expression EXP 6480464 Thalidomide results in increased expression of CYP3A4 mRNA; Thalidomide results in increased expression of CYP3A4 more ... CTD PMID:24460184|PMID:28496040 CYP3A4 Human thalidomide increases hydroxylation EXP 6480464 CYP3A4 protein results in increased hydroxylation of Thalidomide CTD PMID:20443640 CYP3A4 Human thapsigargin multiple interactions EXP 6480464 NR1I2 protein inhibits the reaction [Thapsigargin inhibits the reaction [Rifampin results in increased expression of more ... CTD PMID:25616597 CYP3A4 Human theophylline multiple interactions EXP 6480464 [Ofloxacin co-treated with Clarithromycin] inhibits the reaction [CYP3A4 protein results in increased metabolism of Theophylline] CTD PMID:11408986 CYP3A4 Human theophylline decreases activity EXP 6480464 Theophylline results in decreased activity of CYP3A4 protein CTD PMID:39023798 CYP3A4 Human thiabendazole increases expression EXP 6480464 Thiabendazole results in increased expression of CYP3A4 mRNA CTD PMID:18570159 CYP3A4 Human thiacloprid multiple interactions EXP 6480464 [clothianidin co-treated with thiacloprid] results in increased expression of CYP3A4 protein; [enilconazole co-treated with thiacloprid more ... CTD PMID:32201337 CYP3A4 Human thiacloprid increases expression EXP 6480464 thiacloprid results in increased expression of CYP3A4 mRNA; thiacloprid results in increased expression of CYP3A4 more ... CTD PMID:32201337 CYP3A4 Human thiamethoxam multiple interactions EXP 6480464 [NADP co-treated with CYP3A4 protein] results in increased activity of thiamethoxam CTD PMID:16153789 CYP3A4 Human thiamine(1+) chloride multiple interactions ISO Cyp3a2 (Rattus norvegicus) 6480464 [Methionine co-treated with Thiamine co-treated with Niacinamide co-treated with alpha-Tocopherol co-treated with Zinc] inhibits the more ... CTD PMID:27919644 CYP3A4 Human thioacetamide decreases expression ISO Cyp3a2 (Rattus norvegicus) 6480464 Thioacetamide results in decreased expression of CYP3A11 mRNA; Thioacetamide results in decreased expression of CYP3A2 more ... CTD PMID:16297948|PMID:23411599|PMID:34492290 CYP3A4 Human thioacetamide multiple interactions ISO Cyp3a2 (Rattus norvegicus) 6480464 [Diethylnitrosamine co-treated with Thioacetamide] results in decreased expression of CYP3A11 mRNA CTD PMID:28943392 CYP3A4 Human Thiocoraline affects metabolic processing EXP 6480464 CYP3A4 protein affects the metabolism of thiocoraline CTD PMID:15122071 CYP3A4 Human thioridazine decreases activity EXP 6480464 Thioridazine results in decreased activity of CYP3A4 protein CTD PMID:15135088 CYP3A4 Human thioridazine multiple interactions EXP 6480464 [CYP1A2 protein co-treated with CYP2C9 protein co-treated with CYP3A4 protein co-treated with CYP2D6 protein co-treated more ... CTD PMID:23397584 CYP3A4 Human Thiotepa affects response to substance EXP 6480464 CYP3A4 protein affects the susceptibility to Thiotepa CTD PMID:19076156 CYP3A4 Human Thiotepa affects export EXP 6480464 CYP3A4 gene SNP affects the export of Thiotepa CTD PMID:19076156 CYP3A4 Human thiram increases expression EXP 6480464 Thiram results in increased expression of CYP3A4 mRNA CTD PMID:38568856 CYP3A4 Human thyroxine multiple interactions EXP 6480464 [Thyroxine results in increased activity of NR1I2 protein] which results in increased expression of CYP3A4 more ... CTD PMID:25455453 CYP3A4 Human ticlopidine multiple interactions EXP 6480464 CYP3A4 protein results in increased oxidation of and results in increased cleavage of Ticlopidine metabolite; more ... CTD PMID:19170597|PMID:19299527|PMID:22651985 CYP3A4 Human ticlopidine decreases activity EXP 6480464 Ticlopidine results in decreased activity of CYP3A4 protein CTD PMID:39023798 CYP3A4 Human ticlopidine increases response to substance EXP 6480464 CYP3A4 protein results in increased susceptibility to Ticlopidine CTD PMID:22651985 CYP3A4 Human ticlopidine increases degradation EXP 6480464 CYP3A4 protein results in increased degradation of Ticlopidine CTD PMID:22651985 CYP3A4 Human tinidazole affects metabolic processing EXP 6480464 CYP3A4 protein affects the metabolism of Tinidazole CTD PMID:12920490 CYP3A4 Human tiratricol multiple interactions EXP 6480464 [3,3',5-triiodothyroacetic acid results in increased activity of NR1I2 protein] which results in increased expression of more ... CTD PMID:25455453 CYP3A4 Human tofacitinib increases oxidation EXP 6480464 CYP3A4 protein results in increased oxidation of tofacitinib metabolite CTD PMID:27117606 CYP3A4 Human tofacitinib increases metabolic processing EXP 6480464 CYP3A4 protein results in increased metabolism of tofacitinib CTD PMID:31414593 CYP3A4 Human tolcapone increases response to substance EXP 6480464 CYP3A4 protein results in increased susceptibility to tolcapone CTD PMID:21540358 CYP3A4 Human toluene increases expression ISO Cyp3a2 (Rattus norvegicus) 6480464 Toluene results in increased expression of CYP3A2 mRNA CTD PMID:17209515 CYP3A4 Human toluene multiple interactions ISO Cyp3a2 (Rattus norvegicus) 6480464 1-Butanol promotes the reaction [Toluene results in increased expression of CYP3A2 mRNA] CTD PMID:17209515 CYP3A4 Human tolylfluanid multiple interactions EXP 6480464 [Omite co-treated with Diphenylamine co-treated with phosalone co-treated with Captan co-treated with N-dichlorofluoromethylthio-N',N'-dimethyl-N-p-tolylsulfamide] results in more ... CTD PMID:25028461 CYP3A4 Human topiramate increases activity EXP 6480464 topiramate results in increased activity of CYP3A4 protein CTD PMID:14636322 CYP3A4 Human topiramate increases expression EXP 6480464 topiramate results in increased expression of CYP3A4 mRNA; topiramate results in increased expression of CYP3A4 more ... CTD PMID:14636322 CYP3A4 Human trabectedin decreases activity ISO Cyp3a2 (Rattus norvegicus) 6480464 Trabectedin results in decreased activity of CYP3A2 protein CTD PMID:12154027 CYP3A4 Human trabectedin decreases expression ISO Cyp3a2 (Rattus norvegicus) 6480464 Trabectedin results in decreased expression of CYP3A11 mRNA CTD PMID:12154027 CYP3A4 Human tranexamic acid decreases activity EXP 6480464 Tranexamic Acid results in decreased activity of CYP3A4 protein CTD PMID:39023798 CYP3A4 Human trans-1,2-dichloroethene decreases expression ISO Cyp3a2 (Rattus norvegicus) 6480464 1,2-dichloroethylene results in decreased expression of CYP3A2 protein CTD PMID:9493318 CYP3A4 Human trans-1,2-dichloroethene decreases activity ISO Cyp3a2 (Rattus norvegicus) 6480464 1,2-dichloroethylene results in decreased activity of CYP3A2 protein CTD PMID:9493318 CYP3A4 Human trans-cinnamic acid decreases activity EXP 6480464 cinnamic acid analog results in decreased activity of CYP3A4 protein CTD PMID:15072549 CYP3A4 Human transfluthrin multiple interactions ISO Cyp3a2 (Rattus norvegicus) 6480464 transfluthrin results in increased expression of and results in increased activity of CYP3A2 protein CTD PMID:22080754 CYP3A4 Human tranylcypromine multiple interactions EXP 6480464 Tranylcypromine affects the reaction [[NADP co-treated with CYP1A2 protein co-treated with CYP2C8 protein co-treated with more ... CTD PMID:24120545 CYP3A4 Human trazodone multiple interactions EXP 6480464 Trazodone inhibits the reaction [CYP3A4 protein results in increased oxidation of and results in increased more ... CTD PMID:12584149 CYP3A4 Human trazodone multiple interactions ISO Cyp3a2 (Rattus norvegicus) 6480464 [SOD2 co-treated with CYP3A4] affects the susceptibility to Trazodone CTD PMID:19501153 CYP3A4 Human triadimefon multiple interactions EXP 6480464 [N-(2,3-dichloro-4-hydroxyphenyl)-1-methylcyclohexanecarboxamide co-treated with pyrimethanil co-treated with Fenitrothion co-treated with triadimefon co-treated with quinoxyfen co-treated with more ... CTD PMID:25028461 CYP3A4 Human triadimefon increases expression ISO Cyp3a2 (Rattus norvegicus) 6480464 triadimefon results in increased expression of CYP3A2 mRNA; triadimefon results in increased expression of CYP3A2 more ... CTD PMID:17484520 CYP3A4 Human triazolam affects metabolic processing EXP 6480464 CYP3A4 protein affects the metabolism of Triazolam CTD PMID:15286053|PMID:16042670 CYP3A4 Human triazolam multiple interactions EXP 6480464 [Ketoconazole results in decreased activity of CYP3A4 protein] which results in decreased metabolism of Triazolam; more ... CTD PMID:10952769|PMID:15863898|PMID:19299527|PMID:22447115 CYP3A4 Human Tributyl citrate multiple interactions EXP 6480464 tributyl citrate promotes the reaction [NR1I2 protein results in increased expression of CYP3A4 mRNA] CTD PMID:21742782 CYP3A4 Human trichloroethene increases expression ISO Cyp3a2 (Rattus norvegicus) 6480464 Trichloroethylene results in increased expression of CYP3A2 mRNA CTD PMID:33387578 CYP3A4 Human trichostatin A multiple interactions EXP 6480464 trichostatin A affects the reaction [Dimethyl Sulfoxide promotes the reaction [Rifampin results in increased expression more ... CTD PMID:31877331 CYP3A4 Human triclosan increases activity EXP 6480464 Triclosan results in increased activity of CYP3A4 protein CTD PMID:23899473 CYP3A4 Human triclosan affects expression EXP 6480464 Triclosan affects the expression of CYP3A4 mRNA CTD PMID:34681664 CYP3A4 Human triclosan increases expression ISO Cyp3a2 (Rattus norvegicus) 6480464 Triclosan results in increased expression of CYP3A11 mRNA; Triclosan results in increased expression of CYP3A2 more ... CTD PMID:22659317|PMID:34460931 CYP3A4 Human triclosan increases expression EXP 6480464 Triclosan results in increased expression of CYP3A4 mRNA CTD PMID:29849464 CYP3A4 Human triflumuron multiple interactions EXP 6480464 Troleandomycin inhibits the reaction [CYP3A4 protein results in increased metabolism of triflumuron] CTD PMID:31082524 CYP3A4 Human triflumuron increases metabolic processing EXP 6480464 CYP3A4 protein results in increased metabolism of triflumuron CTD PMID:31082524 CYP3A4 Human trifluridine multiple interactions EXP 6480464 [Trifluridine results in increased activity of NR1I2 protein] which results in increased expression of CYP3A4 more ... CTD PMID:25455453 CYP3A4 Human Triptolide decreases expression ISO Cyp3a2 (Rattus norvegicus) 6480464 triptolide results in decreased expression of CYP3A4 protein CTD PMID:33600922 CYP3A4 Human Triptolide affects metabolic processing ISO Cyp3a2 (Rattus norvegicus) 6480464 CYP3A2 affects the metabolism of triptolide CTD PMID:20223271 CYP3A4 Human Tris(1-aziridinyl)phosphine oxide affects export EXP 6480464 CYP3A4 gene SNP affects the export of Triethylenephosphoramide CTD PMID:19076156 CYP3A4 Human Tris(1-aziridinyl)phosphine oxide affects response to substance EXP 6480464 CYP3A4 protein affects the susceptibility to Triethylenephosphoramide CTD PMID:19076156 CYP3A4 Human tris(2,3-dibromopropyl) phosphate affects metabolic processing EXP 6480464 CYP3A4 protein affects the metabolism of tris(2,3-dibromopropyl)phosphate CTD PMID:2271712|PMID:2655891 CYP3A4 Human tris(2-butoxyethyl) phosphate multiple interactions EXP 6480464 [CYP3A4 protein co-treated with POR protein] results in increased susceptibility to tris(2-butoxyethyl) phosphate CTD PMID:38823534 CYP3A4 Human troglitazone increases response to substance EXP 6480464 CYP3A4 protein results in increased susceptibility to troglitazone CTD PMID:26706816|PMID:28762043 CYP3A4 Human troglitazone multiple interactions ISO Cyp3a2 (Rattus norvegicus) 6480464 [SOD2 co-treated with CYP3A4] affects the susceptibility to Troglitazone CTD PMID:19501153 CYP3A4 Human troglitazone increases expression EXP 6480464 Troglitazone results in increased expression of CYP3A4 mRNA; Troglitazone results in increased expression of CYP3A4 more ... CTD PMID:10752642|PMID:12505310|PMID:12642470|PMID:15466163|PMID:16837568|PMID:17954527|PMID:19022234|PMID:22524704|PMID:25572481|PMID:27551952 CYP3A4 Human troglitazone decreases activity EXP 6480464 troglitazone results in decreased activity of CYP3A4 protein CTD PMID:12642470|PMID:15860655 CYP3A4 Human troglitazone increases metabolic processing EXP 6480464 CYP3A4 protein results in increased metabolism of troglitazone CTD PMID:19356091 CYP3A4 Human troglitazone increases activity EXP 6480464 troglitazone results in increased activity of CYP3A4 protein CTD PMID:10752642 CYP3A4 Human troglitazone multiple interactions EXP 6480464 [CYP1A2 protein co-treated with CYP2C9 protein co-treated with CYP3A4 protein co-treated with CYP2D6 protein co-treated more ... CTD PMID:12642470|PMID:17041008|PMID:22524704|PMID:23397584 CYP3A4 Human troleandomycin multiple interactions EXP 6480464 [Troleandomycin results in decreased activity of CYP3A4 protein] which results in decreased chemical synthesis of more ... CTD PMID:11752104|PMID:12695342|PMID:14652237|PMID:15764719|PMID:16049126|PMID:16207822|PMID:16416302|PMID:1740010|PMID:18505790|PMID:19299527|PMID:19697924|PMID:20863320|PMID:31082524|PMID:9600717 CYP3A4 Human troleandomycin increases expression EXP 6480464 Troleandomycin results in increased expression of CYP3A4 mRNA CTD PMID:18505790 CYP3A4 Human troleandomycin increases activity EXP 6480464 Troleandomycin results in increased activity of CYP3A4 protein CTD PMID:9512926 CYP3A4 Human troleandomycin decreases activity EXP 6480464 Troleandomycin results in decreased activity of CYP3A4 protein CTD PMID:11409940|PMID:11752104|PMID:12467917|PMID:15005856|PMID:15557344|PMID:15860655|PMID:16049126|PMID:16416302|PMID:2271712 CYP3A4 Human uranium atom increases expression ISO Cyp3a2 (Rattus norvegicus) 6480464 Uranium results in increased expression of CYP3A2 mRNA CTD PMID:16039771 CYP3A4 Human uranium atom multiple interactions ISO Cyp3a2 (Rattus norvegicus) 6480464 [Acetaminophen co-treated with Uranium analog] results in decreased expression of CYP3A2 mRNA CTD PMID:17126469 CYP3A4 Human ursodeoxycholic acid affects metabolic processing EXP 6480464 CYP3A4 protein affects the metabolism of Ursodeoxycholic Acid CTD PMID:15708356 CYP3A4 Human ursodeoxycholic acid increases hydroxylation EXP 6480464 CYP3A4 protein results in increased hydroxylation of Ursodeoxycholic Acid CTD PMID:36473578 CYP3A4 Human ursodeoxycholic acid increases expression ISO Cyp3a2 (Rattus norvegicus) 6480464 Ursodeoxycholic Acid results in increased expression of CYP3A2 mRNA CTD PMID:19255942 CYP3A4 Human ursodeoxycholic acid multiple interactions ISO Cyp3a2 (Rattus norvegicus) 6480464 [CYP3A23-3A1 gene mutant form co-treated with CYP3A2 gene mutant form] results in increased abundance of more ... CTD PMID:10453939|PMID:32198087|PMID:34461081 CYP3A4 Human ursodeoxycholic acid multiple interactions EXP 6480464 [CYP3A4 protein results in increased metabolism of Lithocholic Acid] which results in increased abundance of more ... CTD PMID:19487251 CYP3A4 Human ursodeoxycholic acid increases expression EXP 6480464 Ursodeoxycholic Acid results in increased expression of CYP3A4 mRNA CTD PMID:16678547 CYP3A4 Human valproic acid decreases expression EXP 6480464 Valproic Acid results in decreased expression of CYP3A4 mRNA CTD PMID:29154799|PMID:29501571 CYP3A4 Human valproic acid decreases activity EXP 6480464 Valproic Acid results in decreased activity of CYP3A4 protein CTD PMID:39023798 CYP3A4 Human valproic acid increases expression ISO Cyp3a2 (Rattus norvegicus) 6480464 Valproic Acid results in increased expression of CYP3A2 mRNA CTD PMID:35594946 CYP3A4 Human valproic acid increases expression EXP 6480464 Valproic Acid results in increased expression of CYP3A4 mRNA CTD PMID:25084468|PMID:30008028 CYP3A4 Human vancomycin multiple interactions ISO Cyp3a2 (Rattus norvegicus) 6480464 [Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in more ... CTD PMID:30545405 CYP3A4 Human vandetanib affects metabolic processing EXP 6480464 CYP3A4 protein alternative form affects the metabolism of vandetanib CTD PMID:34648813 CYP3A4 Human vandetanib multiple interactions EXP 6480464 Ketoconazole affects the reaction [CYP3A4 protein alternative form affects the metabolism of vandetanib] CTD PMID:34648813 CYP3A4 Human vanoxerine dihydrochloride decreases degradation EXP 6480464 CYP3A4 protein results in decreased degradation of vanoxerine CTD PMID:11502731 CYP3A4 Human vanoxerine dihydrochloride multiple interactions EXP 6480464 [Ketoconazole results in decreased activity of CYP3A4 protein] which results in decreased degradation of vanoxerine; more ... CTD PMID:11502731 CYP3A4 Human veliparib increases metabolic processing EXP 6480464 CYP3A4 protein results in increased metabolism of veliparib CTD PMID:21436403 CYP3A4 Human verapamil multiple interactions EXP 6480464 [Verapamil results in increased activity of NR1I2 protein] which results in increased expression of CYP3A4 more ... CTD PMID:16013069|PMID:19299527|PMID:21915887|PMID:25455453 CYP3A4 Human verapamil affects metabolic processing EXP 6480464 CYP3A4 protein affects the metabolism of Verapamil CTD PMID:15286053|PMID:15692829|PMID:16013069 CYP3A4 Human verapamil decreases activity EXP 6480464 Verapamil results in decreased activity of CYP3A4 protein CTD PMID:15689501|PMID:15860655|PMID:21915887|PMID:39023798 CYP3A4 Human vinclozolin affects chemical synthesis ISO Cyp3a2 (Rattus norvegicus) 6480464 CYP3A2 protein affects the chemical synthesis of vinclozolin metabolite CTD PMID:22002493 CYP3A4 Human vinclozolin increases expression ISO Cyp3a2 (Rattus norvegicus) 6480464 vinclozolin results in increased expression of CYP3A2 protein CTD PMID:25929820 CYP3A4 Human vincristine increases metabolic processing EXP 6480464 CYP3A4 protein results in increased metabolism of Vincristine CTD PMID:19346885 CYP3A4 Human vitamin D increases expression EXP 6480464 Vitamin D analog results in increased expression of CYP3A4 mRNA CTD PMID:17965521 CYP3A4 Human vitamin E decreases expression EXP 6480464 Vitamin E results in decreased expression of CYP3A4 mRNA CTD PMID:19244175 CYP3A4 Human voriconazole decreases activity EXP 6480464 Voriconazole results in decreased activity of CYP3A4 protein CTD PMID:15328084|PMID:15914520 CYP3A4 Human voriconazole affects metabolic processing EXP 6480464 CYP3A4 protein affects the metabolism of Voriconazole CTD PMID:15914520 CYP3A4 Human VX nerve agent increases expression EXP 6480464 VX-agent results in increased expression of CYP3A4 mRNA CTD PMID:39228234 CYP3A4 Human warfarin decreases activity EXP 6480464 Warfarin results in decreased activity of CYP3A4 protein CTD PMID:18420780 CYP3A4 Human warfarin affects response to substance ISO Cyp3a2 (Rattus norvegicus) 6480464 CYP3A2 mRNA affects the susceptibility to Warfarin CTD PMID:11531004 CYP3A4 Human warfarin increases expression ISO Cyp3a2 (Rattus norvegicus) 6480464 Warfarin results in increased expression of CYP3A2 mRNA CTD PMID:11531004 CYP3A4 Human warfarin decreases expression EXP 6480464 Warfarin results in decreased expression of CYP3A4 mRNA CTD PMID:30963258 CYP3A4 Human warfarin affects response to substance EXP 6480464 CYP3A4 SNP affects the susceptibility to Warfarin CTD PMID:28079798 CYP3A4 Human warfarin multiple interactions EXP 6480464 [Warfarin binds to and results in increased activity of NR1I2 protein] which results in increased more ... CTD PMID:20735727 CYP3A4 Human warfarin affects metabolic processing EXP 6480464 CYP3A4 protein affects the metabolism of Warfarin CTD PMID:15280511|PMID:16035367|PMID:2271712 CYP3A4 Human warfarin affects hydroxylation EXP 6480464 CYP3A4 protein affects the hydroxylation of Warfarin CTD PMID:2271712 CYP3A4 Human xanthenes decreases activity EXP 6480464 Xanthenes results in decreased activity of CYP3A4 protein CTD PMID:18686201|PMID:20041016 CYP3A4 Human yohimbine affects metabolic processing EXP 6480464 CYP3A4 gene polymorphism affects the metabolism of Yohimbine CTD PMID:15289791 CYP3A4 Human yohimbine multiple interactions EXP 6480464 Yohimbine analog inhibits the reaction [Calcitriol results in increased expression of CYP3A4 protein] CTD PMID:29782822 CYP3A4 Human zafirlukast multiple interactions EXP 6480464 zafirlukast inhibits the reaction [CYP3A4 protein results in increased metabolism of Midazolam] CTD PMID:15370959 CYP3A4 Human zafirlukast decreases activity EXP 6480464 zafirlukast metabolite results in decreased activity of CYP3A4 protein; zafirlukast results in decreased activity of more ... CTD PMID:15370959|PMID:16167835|PMID:39023798 CYP3A4 Human zafirlukast increases metabolic processing EXP 6480464 CYP3A4 protein results in increased metabolism of zafirlukast CTD PMID:16167835 CYP3A4 Human zearalenone increases expression EXP 6480464 Zearalenone results in increased expression of CYP3A4 mRNA; Zearalenone results in increased expression of CYP3A4 more ... CTD PMID:15569515|PMID:28865950 CYP3A4 Human zearalenone decreases activity EXP 6480464 Zearalenone results in decreased activity of CYP3A4 protein CTD PMID:38341109 CYP3A4 Human zearalenone decreases abundance EXP 6480464 CYP3A4 protein results in decreased abundance of Zearalenone CTD PMID:38341109 CYP3A4 Human zearalenone increases expression ISO Cyp3a2 (Rattus norvegicus) 6480464 Zearalenone results in increased expression of CYP3A2 mRNA CTD PMID:20607812 CYP3A4 Human zearalenone multiple interactions EXP 6480464 [deoxynivalenol co-treated with Zearalenone] affects the expression of CYP3A4 mRNA; [deoxynivalenol co-treated with Zearalenone] results more ... CTD PMID:28865950|PMID:28935499|PMID:36893891 CYP3A4 Human zidovudine multiple interactions ISO Cyp3a2 (Rattus norvegicus) 6480464 [SOD2 co-treated with CYP3A4] affects the susceptibility to Zidovudine CTD PMID:19501153 CYP3A4 Human zileuton decreases activity EXP 6480464 zileuton results in decreased activity of CYP3A4 protein CTD PMID:15482930 CYP3A4 Human zinc atom multiple interactions ISO Cyp3a2 (Rattus norvegicus) 6480464 [Methionine co-treated with Thiamine co-treated with Niacinamide co-treated with alpha-Tocopherol co-treated with Zinc] inhibits the more ... CTD PMID:27919644 CYP3A4 Human zinc atom decreases expression ISO Cyp3a2 (Rattus norvegicus) 6480464 Zinc deficiency results in decreased expression of CYP3A2 mRNA CTD PMID:11705462 CYP3A4 Human zinc(0) multiple interactions ISO Cyp3a2 (Rattus norvegicus) 6480464 [Methionine co-treated with Thiamine co-treated with Niacinamide co-treated with alpha-Tocopherol co-treated with Zinc] inhibits the more ... CTD PMID:27919644 CYP3A4 Human zinc(0) decreases expression ISO Cyp3a2 (Rattus norvegicus) 6480464 Zinc deficiency results in decreased expression of CYP3A2 mRNA CTD PMID:11705462 CYP3A4 Human zolpidem increases metabolic processing EXP 6480464 CYP3A4 protein results in increased metabolism of zolpidem CTD PMID:16449812